Best Dividend Aristocrats For July 2025
- Dividend Aristocrats have underperformed the S&P 500 in 2025, with NOBL up 1.77% versus SPY's 5.55% year-to-date gain. Dividend growth remains healthy, with 44 out of 69 Aristocrats already raising payouts in 2025 and an average growth rate of 4.86%. I identified 21 Aristocrats as both potentially undervalued and offering a projected long-term annualized return of at least 10%.
- 06/29/2025
|
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 06/27/2025
|
Cardinal Health (CAH) Laps the Stock Market: Here's Why
- In the closing of the recent trading day, Cardinal Health (CAH) stood at $165.61, denoting a +1.14% move from the preceding trading day.
- 06/26/2025
|
Want Decades of Passive Income? 5 Stocks to Buy Now and Hold Forever
- The magic of dividends is that you don't need to do anything to earn them aside from holding the stocks that pay them. Someone who accumulates enough dividend stocks could live off their portfolio's passive income stream and never have to work another day in their life.
- 06/26/2025
|
Wall Street Bulls Look Optimistic About Cardinal (CAH): Should You Buy?
- Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
- 06/19/2025
|
Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue?
- Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 06/19/2025
|
Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy?
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 06/16/2025
|
Cardinal Health (CAH) is a Top-Ranked Momentum Stock: Should You Buy?
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 06/13/2025
|
CAH CFO on Pharmaceutical Distributor's Outlook
- Aaron Alt, CFO at Cardinal Health (CAH), joins Diane King Hall at the NYSE set to discuss the company's financial outlook. He describes the drugmaker's share buyback plans and recent FY25 guidance raise.
- 06/12/2025
|
Cardinal Health raises annual profit target
- Drug distributor Cardinal Health raised its annual adjusted profit forecast on Thursday, banking on demand for costly specialty medicines and branded drugs at its pharmaceuticals unit.
- 06/12/2025
|
Cardinal Health Details Momentum and Updated Long-Term Value Creation Plans at Investor Day
- Key announcements: Raising FY25 non-GAAP diluted EPS guidance to $8.15 to $8.20 1 Establishing preliminary FY26 non-GAAP diluted EPS guidance of $9.10 to $9.30 (13% growth at the mid-points)2 Confirming long-term target of 12% to 14% non-GAAP diluted EPS CAGR for FY26 to FY283 Raising long-term target for Pharmaceutical and Specialty Solutions profit to 5% to 7% normalized growth3,4 Raising long-term target for Other profit to ~10% normalized growth3,4,5 Updating GMPD long-term target to $50M+ of profit growth per year after FY26 Expecting at least $10B in total adjusted free cash flow over next three years Raising baseline share repurchase plans to at least $750M per year Company reiterating strategic priorities and providing updates across its businesses DUBLIN, Ohio , June 12, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today will host an Investor Day beginning at 9:00 a.m. ET, where management will detail its growth strategies to maximize the company's potential for all stakeholders.
- 06/12/2025
|
Cardinal Health Analyst Flags Fading Scale Gap, Sees Rising Edge in Specialty Growth
- BofA Securities analyst Allen Lutz reiterated the Buy rating on Cardinal Health, Inc. CAH, raising the price forecast from $165 to $170.
- 06/11/2025
|
Cramer's Stop Trading: Cardinal Health
- Jim Cramer breaks down why he's keeping an eye on shares of Cardinal Health.
- 06/10/2025
|
Cardinal Health launches new medical device for the continuous monitoring of three essential vital signs in one system
- Kendall DL™ Multi System simplifies patient monitoring, drives efficiencies for providers DUBLIN, Ohio , June 4, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the U.S. launch of its multi-parameter, single-patient use monitoring cable and lead wire system that enables the continuous monitoring of cardiac activity, blood oxygen level and temperature with one point of connection. The new Kendall DL™ Multi System is designed to travel with the patient from admission to discharge for smooth transport.
- 06/04/2025
|
Forget UnitedHealth. Cardinal Health Is the Best Healthcare Stock to Buy Right Now
- Retirement can be daunting, but it doesn't need to be.
- 05/29/2025
|
Best Dividend Aristocrats For June 2025
- Dividend Aristocrats have slightly outperformed the S&P 500 year-to-date, despite underperforming in April and May. Dividend growth remains robust, with 41 of 69 Aristocrats announcing increases in 2025 and the average growth rate at 4.75%. 22 Aristocrats appear both undervalued and offer a projected long-term annualized return of at least 10%, based on dividend yield theory and earnings growth.
- 05/27/2025
|
MCK vs. CAH: Which Drug Distribution Giant Has the Healthier Outlook?
- Both McKesson and Cardinal Health dominate drug distribution, but which stock offers better growth and stability in 2025? Here we discuss which company has better long-term potential.
- 05/27/2025
|
Doubt the Market? 3 Stocks to Rideout Fear, Uncertainty and Doubt
- Lately, the market has been delivering more plot twists to investors than a season of Severance. Solid tech earnings come in tandem with pulled guidance from public-facing companies like airlines and retailers.
- 05/26/2025
|
4 Dividend Aristocrats Are Absolutely Crushing the S&P 500 in 2025
- Investors love dividend stocks because they provide dependable passive income streams and an excellent opportunity for solid total return.
- 05/23/2025
|
Cardinal (CAH) Upgraded to Buy: Here's Why
- Cardinal (CAH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- 05/22/2025
|
Should Value Investors Buy Cardinal Health (CAH) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 05/22/2025
|
3 Dental Supplies Stocks Likely to Gain From US-China Trade Deal
- Here we discuss three stocks from the Dental Supplies industry that are likely to earn wealth for investors. These are CAH, LH and ALGN.
- 05/13/2025
|
63 Top Dividend Growth Stocks For May 2025
- I present 63 high-quality dividend growth stocks for investment for May 2025, categorized by yield: High (4%+), Medium (2.5-3.9%), and Low (
- 05/08/2025
|
Cardinal Health releases new report on the cell and gene therapy industry
- Analysis charts the emergence and future of advanced therapies DUBLIN, Ohio , May 7, 2025 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH) released its 2025 Advanced Therapies Report: Revolutionizing patient care – the promise and potential of cell and gene therapies, providing insights into the evolving landscape of cell and gene therapies (CGTs). This inaugural report is based on a comprehensive survey of more than 100 healthcare providers as well as interviews with subject matter experts and a patient who received CAR T-cell therapy, all of whom provide valuable insights into the state of the CGT industry.
- 05/07/2025
|
Cardinal Health Board of Directors Approves Quarterly Dividend
- DUBLIN, Ohio , May 5, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to its quarterly dividend, to $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on July 15, 2025, to shareholders of record at the close of business on July 1, 2025.
- 05/05/2025
|
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 05/05/2025
|
Cardinal Health, Northrop Grumman Among 7 Companies To Announce Dividend Increases In First Half Of May
- This is my latest article where I provide predictions of upcoming dividend increases from companies with long-term dividend growth histories. Industrial engineering company Parker-Hannifin announced its latest payout boost, becoming one of less than a handful of companies with a 70-year dividend growth streak. Investors can expect modest increases from several companies in the first half of May, including a 10% increase from defense company Northrop Grumman.
- 05/04/2025
|
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 05/02/2025
|
Burn Care Market worth $3.35 billion by 2030 with 5.6% CAGR | MarketsandMarkets™
- DELRAY BEACH, Fla., May 2, 2025 /PRNewswire/ -- The global Burn Care Market, valued at US$2.46 billion in 2024, is forecasted to grow at a robust CAGR of 5.6%, reaching US$2.55 billion in 2025 and an impressive US$3.35 billion by 2030. This market is experiencing consistent growth due to several key factors. The number of burn injuries is rising due to factors such as industrial accidents, domestic fires, and other hazards. Furthermore, advancements in treatment technologies and increased awareness and education about burn care contribute to this trend. Additionally, supportive government initiatives play a significant role in market development. The demand for effective burn treatments is rising as the global population ages. Older individuals are more susceptible to slow-healing wounds and burn complications, which, in turn, increases the need for advanced burn care products. Moreover, technological advancements in burn treatment—including innovative burn dressings, biologics, and advanced burn wound assessment devices—enhance treatment efficiency and effectiveness. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=247121470 Browse in-depth TOC on "Burn Care Market" 345 - Tables 45 - Figures 302 - Pages By Based on products, the burn care market is categorized into five segments: advanced burn dressings, burn wound therapy devices, biologics, traditional burn care products, and other burn care products. Among these, the biologics segment is expected to register the highest CAGR during the forecast period. This growth is driven by the rising demand for advanced and effective treatment options for deep and complex burns. Biologics provide targeted healing, minimize long-term complications, and promote tissue regeneration, making them particularly suitable for treating severe burns. The increasing acceptance of these products among healthcare professionals and ongoing innovations in regenerative medicine are contributing to the strong and sustained growth of the biologics segment. By Based on burn degree, the burn care market is divided into first-degree burns (minor burns), second-degree burns (partial-thickness burns), and third-degree burns (full-thickness burns). Of these, the second-degree burns segment accounted for the largest market share of the burn care market in 2024. This is largely because partial-thickness burns occur more frequently. These burns tend to destroy the epidermis and dermis; as such, they require the application of advanced burn care products, which drives consistent demand in this segment. By geography, the market for burn care is divided into five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the burn care market in 2024 with the largest market share. This is primarily because countries like the US and Canada have well-developed healthcare facilities, supporting widespread access to advanced burn care products and treatments. The region also experiences a high rate of burn injuries. The availability of key players and constant investment in research & development further consolidate North America's position in the burn care market. Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=247121470 The major players operating in this market are Smith+Nephew (UK), Mölnlycke Health Care AB (Sweden), Cardinal Health Inc. (US), Integra LifeSciences Holdings Corporation (US), ConvaTec Group Plc (UK), Coloplast Group (Denmark), Solventum Corporation (US), Essity Aktiebolag (Sweden), PAUL HARTMANN AG (Germany), and Organogenesis Holdings Inc. (US). SMITH+NEPHEW (UK) Smith+Nephew is distinguished by its advanced wound care solutions and robust research and development capabilities, enabling it to provide effective burn care products. Mölnlycke Health Care AB has solidified its market position through strategic partnerships. Cardinal Health Inc. utilizes its extensive distribution network and diverse product line to reach a wide range of healthcare facilities, thereby increasing its share in the burn care market. Integra LifeSciences Holdings Corporation is recognized for its broad range of biologics that offer crucial support for severe burns. ConvaTec Group Plc has strengthened its market presence through global expansion and strategic acquisitions. MOLNLYCKE HEALTH CARE AB (SWEDEN): Mölnlycke Health Care AB also boasts a comprehensive product portfolio in the advanced wound care market. The company's leading position in this sector is largely due to its robust global sales and distribution network, which allows it to effectively market its products in various countries. Mölnlycke primarily utilizes inorganic strategies, such as partnerships, to maintain its market position. For example, in May 2024, the company formed a new partnership with the Phoenix Society, a burn survivor organization in the US. Through this collaboration, Mölnlycke will support the Phoenix Society's initiatives with its extensive range of burn care solutions For more information, Inquire Now! Related Reports: Wound Care Biologics Market Advanced Wound Care Market Point of Care Diagnostics Market Wound Care Market Point of Care Molecular Diagnostics Market Get access to the latest updates on Burn Care Companies and Burn Care Market Size About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook . Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress Ave.Suite 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: [email protected]Visit Our Website: https://www.marketsandmarkets.com/ Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
- 05/02/2025
|
Cardinal Health Lifts FY25 EPS Outlook, Sees Growth Despite Tariff Risks
- Cardinal Health Inc. CAH on Thursday reported third-quarter 2025 adjusted EPS of $2.35, up 13% year over year, beating the consensus of $2.17.
- 05/02/2025
|
Cardinal Health, Inc. (CAH) Q3 2025 Earnings Call Transcript
- Cardinal Health, Inc. (NYSE:CAH ) Q3 2025 Earnings Conference Call May 1, 2025 8:30 AM ET Company Participants Matt Sims - Vice President, Investor Relations Jason Hollar - Chief Executive Officer Aaron Alt - Chief Financial Officer Conference Call Participants Lisa Gill - JPMorgan Allen Lutz - Bank of America Joanna Dynak - Evercore Eric Percher - Nephron Michael Cherny - Leerink Partners Kevin Caliendo - UBS George Hill - Deutsche Bank Eric Coldwell - Baird Erin Wright - Morgan Stanley Daniel Grosslight - Citi Charles Rhyee - TD Cowen Steve Baxter - Wells Fargo Brian Tanquilut - Jefferies Steven Valiquette - Mizuho Operator Hello, and welcome to the Third Quarter Fiscal Year 2025 Cardinal Health Incorporated Earnings Conference Call. My name is George, and I'll be the coordinator for today's event.
- 05/01/2025
|
CAH Q3 Earnings Beat Estimates, '25 EPS View Raised, Stock Gains
- Cardinal Health's third-quarter fiscal 2025 results benefit from solid Medical and Other segment revenue growth. However, OptumRx contract expiry hurts Pharmaceutical segment sales.
- 05/01/2025
|
Cardinal (CAH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
- Although the revenue and EPS for Cardinal (CAH) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 05/01/2025
|
Cardinal Health (CAH) Beats Q3 Earnings Estimates
- Cardinal Health (CAH) came out with quarterly earnings of $2.35 per share, beating the Zacks Consensus Estimate of $2.15 per share. This compares to earnings of $2.08 per share a year ago.
- 05/01/2025
|
Cardinal Health lifts full-year profit forecast again on specialty medicine sales
- Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast for the fourth time, betting on strong demand for costly specialty medicines and branded drugs.
- 05/01/2025
|
Cardinal Health Reports Third Quarter Fiscal Year 2025 Results and Raises Fiscal Year 2025 Outlook
- Revenue was flat at $54.9 billion; revenue increased 19% excluding the impact of the previously communicated customer contract expiration GAAP 1 operating earnings were $730 million; GAAP diluted EPS was $2.10 Non-GAAP operating earnings increased 21% to $807 million, driven by segment profit growth across all of the company's operating segments; non-GAAP diluted EPS increased 13% to $2.35 Fiscal year 2025 non-GAAP EPS guidance2 raised and narrowed to $8.05 to $8.15, from $7.85 to $8.00 GI Alliance announces expansion into urology specialty therapeutic area DUBLIN, Ohio , May 1, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported third quarter fiscal year 2025 revenues of $54.9 billion, flat to the third quarter of fiscal year 2024. Third quarter revenue increased 19% excluding the impact of the previously communicated customer contract expiration.
- 05/01/2025
|
MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK
- This earnings season so far has reflected a continued recovery in sales for companies within the Medical sector. Earnings have increased year over year, albeit at a slower pace than revenues.
- 04/30/2025
|
Best Dividend Aristocrats For May 2025
- Despite a strong start, the Dividend Aristocrats are underperforming the S&P 500 in April, with NOBL down 4.88% and SPY down 1.53%. The best-performing Dividend Aristocrats YTD include Consolidated Edison (+25.65%), Cardinal Health (+17.82%), and Coca-Cola (+16.18%). 33 out of 69 Dividend Aristocrats have announced dividend increases in 2025, with an average growth rate of 4.33%.
- 04/29/2025
|
Can Sustained Product Demand Drive CAH Stock Before Q3 Earnings?
- The continued solid uptake of Cardinal Health's products is expected to have driven fiscal third-quarter revenues despite an uncertain macroeconomic environment.
- 04/29/2025
|
Cardinal (CAH) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
- Evaluate the expected performance of Cardinal (CAH) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
- 04/28/2025
|
Cardinal Health (CAH) Reports Next Week: Wall Street Expects Earnings Growth
- Cardinal (CAH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/24/2025
|
Cardinal Health (CAH) Rises Yet Lags Behind Market: Some Facts Worth Knowing
- Cardinal Health (CAH) closed the most recent trading day at $133.69, moving +1.92% from the previous trading session.
- 04/22/2025
|
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
- The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
- 04/22/2025
|
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
- Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
- 04/21/2025
|
Cardinal Health (CAH) Ascends While Market Falls: Some Facts to Note
- Cardinal Health (CAH) closed the most recent trading day at $134.36, moving +0.08% from the previous trading session.
- 04/16/2025
|
4 Stocks to Watch as Dental Supplies Recovers Amid Tariff Headwind
- Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These are CAH, MMSI, XRAY and CNMD.
- 04/14/2025
|
Here's Why Cardinal Health (CAH) is a Strong Value Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 04/11/2025
|
Telix Announces Cardinal Health for Gozellix Commercial Distribution
- MELBOURNE, Australia and INDIANAPOLIS, April 08, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that it has selected Cardinal Health, Inc. (NYSE: CAH, Cardinal Health) as one of its commercial radiopharmaceutical distributors to supply finished unit doses of Gozellix® (kit for the preparation of gallium-68 (68Ga) gozetotide injection), Telix's next-generation PSMA-PET imaging1 agent for prostate cancer in the United States (U.S.).
- 04/08/2025
|
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
- Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
- 04/04/2025
|
Will Cardinal (CAH) Beat Estimates Again in Its Next Earnings Report?
- Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 04/03/2025
|
Trump's Retaliatory Tariffs Threaten Markets: 5 Low-Beta Stocks to Buy
- Investing in defensive stocks like SWX, CMS, TAP, SONY and CAH is a safe bet during times of market volatility.
- 04/03/2025
|
Best Dividend Aristocrats For April 2025
- Dividend Aristocrats are outperforming the S&P 500 in 2025, demonstrating resilience, with NOBL up 1.78% YTD versus SPY's 4.9% decline. Top performers include Consolidated Edison (+22.98%), Brown & Brown (+20.65%), and AbbVie (+16.61%), showcasing strong double-digit gains. 29 out of 69 Dividend Aristocrats have announced dividend increases in 2025, with an average growth rate of 4.15%.
- 03/31/2025
|
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
- Here is how Cardinal Health (CAH) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.
- 03/28/2025
|
Should Value Investors Buy Cardinal Health (CAH) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 03/27/2025
|
Forget Tech: Buy These 5 Non-Tech High Flyers of Q1
- Here we discuss five non-tech stocks that have provided double-digit returns year to date, defying the negative trends of U.S. stock markets. These are TPR, WEC, CNP, CME and CEH.
- 03/27/2025
|
CAH Stock Rises More Than 13% YTD: Should You Buy, Hold or Sell?
- Cardinal Health's recent acquisitions and GMPD recovery look promising. However, the loss of the Optum Rx contract and margin pressure are likely to hurt short-term prospects.
- 03/27/2025
|
Cardinal Health (CAH) Ascends While Market Falls: Some Facts to Note
- Cardinal Health (CAH) closed at $133.98 in the latest trading session, marking a +0.93% move from the prior day.
- 03/26/2025
|
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 03/26/2025
|
Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?
- Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 03/26/2025
|
Cardinal Health (CAH) Stock Drops Despite Market Gains: Important Facts to Note
- Cardinal Health (CAH) concluded the recent trading session at $132.75, signifying a -0.35% move from its prior day's close.
- 03/25/2025
|
Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2025 on May 1
- DUBLIN, Ohio , March 25, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2025 on May 1, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.
- 03/25/2025
|
Cardinal Health, Inc. (CAH) Leerink's 2025 Global Healthcare Conference (Transcript)
- Cardinal Health, Inc. (NYSE:CAH ) Leerink's 2025 Global Healthcare Conference Call March 12, 2025 8:40 AM ET Company Participants Aaron Alt - Chief Financial Officer Matt Sims - Investor Relations Conference Call Participants Mike Cherny - Leerink Mike Cherny Perfect. We'll get started here.
- 03/12/2025
|
Robert Musslewhite and Sudhakar Ramakrishna to join Cardinal Health Board of Directors
- DUBLIN, Ohio , March 10, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors has elected Robert Musslewhite, former Chief Executive Officer of Definitive Healthcare Corp., and Sudhakar Ramakrishna, President and Chief Executive Officer of SolarWinds Corporation, as independent directors, effective March 7, 2025. With more than 20 years of leadership experience, including serving as CEO for two publicly traded companies, Mr.
- 03/10/2025
|
The Dividend Aristocrats Ranked By Quality Scores: March 2025
- S&P Dow Jones Indices added three new members to the S&P 500 Dividend Aristocrats Index, expanding it to 69 companies. I rank Dividend Aristocrats by quality scores, presenting undervalued and overvalued stocks with detailed metrics and fair value estimates. My quality scoring system uses six indicators, each worth 5 points, for a maximum score of 30, categorizing stocks from Exceptional to Inferior.
- 03/05/2025
|
5 Broker-Loved Stocks to Keep an Eye on Amid Trade Tensions
- Investors should monitor stocks like Cardinal Health, DXC Technology, Cross Country Healthcare, Avnet and Asbury for high returns.
- 03/05/2025
|
Watch These 3 Stocks for Solid Earnings Acceleration
- Prairie Operating, Intuit and Cardinal Health are exhibiting strong earnings acceleration.
- 02/26/2025
|
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 02/21/2025
|
5 Broker-Loved Stocks to Keep an Eye on After Recent Analyst Upgrades
- Investors should monitor stocks like Dana, Camping World, ABM, Cardinal Health and DXC for high returns.
- 02/18/2025
|
Should Value Investors Buy Cardinal Health (CAH) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 02/05/2025
|
Cardinal Health Analysts Raise Their Forecasts Following Upbeat Earnings
- Cardinal Health CAH reported better-than-expected second-quarter financial results on Thursday.
- 02/04/2025
|
Cardinal Health Board of Directors Approves Quarterly Dividend
- DUBLIN, Ohio , Feb. 3, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5056 per share out of the Company's capital surplus. The dividend will be payable on April 15, 2025, to shareholders of record at the close of business on April 1, 2025.
- 02/03/2025
|
Cardinal Health, Inc. (CAH) Q2 2025 Earnings Call Transcript
- Cardinal Health, Inc. (NYSE:CAH ) Q2 2025 Earnings Conference Call January 30, 2025 8:30 AM ET Company Participants Matt Sims - Vice President, Investor Relations Jason Hollar - Chief Executive Officer Aaron Alt - Chief Financial Officer Conference Call Participants John Stansel - JPMorgan Erin Wright - Morgan Stanley Allen Lutz - Bank of America Elizabeth Anderson - Evercore Michael Cherny - Leerink Partners Eric Percher - Nephron Kevin Caliendo - UBS Eric Coldwell - Baird Daniel Grosslight - Citi Steven Valiquette - Mizuho Charles Rhyee - TD Cowen Brian Tanquilut - Jefferies Operator Hello, and welcome to the Second Quarter Fiscal Year 2025 Cardinal Health Inc. Earnings Conference Call. My name is George, and I'll be coordinator for today's event.
- 01/30/2025
|
CAH Q2 Earnings and Sales Beat Estimates, 2025 EPS View Raised
- Cardinal Health's second-quarter fiscal 2025 results benefit from solid Other segment revenue growth. However, OptumRx contract expiry hurts Pharmaceutical segment sales.
- 01/30/2025
|
Here's Why Cardinal Health (CAH) is a Strong Value Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 01/30/2025
|
Cardinal (CAH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
- Although the revenue and EPS for Cardinal (CAH) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 01/30/2025
|
Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?
- Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
- 01/30/2025
|
Cardinal Health (CAH) Surpasses Q2 Earnings and Revenue Estimates
- Cardinal Health (CAH) came out with quarterly earnings of $1.93 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $1.82 per share a year ago.
- 01/30/2025
|
Cardinal Health lifts 2025 profit forecast on specialty drugs demand
- Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit.
- 01/30/2025
|
Cardinal Health Reports Second Quarter Fiscal Year 2025 Results and Raises Fiscal Year 2025 Outlook
- Revenue decreased 4% to $55.3 billion; revenue increased 16% excluding the impact of the previously communicated large customer contract expiration GAAP 1 operating earnings were $549 million; GAAP diluted EPS was $1.65 Non-GAAP operating earnings increased 9% to $635 million, driven by the Pharmaceutical and Specialty Solutions segment; non-GAAP diluted EPS increased 2% to $1.93 Fiscal year 2025 non-GAAP EPS guidance2 raised to $7.85 to $8.00, from $7.75 to $7.90 Company announces the completion of its acquisition of 73% ownership of GI Alliance DUBLIN, Ohio , Jan. 30, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2025 revenues of $55.3 billion, a decrease of 4% from the second quarter of fiscal year 2024. Second quarter revenue increased 16% excluding the impact of the previously communicated large customer contract expiration.
- 01/30/2025
|
Why Cardinal Health (CAH) is a Top Momentum Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 01/29/2025
|
Buy These 5 Stocks Set to Win Big After Earnings Results This Week
- We have narrowed our search to five corporate behemoths set to report earnings results this week. These are: CAH, LOGI, NOW, GLW, ADP.
- 01/28/2025
|
Cardinal Health to Report Q2 Earnings: What's in Store for the Stock?
- Despite recent supply-chain challenges, new facilities and growth in branded and specialty pharmaceutical sales are likely to have driven CAH's performance in the fiscal second quarter.
- 01/27/2025
|
Cardinal Health (CAH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- Cardinal (CAH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 01/23/2025
|
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
- Here is how Cardinal Health (CAH) and AIM ImmunoTech Inc. (AIM) have performed compared to their sector so far this year.
- 01/22/2025
|
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 01/20/2025
|
Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue?
- Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 01/17/2025
|
Cardinal Health Stock May Gain With New Texas Distribution Center
- CAH announces the ongoing construction of a new distribution center in Texas, which is likely to support its at-Home Solutions business.
- 01/16/2025
|
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
- Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
- 01/16/2025
|
Cardinal Health (CAH) Increases Yet Falls Behind Market: What Investors Need to Know
- In the latest trading session, Cardinal Health (CAH) closed at $124.71, marking a +0.55% move from the previous day.
- 01/15/2025
|
Cardinal Health, Inc. (CAH) CEO Jason Hollar presents at J.P. Morgan Healthcare Conference (Transcript)
- Cardinal Health, Inc. (NYSE:CAH ) J.P. Morgan Healthcare Conference January 14, 2025 12:00 PM ET Company Participants Aaron Alt - CFO Jason Hollar - CEO Conference Call Participants Lisa Gill - JPMorgan Lisa Gill Good morning.
- 01/14/2025
|
Consumer Sentiment Declines Amid Rate Cut Uncertainty: 4 Safe Bets
- Low-beta defensive stocks like ENSG, CAH, ATO and IDA are a safe bet during times of market volatility.
- 01/14/2025
|
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 01/14/2025
|
Cardinal Health to open new distribution center in Fort Worth, Texas
- New facility will be outfitted with latest robotics and automation technologies DUBLIN, Ohio , Jan. 14, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced construction is underway on a new distribution center in Fort Worth, Texas, which will support its at-Home Solutions business, a leading medical supplies provider that serves more than 5 million patients annually in the United States. The new 340,000 square foot distribution center will consolidate its two existing warehouses into one larger facility, creating approximately 74,000 additional square feet of inventory capacity and retaining its current workforce.
- 01/14/2025
|
Cardinal Health forecasts annual profit at higher end of prior range
- Cardinal Health said on Tuesday it expects annual profit to be at the higher end of its previous forecast range, primarily driven by strong demand for costly specialty medicines and branded drugs at its pharmaceuticals unit.
- 01/14/2025
|
Will Cardinal (CAH) Beat Estimates Again in Its Next Earnings Report?
- Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 01/10/2025
|
Crinetics Announces Positive Topline Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)
- Substantial, Rapid and Sustained Statistically Significant Reductions of Key Biomarkers Achieved Across Doses, Including up to 80% Mean Reduction of Androstenedione
- 01/10/2025
|
Cardinal Health (CAH) Beats Stock Market Upswing: What Investors Need to Know
- Cardinal Health (CAH) closed at $122.53 in the latest trading session, marking a +0.93% move from the prior day.
- 01/09/2025
|
Cardinal Health (CAH) Advances But Underperforms Market: Key Facts
- The latest trading day saw Cardinal Health (CAH) settling at $119.63, representing a +0.28% change from its previous close.
- 01/06/2025
|
5 Of Bairds Top 2025 Red-Hot Stock Ideas Pay Dependable Recurring Dividends
- With all of the major indices making solid moves higher in 2024, we were very interested to see what the top prognosticators across Wall Street think is in store for 2025 as we start the second quarter of the new century.
- 01/06/2025
|
Reasons to Add Cardinal Health Stock to Your Portfolio Now
- CAH continues to grow on the back of its robust product portfolio and a strong quarterly result.
- 01/03/2025
|
Is Cardinal Health (CAH) Stock Undervalued Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 01/02/2025
|
Canada Personal Protective Equipment Market Outlook to 2033 Featuring Cardinal Health, Medline Industries, and 3M
- Dublin, Dec. 30, 2024 (GLOBE NEWSWIRE) -- The "Canada Personal Protective Equipment Market Outlook to 2033 - Gloves, Gowns, Masks, Shoe Covers and Others" report has been added to ResearchAndMarkets.com's offering. The "Canada Personal Protective Equipment Market Outlook to 2033" is a comprehensive databook report, covering key market data on the Canada Personal Protective Equipment market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Examination Table Papers, Face Shields, Gloves, Gowns, Masks, and Shoe Covers The Canada Personal Protective Equipment Market report provides key information and data on:
- 12/30/2024
|
Here's Why Cardinal Health (CAH) is a Strong Value Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 12/27/2024
|
Cardinal Health (CAH) Rises Yet Lags Behind Market: Some Facts Worth Knowing
- Cardinal Health (CAH) reachead $118.83 at the closing of the latest trading day, reflecting a +0.41% change compared to its last close.
- 12/24/2024
|
4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2025
- Investing in large-cap MedTech stocks like MCK, PEN, CAH and PEN can be profitable for investors in 2025.
- 12/20/2024
|
Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2025 on January 30
- DUBLIN, Ohio , Dec. 19, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2025 on January 30, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.
- 12/19/2024
|
Is Cardinal Health (CAH) a Great Value Stock Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 12/16/2024
|
5 Stocks With Upgraded Broker Ratings to Buy for Solid Returns in 2025
- Brokers have deeper insights into stocks and the macroeconomic backdrop. One must follow broker rating upgrades to pick stocks like GAP, CAH, AIT, JLL and UAL.
- 12/16/2024
|
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
- Investing in a company to hold it forever is a simple idea, but it's not easy. Most companies can't maintain competitive advantages forever.
- 12/15/2024
|
Zacks Industry Outlook Becton, Dickinson, BD, McKesson, Cardinal Health and Merit Medical Systems
- Becton, Dickinson, BD, McKesson, Cardinal Health and Merit Medical Systems have been highlighted in this Industry Outlook article.
- 12/13/2024
|
4 Stocks to Watch Amid Dental Supplies Industry Challenges
- Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These are BDX, MCK, CAH and MMSI.
- 12/12/2024
|
Spruce Biosciences Announces Topline Results from CAHmelia-204 in Adult CAH and CAHptain-205 in Adult and Pediatric CAH
- SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological and endocrine disorders with significant unmet medical need, today announced topline results from its CAHmelia-204 study of tildacerfont in adult CAH and its CAHptain-205 study of tildacerfont in adult and pediatric CAH. “We are very grateful to all the patients, families, investigators, and the e.
- 12/10/2024
|
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 12/10/2024
|
Strength Across Segments to Help CAH Stock Offset OptumRx Headwind?
- CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, concentrated revenue generation and regulatory setbacks are a concern.
- 12/05/2024
|
Cardinal Health, Inc. (CAH) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)
- Cardinal Health, Inc. (NYSE:CAH ) Annual Evercore ISI HealthCONx Healthcare Conference December 3, 2024 1:30 PM ET Company Participants Matt Sims - VP, IR Aaron Alt - CFO Conference Call Participants Elizabeth Anderson - Evercore ISI Elizabeth Anderson Hi, everybody. Thanks so much for joining us today.
- 12/03/2024
|
Cardinal Health, Inc. (CAH) Citi's 2024 Global Healthcare Conference (Transcript)
- Cardinal Health, Inc. (NYSE:CAH ) Citi's 2024 Global Healthcare Conference Call December 3, 2024 8:00 AM ET Company Participants Aaron Alt - Chief Financial Officer Matt Sims - Head, Investor Relations Conference Call Participants Daniel Grosslight - Citi Daniel Grosslight Thanks for joining us for the Cardinal Health fireside chat here at Citi's Global Healthcare Conference. My name is Daniel Grosslight.
- 12/03/2024
|
Should Value Investors Buy Cardinal Health (CAH) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 11/29/2024
|
CAH Stock Gains on the Launch of Kendall SmartFlow Compression System
- Cardinal Health launches the next generation of the Kendall Compression Series, Kendall SCD SmartFlow Compression System, to aid pain relating to venous stasis.
- 11/22/2024
|
Cardinal Health launches Kendall SCD SmartFlow™ Compression System
- Next generation of the Kendall™ SCD Series delivers an all-in-one solution for deep vein thrombosis and pulmonary embolism prevention DUBLIN, Ohio , Nov. 20, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the U.S. launch of its Kendall SCD SmartFlow™ Compression System, the next generation of the Kendall™ Compression Series offering an enhanced clinician and patient experience. Featuring clinically proven technology that delivers customized, intermittent pneumatic compression (IPC) to increase blood flow1 in at-risk patients, the Kendall SCD SmartFlow™ System is designed to help prevent venous thromboembolism (VTE) events, as well as enhance blood circulation and treat pain and swelling related to venous stasis.
- 11/20/2024
|
Cardinal Health, Inc. (CAH) UBS Global Healthcare Conference (Transcript)
- Cardinal Health, Inc. (NYSE:CAH ) UBS Global Healthcare Conference November 12, 2024 11:00 AM ET Company Participants Matt Sims - Vice President, Investor Relations Aaron Alt - Chief Financial Officer Conference Call Participants Kevin Caliendo - UBS Kevin Caliendo Good morning, everybody. Welcome to the UBS Healthcare Global Healthcare Conference.
- 11/15/2024
|
Cardinal Health Stock Gains Following Two Strategic Acquisitions
- CAH announces two strategic acquisitions to strengthen its multi-specialty and at-Home Solutions businesses.
- 11/13/2024
|
Is Cardinal Health (CAH) Outperforming Other Medical Stocks This Year?
- Here is how Cardinal Health (CAH) and Adaptive Biotechnologies (ADPT) have performed compared to their sector so far this year.
- 11/13/2024
|
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 11/13/2024
|
GI Alliance to Partner with Cardinal Health Creating a Scaled Multi-Specialty Managed-Services Platform to Benefit Physicians and Patients
- Adds the country's leading gastroenterology (GI) management services organization (MSO) to Cardinal Health's Specialty portfolio supporting over 900 physicians in 345 practices in 20 states Adds the country's leading gastroenterology (GI) management services organization (MSO) to Cardinal Health's Specialty portfolio supporting over 900 physicians in 345 practices in 20 states
- 11/11/2024
|
Cardinal Health buys GI Alliance and Advanced Diabetes Supply Group for about $3.9 bln
- Cardinal Health said on Monday it acquired majority stakes in GI Alliance and Advanced Diabetes Supply Group (ADSG) for about $2.8 billion and $1.1 billion each in an all cash deal.
- 11/11/2024
|
Cardinal Health announces two strategic additions to its portfolio
- Acquisition of a majority stake in GI Alliance, the country's leading gastroenterology management services organization, to accelerate Cardinal Health's multi-specialty growth strategy Acquisition of the Advanced Diabetes Supply Group, a leading national direct-to-patient provider of diabetes medical supplies, to accelerate Cardinal Health's at-Home Solutions growth strategy Company announces plan to hold Investor Day in June 2025 DUBLIN, Ohio , Nov. 11, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has entered into definitive agreements to acquire two companies that accelerate Cardinal Health's strategic growth areas and that will enhance patient care. The company also provided confirmation of its capital deployment plans.
- 11/11/2024
|
Cardinal Health Board of Directors Approves Quarterly Dividend
- DUBLIN, Ohio , Nov. 5, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5056 per share out of the Company's capital surplus. The dividend will be payable on January 15, 2025 to shareholders of record at the close of business on January 2, 2025.
- 11/05/2024
|
Cardinal Health Q1 Earnings: Margins Signal More Upside
- Cardinal Health's Q1 2025 earnings reaffirm my buy rating due to a strengthening pharmacy business and industry tailwinds. Despite initial market overreaction to 2025 guidance, Cardinal Health's management is transparently mitigating risks. A DCF analysis suggests a price target of $128 for CAH stock, offering a 17% upside.
- 11/04/2024
|
Cardinal Health, Inc. (CAH) Soars to 52-Week High, Time to Cash Out?
- Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 11/04/2024
|
Cardinal Health Stock Hits All-Time High as Existing Customers Power Results
- Cardinal Health (CAH) shares hit a new all-time intraday high Friday as the healthcare products provider posted better-than-expected results and raised its outlook even as it took a financial hit from the ending of a big contract.
- 11/01/2024
|
Cardinal Health, Inc. (CAH) Q1 2025 Earnings Call Transcript
- Cardinal Health, Inc. (NYSE:CAH ) Q1 2025 Earnings Conference Call November 1, 2024 8:30 AM ET Company Participants Matt Sims - Vice President, Investor Relations Jason Hollar - Chief Executive Officer Aaron Alt - Chief Financial Officer Conference Call Participants Lisa Gill - JPMorgan Michael Cherny - Leerink Partners Erin Wright - Morgan Stanley Eric Percher - Nephron Research Allen Lutz - Bank of America Kevin Caliendo - UBS Eric Coldwell - Baird George Hill - Deutsche Bank Stephanie Davis - Barclays Elizabeth Anderson - Evercore ISI Daniel Grosslight - Citi Charles Rhyee - TD Cowen Stephen Baxter - Wells Fargo Operator Hello, and welcome to the First Quarter Fiscal Year 2025 Cardinal Health, Incorporated Earnings Conference Call. My name is George, and I'll be your coordinator for today's event.
- 11/01/2024
|
CAH Stocks Gains on Q1 Earnings & Sales Beat and Raised '25 EPS View
- Cardinal Health's first-quarter fiscal 2025 results benefit from solid Pharmaceutical and Specialty Solutions growth. However, OptumRx contract expiry hurts sales.
- 11/01/2024
|
Here's What Key Metrics Tell Us About Cardinal (CAH) Q1 Earnings
- The headline numbers for Cardinal (CAH) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 11/01/2024
|
Cardinal Health (CAH) Q1 Earnings and Revenues Beat Estimates
- Cardinal Health (CAH) came out with quarterly earnings of $1.88 per share, beating the Zacks Consensus Estimate of $1.64 per share. This compares to earnings of $1.73 per share a year ago.
- 11/01/2024
|
Cardinal Health lifts annual profit outlook on strength in specialty medicines unit
- Cardinal Health raised its 2025 adjusted profit forecast on Friday as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit, sending the shares of the company up nearly 4% in premarket trading.
- 11/01/2024
|
Cardinal Health Reports First Quarter Fiscal Year 2025 Results and Raises Fiscal Year 2025 Outlook
- Revenue decreased 4% to $52.3 billion; revenue increased 15% excluding the impact of the previously communicated large customer contract expiration GAAP 1 operating earnings were $568 million; GAAP diluted EPS was $1.70 Non-GAAP operating earnings increased 12% to $625 million, driven by significant growth in Pharmaceutical and Specialty Solutions segment profit Non-GAAP diluted EPS increased 9% to $1.88 Fiscal year 2025 non-GAAP EPS guidance2 raised to $7.75 to $7.90, from $7.55 to $7.70 DUBLIN, Ohio , Nov. 1, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2025 revenue of $52.3 billion, a decrease of 4% from the first quarter of fiscal year 2024. First quarter revenue increased 15% excluding the impact of the previously communicated large customer contract expiration.
- 11/01/2024
|
Cardinal Health celebrates medical product distribution center grand opening in Massachusetts
- New facility in Boylston increases U.S. warehouse capacity and expands specialized handling capabilities DUBLIN, Ohio , Oct. 29, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the grand opening of its new distribution center in Boylston, Massachusetts, supporting its U.S. Medical Products and Distribution business. The facility provides healthcare customers in Massachusetts, New Hampshire, Rhode Island, Maine, Vermont and Eastern Connecticut with modernized operations and expanded capacity, as well as specialized handling capabilities for products with strict storage requirements, available early 2025.
- 10/29/2024
|
Exploring Analyst Estimates for Cardinal (CAH) Q1 Earnings, Beyond Revenue and EPS
- Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Cardinal (CAH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2024.
- 10/29/2024
|
Cardinal Health (CAH) Stock Sinks As Market Gains: Here's Why
- In the most recent trading session, Cardinal Health (CAH) closed at $110.87, indicating a -0.02% shift from the previous trading day.
- 10/28/2024
|
Should Value Investors Buy Cardinal Health (CAH) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 10/28/2024
|
Cardinal Health to Report Q1 Earnings: What's in Store?
- Cardinal Health, Inc. CAH is scheduled to report fiscal first-quarter 2025 results on Nov. 1, before the opening bell.
- 10/25/2024
|
Here's Why Cardinal Health (CAH) is a Strong Value Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 10/17/2024
|
Here's Why Cardinal Health (CAH) is a Strong Momentum Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 10/16/2024
|
Cardinal Health (CAH) Stock Dips While Market Gains: Key Facts
- In the closing of the recent trading day, Cardinal Health (CAH) stood at $111.92, denoting a -0.52% change from the preceding trading day.
- 10/14/2024
|
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 10/11/2024
|
CAH Stock May Gain Following the Distribution Deal With T2 Biosystems
- Cardinal Health and T2 Biosystems announce an agreement selecting the former to sell direct-from-blood diagnostics for the rapid detection of sepsis-causing pathogens.
- 10/09/2024
|
Reasons to Retain Cardinal Health Stock in Your Portfolio Now
- CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
- 10/07/2024
|
T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens
- LEXINGTON, Mass., Oct. 07, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has entered into a multi-year exclusive U.S. agreement with Cardinal Health (NYSE: CAH),. Under the agreement, Cardinal Health will have exclusive rights to sell T2 Biosystems' FDA-cleared direct-from-blood diagnostics for the rapid detection of sepsis-causing pathogens, including the T2Dx® Instrument, the T2Bacteria® Panel, and the T2Candida® Panel.
- 10/07/2024
|
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 10/01/2024
|
Cardinal Health Stock Likely to Gain From the Acquisition of ION
- CAH is set to acquire Oncology Network for $1.115 billion, expanding its oncology offerings while supporting community-based cancer care across 10 states.
- 09/24/2024
|
Cardinal Health to Announce First-Quarter Results for Fiscal Year 2025 on November 1
- DUBLIN, Ohio , Sept. 24, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2025 on November 1, prior to the opening of trading on the New York Stock Exchange.
- 09/24/2024
|
Is Cardinal Health (CAH) Stock Undervalued Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 09/23/2024
|
Cardinal Health to acquire Integrated Oncology Network for $1.12 billion
- Cardinal Health on Friday agreed to acquire Integrated Oncology Network, an independent community oncology network, for $1.12 billion in cash.
- 09/20/2024
|
Cardinal Health to acquire Integrated Oncology Network, a physician-led independent community oncology network
- Transaction demonstrates Cardinal Health's continued strategic investment in specialty and oncology, underscores commitment to independent community healthcare providers Accelerates the development of Navista oncology practice alliance , adding more than 100 providers at more than 50 community-based sites delivering broad-reaching oncology and urology care across 10 states DUBLIN, Ohio , Sept. 20, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has entered into a definitive agreement to acquire Integrated Oncology Network (ION), a physician-led independent community oncology network, for $1.115B in cash.
- 09/20/2024
|
Cardinal Health (CAH) Stock Falls Amid Market Uptick: What Investors Need to Know
- Cardinal Health (CAH) reachead $110.76 at the closing of the latest trading day, reflecting a -0.58% change compared to its last close.
- 09/19/2024
|
Bioactive Dressings - Comprehensive Global and Regional Market Forecast to 2029 - Featuring Strategical Analysis of 3M, Smith+Nephew, Cardinal Health, Braun, Molnlycke Health Care, Convatec & More
- Dublin, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The "Bioactive Dressings Market by Product (Collagen, Alginate, Chitosan, Skin Substitute), Property (Antimicrobial, Non-Antimicrobial), Application (Chronic Wounds (Diabetic Foot, Pressure Ulcers), Acute Wounds (Surgical, Burns))- Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. The global bioactive dressings market is projected to reach USD 5.8 billion by 2029 from USD 3.5 billion in 2024, at a CAGR of 10.5% during the forecast period.
- 09/19/2024
|
CAH Stock May Gain Following the Distribution Agreement With Telix
- Cardinal Health and Telix announce an agreement selecting the former as a commercial radiopharmaceutical distributor to supply finished unit doses of Telix's Zircaix.
- 09/18/2024
|
Why Cardinal Health (CAH) is a Top Momentum Stock for the Long-Term
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 09/17/2024
|
Telix Announces Cardinal Health as U.S. Commercial Distributor for Zircaix®
- MELBOURNE, Australia, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has selected Cardinal Health, Inc. (NYSE: CAH, Cardinal Health) as a commercial radiopharmaceutical distributor to supply finished unit doses of its PET1 agent, Zircaix®2 (TLX250-CDx) for the imaging of kidney cancer in the United States (U.S.), subject to regulatory approval.
- 09/17/2024
|
Here's Why Cardinal Health (CAH) Gained But Lagged the Market Today
- In the latest trading session, Cardinal Health (CAH) closed at $113.28, marking a +0.1% move from the previous day.
- 09/16/2024
|
Not All Dividend Aristocrats Are Created Alike. Here Are the 3 You Should Buy
- Dividend investing has proved to be a reliable source of income for investors while allowing for long-term generational wealth accumulation.
- 09/12/2024
|
BridgeBio Pharma Reports Topline Results from Phase 1/2 Trial of Investigational Gene Therapy for Congenital Adrenal Hyperplasia (CAH)
- - Increase in endogenous cortisol production achieved in all patients in higher dose cohorts of BBP-631, a result seen for the first time ever in CAH patients
- 09/10/2024
|
Cardinal Health, Inc. (CAH) Baird's 2024 Global Healthcare Conference (Transcript)
- Cardinal Health, Inc. (NYSE:CAH ) Baird's 2024 Global Healthcare Conference September 10, 2024 9:05 AM ET Company Participants Matt Sims - VP, IR Jason Hollar - CEO Aaron Alt - CFO Conference Call Participants Eric Coldwell - Baird Eric Coldwell Good morning, everyone. My name is Eric Coldwell.
- 09/10/2024
|
Children's Hospital Association and Cardinal Health commemorate World Suicide Prevention Day with continued focus on youth mental health
- WASHINGTON and DUBLIN, Ohio , Sept. 10, 2024 /PRNewswire/ -- In observance of today's World Suicide Prevention Day, Children's Hospital Association (CHA), Cardinal Health (NYSE: CAH), and Zero Suicide Institute (ZSI) celebrate early success of the Preventing Youth Suicide Collaborative, a collaborative funded by the Cardinal Health Foundation, led by CHA, and informed by ZSI's prevention expertise.
- 09/10/2024
|
Cardinal Health (CAH) Advances But Underperforms Market: Key Facts
- The latest trading day saw Cardinal Health (CAH) settling at $112.80, representing a +0.92% change from its previous close.
- 09/09/2024
|
Cardinal Health (CAH) Morgan Stanley 22nd Annual Global Healthcare Conference Transcript
- Cardinal Health, Inc. (NYSE:CAH ) Morgan Stanley 22nd Annual Global Healthcare Conference September 5, 2024 8:30 AM ET Company Participants Matt Sims - VP, IR Aaron Alt - CFO Conference Call Participants Erin Wright – Morgan Stanley Erin Wright Hi, good morning, everyone. My name is Erin Wright.
- 09/05/2024
|
Reasons to Retain Cardinal Health Stock in Your Portfolio Now
- CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
- 09/04/2024
|
Greenville Center to Boost CAH Stock's at-Home Solution Business
- Cardinal Health announces the opening of its new distribution center in Greenville to support its at-Home Solutions business.
- 09/03/2024
|
3 Consistent Dividend Growers to Buy for Passive Income: TSM, MO, CAH
- Everybody loves dividends, as they provide a passive income stream, limit drawdowns in other positions, and provide more than one way to profit from an investment.
- 08/28/2024
|
Cardinal Health celebrates Greenville, South Carolina, distribution center opening
- 'Warehouse of the Future' to expand nationwide distribution network in support of home healthcare growth DUBLIN, Ohio , Aug. 28, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) officially announced today the recent opening of a new distribution center in Greenville, South Carolina dedicated solely to its at-Home Solutions business, expected to add roughly 200 jobs to the region over time. Cardinal Health at-Home Solutions is a leading provider of home healthcare medical supplies, helping more than five million customers nationwide manage their medical supply needs, including those who have chronic or critical medical conditions.
- 08/28/2024
|
Cardinal Health Q4 Earnings: FY25 Is A Short-Term Blip
- Cardinal Health stock remains a buy due to strong pharmaceutical business growth and increased shareholder returns, despite short-term OptumRx and inflation challenges. Q4 and FY24 earnings exceeded expectations with revenue up 12% and gross margin up 5%, driven by pharmaceutical and medical products. DCF analysis supports a $128 price target, 17% upside, with Wall Street's average at $116; industry tailwinds bolster valuation.
- 08/27/2024
|
Cardinal Health Soars as America's Leading Acute Care Supplier
- Cardinal Health Inc. CAH is a global pharmaceutical and medical products distributor serving over 100,000 hospitals. It's also the largest distributor of medical supplies and surgical products in the United States.
- 08/22/2024
|
Cardinal Health (CAH) to Open New Distribution Center in Ohio
- Cardinal Health's (CAH) new center is set to integrate cutting-edge technology and automation, enhancing efficiency, storage capacity and quality of service.
- 08/22/2024
|
Bert's July Dividend Income Summary (2024)
- In July 2024, we received $1,683.75 in dividend income. We have been buying at least 4 shares of SCHD every single week. I accepted a long time ago that Leggett & Platt's dividend cut was terrible.
- 08/22/2024
|
Cardinal Health expands medical product distribution footprint in Northeast Ohio
- New facility opening in Walton Hills demonstrates ongoing commitment to increase U.S. warehouse capacity and modernize operations DUBLIN, Ohio , Aug. 21, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today its plans to open a new distribution center in Walton Hills, Ohio, supporting its U.S. Medical Products and Distribution business. The facility will integrate new technology solutions, deliver operational efficiencies, and provide expanded capacity in the Cleveland, Ohio area.
- 08/21/2024
|
3 Companies Reporting Remarkable Results: WMT, LLY, CAH
- The 2024 Q2 earnings season is slowly grinding to a halt, with the vast majority of S&P 500 companies already delivering quarterly results. Peeking a bit ahead, earnings for the current period (2024 Q3) are expected to be up 4.3% on 4.6% higher revenues, chaining together consecutive periods of positivity.
- 08/16/2024
|
Cardinal Health Board of Directors Approves Quarterly Dividend
- DUBLIN, Ohio , Aug. 15, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5056 per share out of the Company's capital surplus. The dividend will be payable on October 15, 2024 to shareholders of record at the close of business on October 1, 2024.
- 08/15/2024
|
Cardinal Health Beats Estimates, Boosts Guidance on Strong Drug Sales
- Shares of Cardinal Health (CAH) gained in intraday trading Wednesday as the provider of healthcare services and products posted better-than-anticipated results and raised its outlook on strong drug sales.
- 08/14/2024
|
Cardinal Health (CAH) Beats on Q4 Earnings, Ups '24 EPS View
- Cardinal Health's (CAH) fourth-quarter fiscal 2024 results benefit from solid profit growth in Pharmaceutical and Specialty Solutions. The company raises its EPS guidance for fiscal 2024.
- 08/14/2024
|
Cardinal Health Stock Pops on Beat-and-Raise
- Cardinal Health Inc (NYSE:CAH) stock is gapping higher on the charts today, after the company announced strong fiscal fourth-quarter results and raised its full-year guidance.
- 08/14/2024
|
Here's What Key Metrics Tell Us About Cardinal (CAH) Q4 Earnings
- Although the revenue and EPS for Cardinal (CAH) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 08/14/2024
|
Cardinal Health (CAH) Q4 Earnings and Revenues Top Estimates
- Cardinal Health (CAH) came out with quarterly earnings of $1.84 per share, beating the Zacks Consensus Estimate of $1.72 per share. This compares to earnings of $1.55 per share a year ago.
- 08/14/2024
|
Top 3 Health Care Stocks That May Crash In August
- As of Aug 14, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
- 08/14/2024
|
Cardinal Health lifts 2025 profit outlook on strong demand for costly specialty drugs
- Cardinal Health raised its 2025 profit forecast on Wednesday betting on strong demand for branded and specialty medicines at its pharmaceuticals unit.
- 08/14/2024
|
Cardinal Health's stock up 5% after earnings beat and raised guidance
- Cardinal Health Inc.'s stock CAH, +1.91% rose 5% early Wednesday, after the drug distributor and medical products maker beat estimates for the second quarter and raised its guidance. Dublin, Ohio-based Cardinal Health had net income of $235 million, or 96 cents a share, for the quarter, after a loss of $56 million, or 22 cents a share, in the year-earlier period.
- 08/14/2024
|
Cardinal Health Reports Fourth Quarter and Fiscal Year 2024 Results and Raises Fiscal Year 2025 Guidance
- Fourth quarter revenue increased 12% to $59.9 billion Fourth quarter GAAP1 operating earnings were $401 million and GAAP diluted EPS was $0.96 Fourth quarter non-GAAP operating earnings increased 14% to $605 million and non-GAAP diluted EPS increased 29% to $1.84 Fiscal Year 2024 operating cash flow and adjusted free cash flow reached all-time highs of $3.8 billion and $3.9 billion, respectively Fiscal year 2025 non-GAAP EPS guidance raised to $7.55 to $7.70, from at least $7.50 DUBLIN, Ohio , Aug. 14, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported fourth quarter fiscal year 2024 revenues of $59.9 billion, an increase of 12% from the prior year. GAAP operating earnings were $401 million and GAAP diluted earnings per share (EPS) were $0.96.
- 08/14/2024
|
Cardinal Health Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
- Cardinal Health, Inc. CAH is set to release earnings results for its fourth quarter, before the opening bell on Aug. 14, 2024.
- 08/14/2024
|
Here's Why Cardinal Health (CAH) is a Strong Value Stock
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 08/13/2024
|
Reasons to Retain Cardinal Health (CAH) in Your Portfolio Now
- Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
- 08/13/2024
|
What's in Store for Cardinal Health (CAH) in Q4 Earnings?
- Cardinal Health's (CAH) fourth-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical and Specialty Solutions segment.
- 08/12/2024
|
How To Earn $500 A Month From Cardinal Health Stock Ahead Of Q4 Earnings
- Cardinal Health, Inc. CAH expects to release earnings results for its fourth quarter, before the opening bell on Wednesday, Aug. 14.
- 08/12/2024
|
Seeking Clues to Cardinal (CAH) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
- Beyond analysts' top -and-bottom-line estimates for Cardinal (CAH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2024.
- 08/09/2024
|
Cardinal Health (CAH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Cardinal (CAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 08/07/2024
|
Cardinal Health (CAH) Beats Stock Market Upswing: What Investors Need to Know
- Cardinal Health (CAH) closed at $99.52 in the latest trading session, marking a +1.18% move from the prior day.
- 08/06/2024
|
Dividend Income: Lanny's July 2024 Summary
- In July, we (my wife and I) received a dividend income total of $2,836.82. 2023 was up 24%. 7 months down in 2024 and the S&P 500 is still up almost 13%, despite the recent sell-offs. We have a high likelihood of a rate cut in September, but too much speculation is happening beyond that date. Time is ticking on that FOMC meeting.
- 08/06/2024
|
Cardinal Health: Growth Headwinds Ahead
- Cardinal Health's recent dividend raise (about 1%) reflects growth pressure ahead. With a ~13x P/E, valuation seems reasonable on the surface. However, when adjusted for growth, the current valuation points to an unfavorable return profile.
- 08/01/2024
|
Cardinal Health (CAH) Rises But Trails Market: What Investors Should Know
- Cardinal Health (CAH) reachead $100.83 at the closing of the latest trading day, reflecting a +0.57% change compared to its last close.
- 07/31/2024
|
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 07/26/2024
|
Cardinal Health (CAH) Rises As Market Takes a Dip: Key Facts
- In the most recent trading session, Cardinal Health (CAH) closed at $96.71, indicating a +0.91% shift from the previous trading day.
- 07/24/2024
|
Why the Market Dipped But Cardinal Health (CAH) Gained Today
- In the closing of the recent trading day, Cardinal Health (CAH) stood at $95.84, denoting a +0.44% change from the preceding trading day.
- 07/23/2024
|
Cardinal Health's (CAH) China Syringe Makers Face FDA Warnings
- FDA investigations into Cardinal Health's (CAH) China-based syringe manufacturers, Jiangsu Shenli and Jiangsu Caina, reveal significant quality violations, prompting recalls and import alerts.
- 07/23/2024
|
Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2024 on August 14
- DUBLIN, Ohio , July 23, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2024 on August 14, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.
- 07/23/2024
|
Why the Market Dipped But Cardinal Health (CAH) Gained Today
- Cardinal Health (CAH) closed at $95.97 in the latest trading session, marking a +0.59% move from the prior day.
- 07/17/2024
|
Cardinal Health (CAH) Stock Sinks As Market Gains: Here's Why
- Cardinal Health (CAH) concluded the recent trading session at $93.74, signifying a -0.38% move from its prior day's close.
- 07/15/2024
|
Reasons to Retain Cardinal Health (CAH) in Your Portfolio Now
- Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
- 07/12/2024
|
The 7 Most Undervalued Dividend Stocks to Buy in July 2024
- Dividend stocks have long been investor favorites. Not only do dividends provide a reliable stream of income but they also increase a portfolio's returns over time.
- 07/11/2024
|
Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors
- Cardinal Health (CAH) concluded the recent trading session at $96.01, signifying a -0.9% move from its prior day's close.
- 07/09/2024
|
‘Crash proof' your portfolio with these 10 stocks and 3 ETFs
- You don't get upset for having homeowner's insurance but your house doesn't burn down. The same principle should apply to investors who insure their stock portfolios against a crash.
- 07/09/2024
|
Cardinal Health (CAH) Recalls Kits Containing Shenli's Syringes
- Cardinal Health (CAH) recalls its procedure kits that contain plastic syringes manufactured by a Chinese manufacturer, Jiangsu Shenli.
- 07/04/2024
|
Cardinal Health: Growing Into The Valuation
- Cardinal Health is a market leader in healthcare with stable revenue streams and growth opportunities, despite being potentially overvalued. Recent performance shows solid revenue and profit growth, but valuation metrics suggest potential overvaluation compared to sector averages. Growth drivers include expansion in specialty pharmaceuticals, biosimilars market, and emerging healthcare segments, with a focus on operational efficiency and customer value propositions.
- 07/02/2024
|
Neurocrine Biosciences Announces U.S. FDA Accepts New Drug Applications and Grants Priority Review for Crinecerfont for Pediatric and Adult Patients with CAH
- PDUFA Target Action Dates in Late December 2024 Highly Selective CRF1 Antagonist is the Potential First New Treatment for CAH in 70 Years SAN DIEGO , July 1, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the U.S. Food and Drug Administration (FDA) has accepted its two New Drug Applications (NDA) with Priority Review designations for crinecerfont in the treatment of children, adolescents and adults with classic congenital adrenal hyperplasia (CAH). If approved, crinecerfont would be the first new treatment option for CAH in 70 years and a first-in-class therapy, with a novel approach for the treatment of this rare and serious endocrine disorder.
- 07/01/2024
|
If I Had To Retire With 10 Dividend Aristocrats, It Would Be These
- If you want a massive dividend snowball: Get the right combination of dividend yield and growth for maximum compounding effect. Dividend Aristocrats may not always be the best choice due to high valuations and low yields. I refine a list of Dividend Aristocrats from 60+ to 10 based on yield and growth rates if I had to pick just 10.
- 06/30/2024
|
5 Upcoming Dividend Increases Including A King
- This week's increases include Dividend King Sysco Corporation with a 2% increase, extending its 54-year streak. The tables and lists are generated using data from the U.S. Dividend Champions spreadsheet and NASDAQ. I review some companies closer as part of my review process for including them in my own personal portfolio.
- 06/28/2024
|
5 Cheap Stocks Buying Back Shares at Reasonable Prices
- Buybacks are in fashion. But at today's valuations, companies could be paying up for their own stock—and that's never a good idea, whether you're a CEO or a retail investor.
- 06/20/2024
|
The Dividend Dynasty: 3 Stocks That Will Keep Your Pockets Lined for Years
- Dividend stocks are not on everyone's radar right now, with Nvidia (NASDAQ: NVDA ) moving past Apple (NASDAQ: AAPL ) to become the second-most-valuable company in the world. And, a host of other artificial intelligence stocks, such as Advanced Micro Devices (NASDAQ: AMD ) lead the pack for mega-cap stocks.
- 06/10/2024
|
Crinetics Announces Positive Initial Findings at ENDO 2024 for Atumelnant in Two Ongoing, Open-Label Studies for the Treatment of Congenital Adrenal Hyperplasia (CAH) and ACTH-Dependent Cushing's Syndrome (ADCS)
- 100% of Participants (n=6) With CAH Maintained Androstenedione (A4) Below the Upper Limit of Normal at all Time Points on Atumelnant (80 mg)
- 06/03/2024
|
Neurocrine Biosciences Presented CAHtalyst™ Phase 3 Pediatric and Adult Studies, CAHtalog™ Registry and Disease- and Glucocorticoid-Related Comorbidities Data in CAH at ENDO 2024
- SAN DIEGO , June 3, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) and Diurnal Ltd., a Neurocrine Biosciences company, presented information from its neuroendocrinology pipeline at the Endocrine Society Annual Meeting, ENDO 2024, including primary data just published in The New England Journal of Medicine from its CAHtalyst™ Phase 3 registrational studies of crinecerfont in pediatric and adult patients with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.
- 06/03/2024
|
Neurocrine Biosciences Announces Publication of Primary CAHtalyst™ Pediatric Phase 3 Study Results of Crinecerfont for the Treatment of CAH in The New England Journal of Medicine
- - CAHtalyst™ Pediatric Study Met Primary and Key Secondary Endpoints, with Crinecerfont Treatment Decreasing Androstenedione Levels and Enabling Glucocorticoid Dose Reduction While Maintaining Androstenedione Control - 30% of Crinecerfont Participants Achieved a Physiologic Glucocorticoid Dose at Week 28 while Maintaining Androgen Control versus 0% of Placebo Participants - Favorable Trends in Endpoints Reflecting Supraphysiologic Glucocorticoid Dosing and Androgen Excess - Crinecerfont was Generally Well Tolerated SAN DIEGO , June 3, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that the primary study results from its CAHtalyst™ Pediatric Phase 3 study investigating crinecerfont for the treatment of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency have been published in The New England Journal of Medicine online edition and will appear in a future print issue of the journal. The CAHtalyst Pediatric Phase 3 study met the primary and key secondary endpoints related to androgen reduction (during an initial glucocorticoid-stable period) and glucocorticoid (GC) dose reduction while maintaining androgen control.
- 06/03/2024
|
Neurocrine Biosciences Announces Publication of Primary CAHtalyst™ Adult Phase 3 Study Results of Crinecerfont for the Treatment of CAH in The New England Journal of Medicine
- - CAHtalyst™ Adult Phase 3 Study Met Primary and Important Key Secondary Endpoints, with Crinecerfont Treatment Decreasing Androstenedione Levels and Enabling Glucocorticoid Dose Reduction While Maintaining Androstenedione Control - 62.7% of Crinecerfont Participants Achieved a Physiologic Glucocorticoid Dose while Maintaining Androstenedione Control versus 17.5% of Placebo Participants - Favorable Trends in Endpoints Reflecting Consequences of Supraphysiologic Glucocorticoid Dosing - Crinecerfont was Generally Well Tolerated SAN DIEGO , June 3, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that the primary study results from its CAHtalyst™ Phase 3 study investigating crinecerfont for the treatment of adults ages 18 and older with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency have been published in The New England Journal of Medicine online edition and will appear in a future print issue of the journal. The study met the primary and important key secondary endpoints related to androgen reduction (during an initial glucocorticoid-stable period) and glucocorticoid (GC) dose reduction while maintaining androgen control.
- 06/03/2024
|
Cardinal Health, Inc. (CAH) Leerink Partners Healthcare Crossroads Conference (Transcript)
- Cardinal Health, Inc. (NYSE:CAH ) Leerink Partners Healthcare Crossroads Conference May 29, 2024 10:00 AM ET Company Participants Matt Sims - Head, IR Aaron Alt - CFO Conference Call Participants Michael Cherny - Leerink Partners Michael Cherny Great. We'll get started now.
- 05/29/2024
|
Here's Why Cardinal Health (CAH) is a Strong Value Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 05/29/2024
|
Reasons to Retain Cardinal Health (CAH) in Your Portfolio Now
- Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. Gross margins improve.
- 05/28/2024
|
Neurocrine Biosciences to Present New Phase 3 CAHtalyst™ Data in Adult and Pediatric Patients with CAH and Study Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH at ENDO 2024
- New CAHtalyst™ Pediatric and CAHtalyst™ Adult Phase 3 Clinical Study Data in Congenital Adrenal Hyperplasia CAHtalog™ Registry Data Highlighting Impact of Supraphysiologic Glucocorticoid Dosing Phase 2 (CHAMPAIN) Study Data for MRHC vs. Plenadren in Primary Adrenal Insufficiency Long-Term Study Data for MRHC in Adults with CAH SAN DIEGO , May 28, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it will present key information from its neuroendocrinology pipeline, including new Phase 3 clinical study data from its CAHtalyst™ registrational studies of crinecerfont in pediatric and adult patients with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency and data from its modified-release hydrocortisone (MRHC) studies in primary adrenal insufficiency and CAH.
- 05/28/2024
|
Investors Heavily Search Cardinal Health, Inc. (CAH): Here is What You Need to Know
- Cardinal (CAH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- 05/17/2024
|
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 05/13/2024
|
Cardinal Health Board of Directors Approves Increase to Quarterly Dividend
- DUBLIN, Ohio , May 7, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to its quarterly dividend, to $0.5056 per share, out of the Company's capital surplus. The dividend will be payable on July 15, 2024 to shareholders of record at the close of business on July 1, 2024.
- 05/07/2024
|
Woman Discovers She Is A Male After Doctors Find Testicle In Her Stomach
- Doctors found a testicle in her abdomen and diagnosed her with a rare disorder called Congenital Adrenal Hyperplasia (CAH)...
- 05/06/2024
|
3 Stocks to Give You Shelter From the Coming Market Crash
- Sometimes the best offense is a good defense. In today's market, buying defensive stocks is probably one of the best strategies you can adopt to protect your portfolio's gains.
- 05/06/2024
|
Here is What to Know Beyond Why Cardinal Health, Inc. (CAH) is a Trending Stock
- Recently, Zacks.com users have been paying close attention to Cardinal (CAH). This makes it worthwhile to examine what the stock has in store.
- 05/06/2024
|
For Cardinal Health, the Proof Will be in Its Performance
- Investors are familiar with the phrase "buy the rumor, sell the news." However, Cardinal Health Inc. NYSE: CAH proved that investors can buy and sell the news.
- 05/03/2024
|
5 Expected Dividend Increases In May 2024
- 5 Expected Dividend Increases In May 2024
- 05/03/2024
|
Compared to Estimates, Cardinal (CAH) Q3 Earnings: A Look at Key Metrics
- The headline numbers for Cardinal (CAH) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 05/02/2024
|
Cardinal Health, Inc. (CAH) Q3 2024 Earnings Call Transcript
- Cardinal Health, Inc. (NYSE:CAH ) Q3 2024 Earnings Conference Call May 2, 2024 8:30 AM ET Company Participants Matt Sims - VP, IR Jason Hollar - CEO Aaron Alt - CFO Conference Call Participants Lisa Gill - JP Morgan Michael Cherny - Leerink Partners George Hill - Deutsche Bank Allen Lutz - Bank of America Kevin Caliendo - UBS Eric Percher - Nephron Research Stephanie Davis - Barclays Eric Coldwell - Baird Elizabeth Anderson - Evercore ISI Stephen Baxter - Wells Fargo Lucas Romanski - TD Cowen Daniel Grosslight - Citi Operator Hello, and welcome to the Third Quarter Fiscal Year 2024 Cardinal Health Incorporated Earnings Conference Call. My name is George.
- 05/02/2024
|
Cardinal Health (CAH) Beats on Q3 Earnings, Ups '24 EPS View
- Cardinal Health's (CAH) third-quarter fiscal 2024 results benefit from solid profit growth in Pharmaceutical and Specialty Solutions. The company raises its EPS guidance for fiscal 2024.
- 05/02/2024
|
Cardinal Health lifts 2024 profit view on demand for costly specialty drugs
- Cardinal Health raised its annual profit forecast on Thursday, betting on strength in its pharmaceutical unit selling costly specialty drugs used to treat complex conditions such as cancer.
- 05/02/2024
|
Cardinal Health's stock falls on mixed quarterly results
- Cardinal Health Inc.'s shares CAH, -0.84% fell 1.2% premarket on Thursday after the company reported mixed results for its fiscal third quarter but raised its full-year profit outlook. The drug distributor and lab-equipment provider reported net income of $258 million, or $1.05 per share, down from $345 million, or $1.34 per share, in the year-earlier period.
- 05/02/2024
|
Cardinal Health Reports Third Quarter Fiscal Year 2024 Results and Raises Fiscal Year 2024 Non-GAAP EPS Guidance
- Revenue increased 9% to $54.9 billion GAAP1 operating earnings were $367 million; GAAP diluted EPS was $1.05 Non-GAAP operating earnings increased 10% to $666 million; non-GAAP diluted EPS increased 20% to $2.08 Fiscal year 2024 non-GAAP EPS guidance 2 raised and narrowed to $7.30 to $7.40, from $7.20 to $7.35 Company provides preliminary fiscal year 2025 non-GAAP EPS guidance of at least $7.50 DUBLIN, Ohio , May 2, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported third quarter fiscal year 2024 revenues of $54.9 billion, an increase of 9% from the third quarter of fiscal year 2023. Third quarter GAAP operating earnings were $367 million and GAAP diluted earnings per share (EPS) were $1.05, which included a non-cash, pre-tax goodwill impairment of $90 million related to the Global Medical Products and Distribution (GMPD) segment as a result of the reallocation of goodwill related to the reporting structure update.
- 05/02/2024
|
Shhh! 3 Secret Retirement Stocks Flying Below Wall Street's Radar
- Investing for retirement can be one of the most essential steps to securing a future of overall financial stability. Nowadays, many investors need to start preparing a nest egg at a young age despite the idea of retirement seeming unnecessary.
- 05/01/2024
|
What's in Store for Cardinal Health (CAH) in Q3 Earnings?
- Cardinal Health's (CAH) third-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical and Specialty Solutions segment.
- 04/29/2024
|
Seeking Clues to Cardinal (CAH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
- Besides Wall Street's top -and-bottom-line estimates for Cardinal (CAH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
- 04/29/2024
|
Apple, Cardinal Health Among 12 Companies To Announce Dividend Increases In First Half Of May
- Apple, Cardinal Health Among 12 Companies To Announce Dividend Increases In First Half Of May
- 04/29/2024
|
Here's What You Should Know About EBAY Ahead of Q1 Earnings
- EBAY's first-quarter 2024 performance will likely reflect strength across its advertising business amid softness in its active buyer base.
- 04/26/2024
|
3 Medical Products Stocks Set to Beat This Earnings Season
- Here are three stocks, TXG, CAH and HOLX, which are expected to beat earnings estimates in the ongoing reporting cycle.
- 04/26/2024
|
US FDA sends warning to Cardinal Health for marketing unapproved devices
- The U.S. Food and Drug Administration on Thursday sent a warning letter to Cardinal Health after an inspection of its facility in Illinois showed that the company was marketing unapproved devices.
- 04/25/2024
|
A Repeat of 2022? 7 Defensive Stocks to Buy Before the Correction.
- Are we headed for a repeat of 2022's brutal selloff? While no one can predict the future with certainty, current market trends are raising some ominous red flags.
- 04/24/2024
|
Cardinal Health (CAH) Increases Yet Falls Behind Market: What Investors Need to Know
- Cardinal Health (CAH) closed the most recent trading day at $103.37, moving +0.53% from the previous trading session.
- 04/23/2024
|
Is Trending Stock Cardinal Health, Inc. (CAH) a Buy Now?
- Recently, Zacks.com users have been paying close attention to Cardinal (CAH). This makes it worthwhile to examine what the stock has in store.
- 04/23/2024
|
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
- Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
- 04/22/2024
|
Cardinal Health Won't Renew OptumRx Distribution Pact. Guidance Is Unchanged.
- The pharmaceutical distribution contract with OptumRx will expire in June.
- 04/22/2024
|
Cardinal Health's stock slides 3.6% after announcing contract with OptumRx will not be renewed after end-June
- Cardinal Health Inc. ‘s stock CAH, +2.07% fell 3.6% early Monday, after the pharmaceuticals distributor and medical lab products maker said its contracts with pharmacy benefits manager OptumRx will expire at the end of June and will not be renewed. The Dublin, Ohio-based company said it still expects 2024 EPS of $7.20 to $7.35 despite the end of the contract, which generated 16% of its revenue in fiscal 2023.
- 04/22/2024
|
Cardinal Health: Solid Business But Overvalued
- Cardinal Health is overvalued, with a dividend yield lower than its historical average and a high P/E ratio. Growth projections for the Company are moderate, with a projected growth rate of 7.8% for the next 5 years. Return projections using the discounted dividend model suggest that CAH is still overvalued, with a fair price of around $79 compared to its current price of $106.
- 04/18/2024
|
Cardinal Health (CAH) Increases Despite Market Slip: Here's What You Need to Know
- In the latest trading session, Cardinal Health (CAH) closed at $107.03, marking a +1.84% move from the previous day.
- 04/15/2024
|
CPI Shock Waves: 3 Undervalued Stocks to Ride the Volatility
- CPI, the Consumer Price Index, is a metric used to gauge the rate of inflation and deflation. It's released by the Bureau of Labor Statistics (BLS) and reports the monthly fluctuations in consumer goods and services prices.
- 04/15/2024
|
Cardinal Health, Inc. (CAH) is Attracting Investor Attention: Here is What You Should Know
- Cardinal (CAH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- 04/12/2024
|
3 Medical Device Stocks With Solid Dividend Yield: CAH & Others
- Here we discuss three medical device stocks, Cardinal Health (CAH), Baxter International (BAX) and Fresenius Medical Care (FMS), with a solid five-year dividend growth history.
- 04/11/2024
|
Here's Why Cardinal Health (CAH) Fell More Than Broader Market
- Cardinal Health (CAH) concluded the recent trading session at $109.47, signifying a -0.41% move from its prior day's close.
- 04/08/2024
|
Should Value Investors Buy Cardinal Health (CAH) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 04/08/2024
|
Why Cardinal (CAH) is Poised to Beat Earnings Estimates Again
- Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 04/04/2024
|
Reasons to Add Cardinal Health (CAH) to Your Portfolio Now
- Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. However, the rising cost of products is a concern.
- 04/04/2024
|
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
- Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
- 04/04/2024
|
5 Broker-Loved Stocks That Hold Promise Despite Volatility
- We believe that stocks like General Motors (GM), Cardinal Health (CAH), Cencora (COR), Alta Equipment (ALTG) and Asbury (ABG) should be on an investor's watchlist.
- 03/27/2024
|
5 Solid Dividend Growth Stocks to Buy
- NetApp (NTAP), Installed Building (IBP), Ralph Lauren (RL), Applied Materials (AMAT), and Cardinal Health (CAH) could outperform the market this year.
- 03/26/2024
|
Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2024 on May 2
- DUBLIN, Ohio , March 26, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2024 on May 2, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.
- 03/26/2024
|
Here's Why Cardinal Health (CAH) is a Strong Value Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 03/25/2024
|
3 Reasons Growth Investors Will Love Cardinal (CAH)
- Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.
- 03/21/2024
|
The Cash Cow Cavalry: 3 Stocks Leading the Charge to Profitability
- Investors care about the bottom line. What does this mean?
- 03/21/2024
|
Here's Why Cardinal Health (CAH) is a Strong Momentum Stock
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 03/20/2024
|
5 Low-Beta Stocks for Safe Returns as Inflation Rises Again
- Low-beta stocks like Atmos Energy Corporation (ATO), Balchem Corporation (BCPC), Cardinal Health, Inc. (CAH), Casey's General Stores, Inc. (CASY) and Colgate-Palmolive Company (CL) are a safe bet amid the ongoing market volatility.
- 03/15/2024
|
The 3 Most Undervalued Stocks With Solid Fundamentals to Buy in March 2024
- Undervalued stocks are typically always a solid investment option in a bullish or bearish market due to the fact that they offer considerable upside. Solid fundamentals are the backbone of a company's overall success.
- 03/14/2024
|
Cardinal Health, Inc. (CAH) Presents at Barclays 26th Annual Global Healthcare Conference (Transcript)
- Cardinal Health, Inc. (CAH) Presents at Barclays 26th Annual Global Healthcare Conference (Transcript)
- 03/13/2024
|
Cardinal Health (CAH) Hits 52-Week High: What's Driving It?
- Investors are optimistic about Cardinal Health's (CAH) diversified product portfolio.
- 03/11/2024
|
5 Stocks Favored by Brokers Amid Current Uncertainty
- We believe that stocks like General Motors (GM), Cardinal Health (CAH), Deutsche Bank (DB), Group 1 (GPI) and Centene (CNC) should be on an investor's watchlist.
- 03/08/2024
|
5 Dividend Stocks With High Growth Prospects
- Cardinal Health (CAH), Toll Brothers (TOL), Iron Mountain (IRM), NetApp (NTAP) and Ralph Lauren (RL) have strong dividend growth prospects.
- 03/08/2024
|
Best Growth Stocks to Buy for March 8th
- POWL, CAH and PAGS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on March 8, 2023.
- 03/08/2024
|
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 03/07/2024
|
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 03/06/2024
|
4 Stocks Trading Near 52-Week High With More Upside Potential
- Investors target stocks that have lately been on a bull run. Stocks like PPC, SUN, CAH and TXT are seeing price strength and have a high chance of carrying the momentum forward.
- 03/06/2024
|
Best Growth Stocks to Buy for March 6th
- PAGS, CAH and NVDA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on March 6, 2023.
- 03/06/2024
|
3 Top-Ranked Stocks to Buy for Stability
- Targeting low-beta stocks can provide a valuable layer of stability for portfolios. After all, defense wins ballgames.
- 03/05/2024
|
5 Defensive Stocks to Buy as Consumer Sentiment Dips Again
- Investing in defensive stocks like The Ensign Group (ENSG), Cardinal Health (CAH), Consolidated Water (CWCO), Colgate-Palmolive (CL) and American Water Works, Inc. (AWK) is a safe bet as consumer sentiment is once again sinking.
- 03/05/2024
|
Best Growth Stocks to Buy for March 4th
- PAGS, CAH and NVDA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on March 4, 2023.
- 03/04/2024
|
Best Momentum Stocks to Buy for March 1st
- SPXC, CAH and TAST made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 1, 2023.
- 03/01/2024
|
New Strong Buy Stocks for March 1st
- BMA, CAH, RCL, SPXC and RITM have been added to the Zacks Rank #1 (Strong Buy) List on March 1, 2023.
- 03/01/2024
|
Best Income Stocks to Buy for March 1st
- BMA, CAH and RITM made it to the Zacks Rank #1 (Strong Buy) income stocks list on March 1, 2023.
- 03/01/2024
|
Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?
- Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 02/29/2024
|
3 Reasons Why Growth Investors Shouldn't Overlook Cardinal (CAH)
- Cardinal (CAH) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 02/28/2024
|
How to Find Top-Ranked Stocks to Buy in March
- Exploring how investors can use the Filtered Zacks Rank 5 Stock Screen to help find potentially winning stocks to buy in March and throughout what looks set to be a strong 2024.
- 02/27/2024
|
Best Growth Stocks to Buy for February 27th
- POWL, CAH and TXT made it to the Zacks Rank #1 (Strong Buy) growth stocks list on February 27, 2023.
- 02/27/2024
|
Best Growth Stocks to Buy for February 23rd
- CAH, POWL and PAX made it to the Zacks Rank #1 (Strong Buy) growth stocks list on February 23, 2024.
- 02/23/2024
|
Best Value Stocks to Buy for February 23rd
- BLDR and CAH made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 23, 2024.
- 02/23/2024
|
Best Income Stocks to Buy for February 23rd
- AROC, JSAIY and CAH made it to the Zacks Rank #1 (Strong Buy) income stocks list on February 23, 2024.
- 02/23/2024
|
New Strong Buy Stocks for February 23rd
- IRDM, JSAIY, CAH, LNTH and CENTA have been added to the Zacks Rank #1 (Strong Buy) List on February 23, 2024.
- 02/23/2024
|
Why Cardinal Health (CAH) is a Top Momentum Stock for the Long-Term
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 02/22/2024
|
5 Stocks Favored by Brokers Amid the Current Uncertainty
- We believe that stocks like Deutsche Bank (DB), Cross Country Healthcare (CCRN), Bread Financial (BFH), American Axle (AXL) and Cardinal Health (CAH) should be on an investor's watchlist.
- 02/22/2024
|
Is Cardinal Health (CAH) Stock Undervalued Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 02/19/2024
|
DivHut Dividend Income Update: January 2024
- DivHut Dividend Income Update: January 2024
- 02/16/2024
|
Final Trades: Invesco's Equal Weight Energy ETF, Cardinal Health and Shake Shack
- Today's “Halftime Report” Investment Committee, Bryn Talkington, Josh Brown and Jason Snipe, give their top picks to watch for the second half.
- 02/15/2024
|
Is Cardinal (CAH) a Solid Growth Stock? 3 Reasons to Think "Yes"
- Cardinal (CAH) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 02/12/2024
|
5 Broker-Loved Stocks to Watch Amid Current Market Swings
- We believe that stocks like American Airlines (AAL), Delta Air Lines (DAL), Cleveland-Cliffs (CLF), Best Buy (BBY) and Cardinal Health (CAH) should be on an investor's watchlist.
- 02/06/2024
|
Jobless Claims Increased More Than Expected
- New Jobless Claims numbers this morning continue to put a subtly different tilt on our current labor market: just like yesterday's lower-than-expected ADP ( ADP ) private-sector payroll tallies, ahead of today's opening bell we see both new and longer-term jobless claims jump unexpectedly higher. Initial claims came in 10K higher than estimates to 224K — the highest weekly print since mid-August of last year, and north of the upwardly revised previous week's 215K.
- 02/01/2024
|
Cardinal Health (CAH) Buys Specialty Networks to Boost Workflow
- Cardinal Health (CAH) acquires Specialty Network to technologically strengthen its specialty therapeutic areas. The acquisition also supports the company's ongoing Navista Network.
- 02/01/2024
|
Cardinal Health, Inc. (CAH) Q2 2024 Earnings Call Transcript
- Cardinal Health, Inc. (CAH) Q2 2024 Earnings Call Transcript
- 02/01/2024
|
Cardinal Health (CAH) Beats on Q2 Earnings, Ups '24 EPS View
- Cardinal Health's (CAH) second-quarter fiscal 2024 results benefit from the Pharmaceutical segment's solid performance.
- 02/01/2024
|
Should Value Investors Buy Cardinal Health (CAH) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 02/01/2024
|
Compared to Estimates, Cardinal (CAH) Q2 Earnings: A Look at Key Metrics
- The headline numbers for Cardinal (CAH) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 02/01/2024
|
Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?
- Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 02/01/2024
|
Cardinal Health lowers medical unit profit forecast, shares fall
- Cardinal Health lowered the full-year profit forecast for its medical segment on Thursday, taking the shine off the company's upbeat second-quarter results and sending its shares down more than 5%.
- 02/01/2024
|
Cardinal Health (CAH) Tops Q2 Earnings and Revenue Estimates
- Cardinal Health (CAH) came out with quarterly earnings of $1.82 per share, beating the Zacks Consensus Estimate of $1.56 per share. This compares to earnings of $1.32 per share a year ago.
- 02/01/2024
|
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
- Here is how Cardinal Health (CAH) and CSL Limited Sponsored ADR (CSLLY) have performed compared to their sector so far this year.
- 01/31/2024
|
4 Stocks Backed by High Efficiency to Enrich Your Portfolio
- Invest in companies like Axonics (AXNX), Enerpac Tool Group (EPAC), Cardinal Health (CAH) and Acuity Brands (AYI) due to higher efficiency levels.
- 01/31/2024
|
Cardinal Health to buy Specialty Networks for $1.2 billion in cash to boost analytics capabilities
- Cardinal Health Inc. CAH, +0.73% announced Wednesday an agreement to buy Specialty Networks for $1.2 billion in cash. Cardinal said the acquisition expands its offering in therapeutic areas by boosting its analytics capabilities and service offerings, and increases its data and research opportunities with biopharmaceutical manufacturers.
- 01/31/2024
|
What's in Store for Cardinal Health (CAH) in Q2 Earnings?
- Cardinal Health's (CAH) second-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical segment.
- 01/30/2024
|
Cardinal (CAH) is an Incredible Growth Stock: 3 Reasons Why
- Cardinal (CAH) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 01/26/2024
|
5 Low Leverage Stocks to Buy on Expectations of Rate Cuts
- The crux of safe investment lies in choosing a company that is not burdened with debt, as a debt-free stock is almost impossible to find. You may buy NSIT, ACA, CAH, PLAB and WING.
- 01/23/2024
|
Here's Why Cardinal Health (CAH) is a Strong Value Stock
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 01/16/2024
|
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 01/16/2024
|
Is Cardinal Health (CAH) Stock Outpacing Its Medical Peers This Year?
- Here is how Cardinal Health (CAH) and Asensus Surgical (ASXC) have performed compared to their sector so far this year.
- 01/15/2024
|
Cardinal Health, Inc. (CAH) J.P. Morgan 42nd Annual Healthcare Conference (Transcript)
- Cardinal Health, Inc. (CAH) J.P. Morgan 42nd Annual Healthcare Conference (Transcript)
- 01/09/2024
|
Cardinal Health's stock rises in range of a record after upbeat profit outlook
- Shares of Cardinal Health Inc. CAH, -0.52% rallied 1.7% in premarket trading Tuesday, after the drug distributor said it expects fiscal 2024 earnings to be at the high-end of previous guidance. The stock was on track to open at the highest price seen since it closed at a record $108.05 on Dec. 13.
- 01/09/2024
|
5 Stocks in S&P 500 ETF That Braved the Worst Start Since 2016
- The S&P 500 had the worst start to a year since 2016, reflecting a sharp reversal of the roaring rally in the final two months of 2023. Despite the losses, some stocks in the ETF stood tall.
- 01/08/2024
|
5 Low-Leverage Stocks to Buy Amid Mixed Investor Sentiments
- The crux of safe investment lies in choosing a company that is not burdened with debt, as a debt-free stock is almost impossible to find. You may buy LOB, MAR, CAH, FN and WING.
- 01/08/2024
|
Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2024 on February 1
- DUBLIN, Ohio , Jan. 2, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2024 on February 1, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.
- 01/02/2024
|
Will My Portfolio's Top 3 Performing Stocks From 2023 Deliver Again in 2024?
- Because buying dividend stocks is such a successful investment strategy over the past 100 years I gravitate towards them in my portfolio. It means I also look for stocks that have a proven track record of raising their payouts over time.
- 01/01/2024
|
3 Top Dividend Aristocrats to Buy Ahead of 2024
- Some of the dividend aristocrats, such as Cardinal Health (CAH), Atmos Energy (ATO) and NextEra Energy (NEE), have a better-quality business and strong underlying fundamentals.
- 12/28/2023
|
29 Undervalued Dividend Aristocrats: December 2023
- The S&P 500 Dividend Aristocrats Index contains 67 dividend growth stocks called the Dividend Aristocrats.
- 12/22/2023
|
Cardinal Health Is Setting Up For A Great 2024
- Cardinal Health is a global healthcare company that operates in over 40 countries and covers pharmaceutical distribution and medical products. Based on strong Q1 earnings, the Company is growing on multiple fronts. In addition, cost mitigation is starting to drive results in widening margins. With a price target of $115 and mitigated risks, CAH is a buy.
- 12/21/2023
|
5 Broker-Favorite Stocks to Keep an Eye on as 2024 Approaches
- We believe that stocks like American Airlines (AAL), ABM Industries (ABM), Cardinal Health (CAH), Cleveland-Cliffs (CLF) and Cencora (COR) should be on an investor's watchlist.
- 12/18/2023
|
Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue?
- Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 12/13/2023
|
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
- Here is how Cardinal Health (CAH) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.
- 12/12/2023
|
Is Cardinal Health (CAH) Stock Undervalued Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 12/12/2023
|
Reasons to Add Cardinal Health (CAH) to Your Portfolio Now
- Cardinal Health (CAH) continues to gain traction from a solid pharmaceutical segment and a diversified product portfolio. However, the rising cost of products is a concern.
- 12/12/2023
|
3 No-Brainer Stocks to Buy in December
- Buying stocks has proved to be one of the best ways to generate wealth over time. The strategy has beat buying gold, bonds, real estate, and even cryptocurrencies.
- 12/07/2023
|
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 12/07/2023
|
Cardinal (CAH) Upgraded to Buy: Here's What You Should Know
- Cardinal (CAH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- 12/06/2023
|
5 Broker-Friendly Stocks to Keep an Eye on Amid Volatility
- We believe that stocks like Brinker International (EAT), Cardinal Health (CAH), The Andersons (ANDE), Avnet (AVT) and Group 1 Automotive (GPI) should be on an investor's watchlist.
- 12/01/2023
|
5 Dividend Stocks Having Strong Growth Potential
- Cboe Global (CBOE), Cardinal Health (CAH), Assurant (AIZ), Installed Building Products (IBP) and FedEx (FDX) have a strong dividend growth potential.
- 12/01/2023
|
This Combination of 3 Stocks Provides Monthly Income
- Receiving steady dividend payouts is always a great feeling, as paydays are always the best. Of course, most dividends are paid quarterly.
- 11/30/2023
|
Earn A Potential 10% Plus Income With Options (December 2023)
- We explain why selling cash-covered puts and covered calls are relatively safe choices for earning a high income. We will discuss how to formulate a sustainable and repeatable options income strategy. In this monthly series, we present how to go about selecting the right kind of stocks for options income. We present two lists of 10 stocks with multiple scenarios: PUT options, CALL options, and deep-in-the-money CALL options.
- 11/27/2023
|
3 Reasons Why Growth Investors Shouldn't Overlook Cardinal (CAH)
- Cardinal (CAH) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 11/24/2023
|
Cardinal Health (CAH) Gets FDA Warning for Monoject Syringes
- The FDA is alerting healthcare providers and facilities against the use of Cardinal Health's (CAH) Monoject syringes with syringe pumps and PCS pumps.
- 11/24/2023
|
Should Value Investors Buy Cardinal Health (CAH) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 11/23/2023
|
Cardinal Health (CAH) Hits 52-Week High: What's Aiding It?
- Investors are optimistic about Cardinal Health's (CAH) diversified product portfolio.
- 11/23/2023
|
5 Top Dividend Growth Stocks for Your Portfolio
- Cboe Global Markets (CBOE), Parker-Hannifin (PH), Microsoft (MSFT), FedEx (FDX) and Cardinal Health (CAH) could be solid choices for your portfolio.
- 11/15/2023
|
Dividend Income Update October 2023
- Without rehashing the wild ride we experienced in the market the last couple of months with triple digit gains and losses, I could find comfort in one thing, my dividends. Dividends may not increase every year and a cut or elimination is even possible, but the odds are greatly reduced when you diversify among different companies and sectors and focus on dividend quality. Another four-digit month came in this year. As you can imagine, I am quite happy seeing that.
- 11/14/2023
|
4 Growth Stocks to Take Advantage of the November Rally
- With things looking up for the stock market this November, investing in growth stocks such as American Eagle Outfitters (AEO), Abercrombie & Fitch (ANF), Cardinal Health (CAH) and Runway Growth Finance (RWAY) seems prudent.
- 11/14/2023
|
Royal Rule: Buy These 3 Dividend Aristocrats on Every. Single. Dip.
- There is no substitute for dividend stocks when it comes to making money on Wall Street. Time and again studies show dividend payers significantly outperform those that do not.
- 11/13/2023
|
Cardinal Health (CAH) Launches Surgical Gown for Safe Surgery
- Cardinal Health's (CAH) SmartGown EDGE Breathable Surgical Gown will enable clinical teams to focus on delivering safe patient care by reducing instrument handoffs and contamination.
- 11/10/2023
|
Is Cardinal (CAH) a Solid Growth Stock? 3 Reasons to Think "Yes"
- Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.
- 11/07/2023
|
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 11/07/2023
|
Cardinal Health (CAH) Beats on Q1 Earnings, Ups '24 EPS View
- Cardinal Health's (CAH) first-quarter fiscal 2024 results benefit from the Pharmaceutical segment's solid performance.
- 11/03/2023
|
Cardinal Health (CAH) Surpasses Q1 Earnings and Revenue Estimates
- Cardinal Health (CAH) came out with quarterly earnings of $1.73 per share, beating the Zacks Consensus Estimate of $1.40 per share. This compares to earnings of $1.20 per share a year ago.
- 11/03/2023
|
Cardinal Health's stock rises into record territory after profit beat, raised outlook
- Shares of Cardinal Health Inc. CAH, +0.21% climbed 1.3% into record territory in premarket trading Friday, after the drug distributor reported fiscal first-quarter profit that beat expectations and raised its full-year outlook, while revenue came up a bit shy. Net income for the quarter to Sept.
- 11/03/2023
|
What's in Store for Cardinal Health (CAH) in Q1 Earnings?
- Cardinal Health's (CAH) first-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical segment.
- 11/01/2023
|
Aim For High Income And Less Risk With Options (November 2023)
- We explain why selling cash-covered puts and covered calls are relatively safe choices for earning a high income. We will discuss how to formulate a sustainable and repeatable options income strategy. In this monthly series, we present how to go about selecting the right kind of stocks for options income. We present two lists of 10 stocks with multiple scenarios: Put options, call options, and deep-in-the-money call options.
- 10/29/2023
|
3 Supercharged Dividend Stocks to Buy if There's a Stock Market Sell-Off
- AbbVie is a high-yield dividend stock that packs a punch. Stryker is a well-rounded business.
- 10/17/2023
|
5 Stocks That Brokers Favor Despite the Ongoing Uncertainty
- We believe that stocks like Rev Group (REVG), CVR Energy (CVI), Cardinal Health (CAH), Commercial Vehicle Group (CVGI) and Archer Daniels (ADM) should be on an investor's watchlist.
- 10/16/2023
|
Is Cardinal Health (CAH) Stock Undervalued Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 10/11/2023
|
Reasons to Add Cardinal Health (CAH) in Your Portfolio
- Cardinal Health (CAH) continues to gain traction from solid pharmaceutical segment and a diversified product portfolio. However, the rising cost of products is a concern.
- 10/11/2023
|
The Top 7 Stocks to Own During a Downturn
- As uncertainty seems to dominate, it might be time to look for stocks to own during a downturn. For 10 straight months, investors enjoyed a strong comeback rally in the S&P 500.
- 10/11/2023
|
Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy?
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 10/09/2023
|
7 Top Healthcare Stocks That Pay Dividends
- Facing an uncertain market environment, investors ought to consider the top healthcare stocks that pay dividends. Sure, the Federal Reserve may be in a position to facilitate a soft landing for the economy, per bullish analysts.
- 10/04/2023
|
Cardinal Health (CAH) Launches Next-Gen Enteral Feeding Pump
- Cardinal Health's (CAH) Kangaroo OMNI enteral feeding pump, with new portable design and effectiveness in terms of personalized care, is likely to improve the quality of life for patients.
- 10/03/2023
|
5 Stocks Favored by Brokers Amid the Current Turbulence
- We believe that stocks like CVR Energy (CVI), Delek US Holdings (DK), Bread Financial (BFH), Dish Network (DISH) and Cardinal Health (CAH) should be on an investor's watchlist.
- 09/27/2023
|
Here's Why Cardinal Health (CAH) is a Strong Value Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 09/18/2023
|
Cardinal Health, Inc. (CAH) Baird's Global Healthcare Conference 2023 (Transcript)
- Cardinal Health, Inc. (NYSE:CAH ) Baird's Global Healthcare Conference 2023 September 13, 2023 8:30 AM ET Company Participants Matt Sims - Investor Relations Jason Hollar - Chief Executive Officer Aaron Alt - Chief Financial Officer Conference Call Participants Eric Coldwell - Baird Eric Coldwell Good. Okay, great.
- 09/13/2023
|
Reasons to Retain Cardinal Health (CAH) in Your Portfolio
- Cardinal Health (CAH) continues to gain traction from solid pharmaceutical segment and a diversified product portfolio. However, the rising cost of products is a concern.
- 09/11/2023
|
The 3 Best Safe Stocks to Buy Now: September 2023
- Summer is unofficially over, but what a difference a year makes. The S&P 500 lost 19% in 2022 yet has rallied 17% higher since the end of July.
- 09/08/2023
|
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 09/01/2023
|
Cardinal Health's (CAH) Latest Launch to Enhance Neonatal Feeding
- Cardinal Health's (CAH) latest offering is likely to help premature and newborn infants develop the oral coordination skills important for the faster transition to independent feeding.
- 08/31/2023
|
3 Healthcare Stocks to Help Your Portfolio Get Well
- Many investors continue to look for growth wherever they can find it. That makes the healthcare sector very compelling.
- 08/16/2023
|
Cardinal Health (CAH) Q4 Earnings and Revenues Beat Estimates
- Cardinal Health (CAH) came out with quarterly earnings of $1.55 per share, beating the Zacks Consensus Estimate of $1.48 per share. This compares to earnings of $1.05 per share a year ago.
- 08/15/2023
|
Compared to Estimates, Cardinal (CAH) Q4 Earnings: A Look at Key Metrics
- Although the revenue and EPS for Cardinal (CAH) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 08/15/2023
|
Cardinal Health (CAH) Beats on Q4 Earnings, Ups '24 EPS View
- Cardinal Health's (CAH) fiscal fourth-quarter results benefit from the Pharmaceutical segment's solid performance.
- 08/15/2023
|
Cardinal Health raises 2024 profit forecast on drug distribution strength
- Drug distributor Cardinal Health Inc raised its 2024 profit forecast on Tuesday, as it sees strong demand for specialty and generic medicines to continue to boost sales in its pharmaceuticals unit.
- 08/15/2023
|
Cardinal Health Beats on Earnings, Raises Guidance on Strong Pharmaceutical Sales
- Cardinal Health reported fiscal fourth-quarter earnings of $1.55 a share on revenue of $53.5 billion.
- 08/15/2023
|
Cardinal Health's stock dips premarket after company swings to a loss
- Cardinal Health Inc.'s stock CAH slid 1% in premarket trade Tuesday, after the health services company swung to a loss for its fiscal fourth quarter from a profit a year ago. Dublin, Ohio-based Cardinal Health had a loss of $64 million, or 25 cents a share, for the quarter, after income of $138 million, or 50 cents a share, in the year-earlier period.
- 08/15/2023
|
Time to Buy These Medical Stocks as Earnings Approach
- Quarterly results from large retailers will highlight this week's earnings lineup but there are a few healthcare companies that investors will want to pay attention to as well.
- 08/14/2023
|
Prescribing Profits: 3 Stocks to Ride the Healthcare Relative Strength
- After a couple of weeks where the broad market experienced some weakness, the healthcare sector is showing considerable resiliency. Over the last month, the Healthcare Select Sector ETF XLV has been the second strongest sector in the market, behind just the energy market.
- 08/14/2023
|
Is a Beat Likely for Cardinal Health (CAH) in Q4 Earnings?
- Cardinal Health's (CAH) fiscal fourth-quarter 2023 results are expected to reflect solid performance in the Pharmaceutical segment.
- 08/10/2023
|
7 Dividend Aristocrats That Have Raised Their Payouts for 25 Years or More
- In recent years, dividend aristocrats have become a popular choice among investors of all stripes. Dividend aristocrats, or S&P 500 index components with at least 25 consecutive years of dividend growth, have historically delivered total returns on par with the S&P 500 but with lower volatility.
- 08/09/2023
|
Dividend Income Update July 2023
- July was exciting as ever as my year-over-year numbers continue to highlight the trifecta magic of dividend investing, which includes adding fresh capital, dividend raises and basic compounding to create an ever increasing passive income stream. I have to say I'm quite pleased with my July totals. Not too far from that coveted four-digit milestone too. After all, dividends don't lie. It's real cash being returned to investors. With patience and consistency these results and better can be achieved.
- 08/07/2023
|
Cardinal Health: Better EPS Growth Clarity, Buying Back Shares, A Buy On Valuation
- Health Care Services stocks have underperformed in the US market, but Cardinal Health has bucked the trend. CAH is one of the largest drug and medical product distributors, with strong earnings growth and a positive outlook. The firm is also buying back its shares with ample FCF. The stock is undervalued, with a compelling valuation and a powerful uptrend, making it a buy ahead of earnings on the 15th.
- 08/07/2023
|
AI Play Oracle, Amazon Rival Lead 5 Stocks Near Buy Points
- AI and cloud play Oracle leads five stocks to watch near buy points, along with Amazon rival MercadoLibre.
- 08/05/2023
|
3 MedTech Stocks Likely to Top Estimates This Earnings Season
- MedTech companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how EYE, CAH and HSIC are poised ahead of their earnings releases.
- 08/03/2023
|
Buckle Up! 3 Healthcare Stocks Set to Soar to New Heights
- Everyone seems to be focused on the Nasdaq, as tech stocks lead the way higher. While that may be the case, we've seen soaring healthcare stocks too.
- 08/03/2023
|
Will Cardinal (CAH) Beat Estimates Again in Its Next Earnings Report?
- Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 07/18/2023
|
Cardinal Health shares fall after downgrade
- Shares of Cardinal Health Inc. CAH, -0.30% were down 1% premarket on Monday after analysts at Evercore ISI downgraded the stock to an in-line rating, from outperform previously. The healthcare services company's share valuation now fully reflects its improving fundamentals and potential upside, the analysts wrote in a research note Monday.
- 07/10/2023
|
Dividend Champion, Contender, And Challenger Highlights: Week Of June 25
- A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
- 06/25/2023
|
9 Upcoming Dividend Increases Including A Dividend King
- Dividend increases typically indicate strong business performance and a commitment to rewarding shareholders. The article provides a list of companies with at least five years of consistent dividend growth and upcoming dividend increases. They have an average increase of 2.9% and a median increase of 2.5%.
- 06/23/2023
|
Using Return On Capital Employed To Generate Alpha With Dividend Aristocrats
- Return on Capital Employed (ROCE) is a financial ratio that measures a company's profitability and efficiency in utilizing its capital to generate returns. Strategies that focus on investing in companies with high ROCE or significant improvements in ROCE have historically outperformed the overall market. ROCE should be incorporated into stock research as it is an important metric for evaluating the long-term performance of a business.
- 06/22/2023
|
Cardinal Health (CAH) Hits 52-Week High: What's Aiding It?
- Investors are optimistic about Cardinal Health's (CAH) diversified product portfolio.
- 06/21/2023
|
Reasons to Retain Cardinal Health (CAH) in Your Portfolio
- Cardinal Health (CAH) continues to gain traction from solid pharmaceutical segment and a diversified product portfolio. However, the rising cost of products is a concern.
- 06/19/2023
|
Cardinal Health (CAH) to Build Distribution Center in Greenville
- Cardinal Health's (CAH) new facility will be its largest at-Home Solutions distribution center that will support business growth by providing new space and automation.
- 06/16/2023
|
Can Cardinal Health Fly Higher In 2023?
- Shares of Cardinal Health NYSE: CAH have nearly doubled over the last year and are leading the S&P 500 in 2023, but the gains are not over. The company updated its outlook at the recent investor day, and the details are bullish for the market.
- 06/12/2023
|
Strategic Updates Send Pharma Stock Higher
- Cardinal Health Inc (NYSE:CAH) is well into its Investor Day, which started at 9 a.m.
- 06/08/2023
|
Cardinal Health sets new $3.5 bln stock buyback and issues 2024 profit guidance
- Cardinal Health Inc. CAH, -1.27% on Thursday said it authorized a new $3.5 billion stock buyback program until the end of 2027. Cardinal Health said it expects 2024 adjusted profit of $6.45 to $6.70 a share, compared to the Wall Street analyst estimate of $6.55 a share, according to FactSet data.
- 06/08/2023
|
Cardinal Health's ‘Outcomes' Business Merges With Pharmacy Tech Firm TDS
- Medical products maker Cardinal Health is combining its Outcomes business with pharmacy tech firm Transaction Data Systems. The deal will give Cardinal Health a minority stake in the combined entity, with Debbie Weitzman, CEO of Cardinal Health's pharmaceutical segment, joining the Transaction Data Systems (TDS) board of directors, according to a Monday (June 5) press release.
- 06/05/2023
|
Cardinal Health Teams With Square on Pharmacy POS Payments
- Cardinal Health, a manufacturer and distributor of medical and laboratory products, has teamed up with Square to provide payment solutions for independent pharmacies. This collaboration aims to help independent pharmacies increase operational efficiency, stay current with customer payment preferences, and access integrated software tools for their business.
- 05/31/2023
|
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 05/30/2023
|
7 Overvalued Blue-Chip Stocks to Sell Before June 2023
- When looking at a number of overvalued blue-chip stocks, “Sell in May and Go away” fits. Typically, blue-chip stocks are generally among the safest stocks to own.
- 05/28/2023
|
Cardinal Health: Focus On Core Strengths And Operational Efficiency Enabling Margin Expansion
- In the past year, Cardinal Health (CAH: +50.95%) has rallied significantly, with share price action superior to both the broad market (SPY: +5.51%) and the healthcare industry (IXHC: +12.81%). This reflects a 34.80% in free cash flow from 2021-22 to $2.73bn and revenue growth of 11.62% in the same period.
- 05/24/2023
|
Cardinal Health: Not A Long-Term Investment
- Cardinal Health reported solid third quarter results and raised full-year guidance. In the last twelve months, Cardinal Health's stock outperformed as the stock price saw a reversion to the mean from previously extreme undervaluation.
- 05/24/2023
|
3 Top S&P 500 Stocks to Buy as Index Tastes 4200 Mark
- Banking on recent strengths, investors should place their bets on sound stocks like McDonald's (MCD), W.W. Grainger (GWW) & Cardinal Health (CAH) that are poised to scale upward along with the broader S&P 500 Index.
- 05/23/2023
|
Reasons to Retain Cardinal Health (CAH) in Your Portfolio
- Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and a diversified product portfolio. However, the rising cost of products is a concern.
- 05/18/2023
|
Shhh! 3 Healthcare Stocks Quietly Hitting 52-Week Highs
- Everyone seems to be talking about semiconductors, artificial intelligence (AI) and mega-cap tech. However, no one seems to be talking about healthcare stocks to buy.
- 05/17/2023
|
5 Attractive Value Picks Based on Discounted PEG
- Here are five stocks that meet our screening criteria - CAH, BYD, F, NXPI, AIG.
- 05/15/2023
|
Dividend Champion, Contender, And Challenger Highlights: Week Of May 14
- A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
- 05/13/2023
|
Cardinal Health raises quarterly dividend to 50.06 cents a share
- Cardinal Health CAH said Thursday its board has approved an increase in the company's quarterly dividend to 50.06 cents a share. The company paid out 49.57 cents a share in the last quarter.
- 05/11/2023
|
Dividend Portfolio Update: April 2023
- Markets continue to look shaky, real estate is starting to crack, precious metals doing pretty well but are still manipulated well below true value and the crypto world has started to thaw but nowhere near mania mode, yet. These lows and uncertain times are when the real profits and income is generated for the future.
- 05/10/2023
|
Cardinal Health (CAH) Beats on Q3 Earnings, Ups '23 EPS View
- Cardinal Health's (CAH) fiscal third-quarter results benefit from the Pharmaceutical segment's solid performance.
- 05/04/2023
|
Cardinal Health (CAH) Tops Q3 Earnings and Revenue Estimates
- Cardinal Health (CAH) came out with quarterly earnings of $1.74 per share, beating the Zacks Consensus Estimate of $1.48 per share. This compares to earnings of $1.45 per share a year ago.
- 05/04/2023
|
2 Medical Stocks to Buy Before Earnings
- Cardinal Health (CAH) and Ligand Pharmaceuticals (LGND) are two healthcare companies that investors certainly want to watch going into their quarterly reports.
- 05/02/2023
|
Is a Beat Likely for Cardinal Health (CAH) in Q3 Earnings?
- Cardinal Health's (CAH) third-quarter fiscal 2023 results are expected to reflect solid performance in the Pharmaceutical segment. However, inflationary pressure is likely to have continued.
- 05/02/2023
|
Bert's March 2023 Dividend Income Summary
- I invest in dividend stocks to grow my passive income with dividend income. We received $743.05 in April dividend income.
- 05/02/2023
|
Cardinal (CAH) is an Incredible Growth Stock: 3 Reasons Why
- Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.
- 04/28/2023
|
Will Cardinal (CAH) Beat Estimates Again in Its Next Earnings Report?
- Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 04/27/2023
|
Reasons to Retain Cardinal Health (CAH) in Your Portfolio
- Cardinal Health (CAH) continues to gain traction from solid pharmaceutical segment and a diversified product portfolio. However, the rising cost of products is a concern.
- 04/17/2023
|
These 3 Health Care Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts - Cardinal Health (NYSE:CAH), Amgen (NASDAQ:AMGN)
- During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
- 04/12/2023
|
Cardinal Health, Inc. (CAH) Is a Trending Stock: Facts to Know Before Betting on It
- Cardinal (CAH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
- 04/10/2023
|
5 S&P 500 Stocks Showing Strength As Recession Fears Rise
- Medical stocks are holding up amid economic and market uncertainty. The post 5 S&P 500 Stocks Showing Strength As Recession Fears Rise appeared first on Investor's Business Daily.
- 04/07/2023
|
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
- Here is how Cardinal Health (CAH) and Aspira (AWH) have performed compared to their sector so far this year.
- 04/06/2023
|
My Dividend Growth Portfolio - Q1 2023 Summary
- In 2015, I started publishing updates regarding my dividend growth portfolio, and I keep doing so every quarter. This is part of being transparent with my readers, so they can see what I hold and its correlation with my writing.
- 04/06/2023
|
5 Solid Dividend Growth Stocks to Buy in April
- Interpublic Group of Companies (IPG), Cardinal Health (CAH), Darden Restaurants. (DRI), Lam Research (LRCX) and Boyd Gaming (BYD) could be compelling picks for April.
- 04/05/2023
|
Should Value Investors Buy Cardinal Health (CAH) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 03/30/2023
|
Selecting Dividend Aristocrats Using SCHD Methodology - Mounting A Comeback
- I propose leveraging the stock selection criteria from the underlying index of SCHD to build a portfolio with a subset of Dividend Aristocrats. I am tracking two portfolios built using this process and comparing the results to NOBL and SCHD.
- 03/28/2023
|
Investors Heavily Search Cardinal Health, Inc. (CAH): Here is What You Need to Know
- Cardinal (CAH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
- 03/28/2023
|
Dividend Champion, Contender, And Challenger Highlights: Week Of March 26
- A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
- 03/25/2023
|
Don't Wait for Your Dividends. Here's How You Can Collect Cash Every Month.
- Cardinal Health's healthcare operations make it resilient as it generates billions in free cash flow. General Mills' strong brands have enabled the business to pass on higher prices to consumers.
- 03/22/2023
|
3 Inflation-Resistant Businesses That Recently Raised Guidance
- The vast majority of Adobe's revenue comes from subscriptions, making this a fairly stable business to invest in right now. Tapestry's high-end apparel and accessories cater to affluent customers who may be less affected by inflation.
- 03/21/2023
|
7 Stocks Set to Soar When the Market Recovers
- While time in the market generally beats out timing the market, it's understandable that some investors may want to hold off on looking for stocks to buy. After all, equities continue to digest the sudden failure of a handful of financial institutions.
- 03/16/2023
|
Healthcare Stocks With at Least 30 Years of Dividend Increases
- While it is not the only factor to consider, the annual dividend can solidify whether a stock will benefit you financially. And among the many industry sectors to invest in, healthcare can be one of the most stable, especially regarding the dividend yield.
- 03/14/2023
|
Here is What to Know Beyond Why Cardinal Health, Inc. (CAH) is a Trending Stock
- Cardinal (CAH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- 03/14/2023
|
5 Safe Stocks to Buy as SVB Collapse Shakes Wall Street
- At this stage, it will be prudent to stay with safe stocks.Five such stocks are: CAH, CINF, CLX, KO and GIS.
- 03/13/2023
|
After Plunging -10.82% in 4 Weeks, Here's Why the Trend Might Reverse for Cardinal (CAH)
- Cardinal (CAH) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
- 03/13/2023
|
The 4 Dividend Aristocrat Buys For March
- "Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years." --Kiplinger.com/Investing. 67 Aristocrats screened as of March 8, 2023, represented all eleven Morningstar Sectors. Broker estimated top ten net gains ranged 16.32%-32.64% topped by WBA & VFC.
- 03/10/2023
|
Cardinal Health's (CAH) New Tie-Up to Boost Patient Outcomes
- Cardinal Health's (CAH) latest partnership is expected to improve patients' healthcare journey by offering a more integrated experience that connects all sites of care.
- 03/08/2023
|
3 Reasons Growth Investors Will Love Cardinal (CAH)
- Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.
- 03/07/2023
|
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 03/06/2023
|
Lightning Round: Cardinal Health is a very good stock to own here
- Mad Money host Jim Cramer weighs in on all manner of stocks, including CyberArk, Snowflake, Cardinal Health and Kyndryl Holdings.
- 03/01/2023
|
Is Trending Stock Cardinal Health, Inc. (CAH) a Buy Now?
- Cardinal (CAH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- 02/28/2023
|
Selecting Dividend Aristocrats Using SCHD Methodology - Falling Behind
- I propose leveraging the stock selection criteria from the underlying index of SCHD to build a portfolio with a subset of Dividend Aristocrats. I am tracking two portfolios built using this process and comparing the results to NOBL and SCHD.
- 02/22/2023
|
Cardinal Health: Downgrading Due To Absence Of Safety Margin (Rating Downgrade)
- Cardinal Health, Inc.'s consistent fundamentals and growth prospects were reinforced by Q2 2023 earnings. Although Cardinal Health had a successful Q2, I believe it is prudent to be cautious before buying shares of the stock.
- 02/21/2023
|
Cardinal Health, Inc. (CAH) is Attracting Investor Attention: Here is What You Should Know
- Recently, Zacks.com users have been paying close attention to Cardinal (CAH). This makes it worthwhile to examine what the stock has in store.
- 02/17/2023
|
5 Dividend Growth Stocks to Buy Amid Market Volatility
- Microchip Technology (MCHP), Caterpillar (CAT), Xcel Energy (XEL), Cardinal Health (CAH) and Archer-Daniels-Midland (ADM) could be compelling dividend growth picks amid market volatility.
- 02/16/2023
|
Is This Warren Buffett Stock a Buy for Dividend Growth Investors?
- This Buffett-backed business leads the medical distribution industry.
- 02/16/2023
|
Is Cardinal Health (CAH) Stock Undervalued Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 02/13/2023
|
Dividend Income Update: January 2023
- Dividends may not increase every year and a cut or elimination is even possible but the odds are greatly reduced when you diversify among different companies and sectors and focus on dividend quality. The market may move up and down irrationally and seemingly on a whim while our dividends remain much more stable, reliable, and predictable.
- 02/13/2023
|
The Dividend Aristocrats Ranked By Quality Scores
- The annual rebalancing and subsequent changes to the S&P 500 Dividend Aristocrats Index have produced a new list of 67 dividend growth stocks called the Dividend Aristocrats. I rank the Dividend Aristocrats using Quality Snapshots, an elegant and effective system for assessing the quality of dividend growth stocks.
- 02/11/2023
|
Chairman Powell Says Inflation Is Cooling: 2 Stocks Set To Soar
- Chairman Powell is becoming more dovish due to declining inflation. As a result, we expect interest rates to peak soon and likely begin falling again before too long.
- 02/08/2023
|
This Portfolio of 3 Dividend Aristocrats Pays Monthly
- By targeting companies that pay out dividends in different months, investors can construct a portfolio that allows them to reap monthly income. Who doesn't love payday?
- 02/07/2023
|
Here is Why Growth Investors Should Buy Cardinal (CAH) Now
- Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.
- 02/07/2023
|
Hedge Funds Love These 8 Dividend Blue Chips, And So Should You
- Hedge funds employ some of the world's brightest analysts, with the most resources for analyzing companies. Lists of the most widely owned blue-chips among hedge funds can be a good source of new investing ideas.
- 02/07/2023
|
Bert's January 2023 Dividend Income Summary
- We received $736.32 in January dividend income! This represents an 18.46% dividend increase compared to last year. The strong dividend income growth is great! That is exactly how you want to start the year off. Our dividend income grew nearly $115 from January 2022.
- 02/07/2023
|
Cardinal Health, Inc. (CAH) Is a Trending Stock: Facts to Know Before Betting on It
- Zacks.com users have recently been watching Cardinal (CAH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
- 02/06/2023
|
Cardinal (CAH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
- While the top- and bottom-line numbers for Cardinal (CAH) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 02/06/2023
|
Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy?
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 02/03/2023
|
5 Dental Supplies Stocks to Buy Amid Recovering Prospects
- Here, we discuss five stocks from the Dental Supplies industry that are likely to create wealth for investors - MCK, ABC, LH, CAH and MMSI.
- 02/03/2023
|
Cardinal Health, Inc. (CAH) Q2 2023 Earnings Call Transcript
- Cardinal Health, Inc. (NYSE:CAH ) Q2 2023 Earnings Conference Call February 2, 2023 8:30 AM ET Company Participants Kevin Moran – Vice President-Investor Relations Jason Hollar – Chief Executive Officer Aaron Alt – Chief Financial Officer Trish English – Interim Chief Financial Officer Conference Call Participants Lisa Gill – JPMorgan Elizabeth Anderson – Evercore Michael Cherny – Bank of America Erin Wright – Morgan Stanley George Hill – Deutsche Bank Andrea Alfonso – UBS Charles Rhyee – Cowen Steven Valiquette – Barclays Eric Percher – Nephron Research Taji Phillips – Jefferies A.J. Rice calling – Credit Suisse Operator Hello, and welcome to the Second Quarter FY2023 Cardinal Health Earnings Conference Call.
- 02/02/2023
|
Cardinal Health (CAH) Q2 Earnings and Revenues Beat Estimates
- Cardinal (CAH) delivered earnings and revenue surprises of 16.81% and 2.04%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 02/02/2023
|
Cardinal Health swings to a loss but stock rises after adjusted earnings beat estimates
- Cardinal Health Inc. CAH, -1.98% said Thursday it swung to a second-quarter loss of $130 million, or 50 cents a share, from a profit of $49 million, or 17 cent a share in the year-ago quarter. The company reported adjusted net income of $1.32 a share, ahead of the Wall Street forecast of $1.14 a share, according to estimates compiled by FactSet.
- 02/02/2023
|
5 Top Dividend Growth Stocks to Buy in the Month of Love
- Archer-Daniels (ADM), Agilent Technologies (A), Republic Services (RSG), Deere & Company (DE) and Cardinal Health (CAH) seem solid picks for this month.
- 02/01/2023
|
Cardinal Health (CAH) to Post Q2 Earnings: What's in Store?
- Cardinal Health's (CAH) second-quarter fiscal 2023 results are likely to reflect solid performance in the Pharmaceutical segment. However, inflation and supply chain constraints are likely to have continued.
- 01/30/2023
|
Is Cardinal Health (CAH) Stock Outpacing Its Medical Peers This Year?
- Here is how Cardinal Health (CAH) and COMPASS Pathways PLC Sponsored ADR (CMPS) have performed compared to their sector so far this year.
- 01/27/2023
|
Should Value Investors Buy Cardinal Health (CAH) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 01/26/2023
|
Selecting Dividend Aristocrats Using SCHD Methodology - Slow And Steady
- I propose leveraging the stock selection criteria from the underlying index of SCHD to build a portfolio with a subset of Dividend Aristocrats. I am tracking two portfolios built using this process and comparing the results to NOBL and SCHD.
- 01/23/2023
|
Cardinal Health, Inc. (CAH) is Attracting Investor Attention: Here is What You Should Know
- Cardinal (CAH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- 01/23/2023
|
4 Value Stocks That Can Gain Even If Cheap Stocks Fall Out of Favor
- PayPal Holdings, DXC Technology, Molina Healthcare and Cardinal Health all have strong growth potential, which should keep powering their stocks, according to Credit Suisse.
- 01/20/2023
|
My Dividend Growth Portfolio - Q4 2022 Summary
- In 2015, I started publishing updates regarding my dividend growth portfolio, and I keep doing so every quarter. This is part of being transparent with my readers, so they can see what I hold and its correlation with my writing.
- 01/18/2023
|
Cardinal Health (CAH) Flat As Market Gains: What You Should Know
- Cardinal Health (CAH) closed at $76.52 in the latest trading session, marking no change from the prior day.
- 01/12/2023
|
Cardinal Health, Inc. (CAH) Is a Trending Stock: Facts to Know Before Betting on It
- Recently, Zacks.com users have been paying close attention to Cardinal (CAH). This makes it worthwhile to examine what the stock has in store.
- 01/11/2023
|
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 01/10/2023
|
Cardinal Health, Inc. (CAH) 41st Annual J.P. Morgan Healthcare Conference Transcript
- Cardinal Health, Inc. (NYSE:CAH ) 41st Annual J.P. Morgan Healthcare Conference January 9, 2023 1:30 PM ET Company Participants Jason Hollar - Chief Executive Officer Conference Call Participants Lisa Gill - JPMorgan Lisa Gill Good morning.
- 01/09/2023
|
Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash
- If the tide runs out, you won't be caught swimming naked with these two stocks in your portfolio.
- 01/07/2023
|
2 Dividend Aristocrat Stocks to Buy and Never Sell
- Dividend Aristocrats are steady and maybe a bit boring. But that can be a good thing, especially during periods of volatility
- 01/06/2023
|
Looking for a Growth Stock? 3 Reasons Why Cardinal (CAH) is a Solid Choice
- Cardinal (CAH) could produce exceptional returns because of its solid growth attributes.
- 01/06/2023
|
5 Top Recession-Proof Dividend Stocks to Buy in 2023
- Investors should place their bets now on dividend-paying recession-proof stocks such as Cardinal Health (CAH), Conagra Brands (CAG), Ingredion (INGR), Atmos Energy (ATO) and NRG Energy (NRG) for a steady income.
- 01/06/2023
|
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
- Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
- 01/03/2023
|
Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2023 on February 2
- DUBLIN, Ohio , Jan. 3, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2023 on February 2, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.
- 01/03/2023
|
My Dividend Growth Portfolio - Final 2022 Recap
- 2022 was another fantastic year for dividend growth, with my income increasing by over 13%. I recount every sale made during the year and the replacement purchases.
- 01/02/2023
|
2023 Dividend Growth Portfolio Review And Look Ahead
- Review of the current holdings and sectors in the portfolio, and how it has changed over the years. Income projections for 2023, and potential pitfalls.
- 01/01/2023
|
Selecting Dividend Aristocrats Using SCHD's Methodology - Initial Results
- I propose leveraging the stock selection criteria from the underlying index of SCHD to build a portfolio with a subset of Dividend Aristocrats. I am tracking two portfolios built using this process and comparing the results to NOBL and SCHD.
- 12/29/2022
|
Cardinal Health Is A Tempting Healthcare Income Play
- Cardinal Health has outperformed the broader market in 2022. While Cardinal Health's recent dividend growth rate has been slow, the company is a Dividend Aristocrat with a proven commitment to increasing payouts.
- 12/28/2022
|
What Makes Cardinal Health (CAH) a Strong Momentum Stock: Buy Now?
- Does Cardinal Health (CAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 12/27/2022
|
5 Broker-Friendly Stocks to Bank On as Volatility Persists
- Broker-favorite stocks like Cardinal Health (CAH), American Airlines (AAL), Boise Cascade (BCC), AmerisourceBergen (ABC) and Centene (CNC) should be on an investors' watchlist.
- 12/27/2022
|
5 Top-Ranked Dividend Growth Stocks for 2023
- Archer-Daniels-Midland (ADM), Cardinal Health (CAH), Insperity (NSP), Deere & Company (DE), and H&R Block (HRB) could be compelling picks for 2023.
- 12/27/2022
|
Buy This Warren Buffett-Owned Stock for 2023 and Beyond
- This healthcare products distributor's business model can withstand a recession.
- 12/26/2022
|
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
- These companies are safe havens during tough times, with above-average dividends.
- 12/24/2022
|
Is Cardinal Health (CAH) Stock Undervalued Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 12/23/2022
|
3 Top S&P 500 Performers of 2022
- Investors are more than aware of how harsh the market has been in 2022, with many stocks residing in the red year-to-date. Still, these three stocks have snapped the bearish trend, delivering substantial gains to shareholders.
- 12/21/2022
|
3 Reasons Why Cardinal (CAH) Is a Great Growth Stock
- Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.
- 12/21/2022
|
3 Medical Stocks Creating Wealth Despite Macro Challenges
- Here we discuss three stocks - CAH, LNTH and TMDX - that have been creating wealth for their investors in 2022 as several competitors faltered amid macro challenges. Will the trend continue?
- 12/21/2022
|
4 S&P 500 Stocks Up More Than 30% YTD With More Room to Run
- Despite the S&P 500 incurring a 15.7% YTD loss owing to inflation and high interest rates, stocks like ENPH, HAL, CAH and WRB have soared. They are poised to maintain the momentum in 2023.
- 12/14/2022
|
3 Stocks Silently Outperforming Energy in 2022
- Outperforming the Zacks Oils and Energy sector in 2022 is no easy task. However, bulls have silently roamed in all three of these stocks, breaking the overall bearish trend we've become accustomed to.
- 12/01/2022
|
Cardinal Health, Inc. (CAH) Evercore ISI 5th Annual Healthcare Conference Transcript
- Cardinal Health, Inc. (NYSE:CAH ) Evercore ISI 5th Annual Healthcare Conference November 30, 2022 8:50 AM ET Company Participants Kevin Moran – Investor Relations Jason Hollar – Chief Executive Officer Conference Call Participants Elizabeth Anderson – Evercore ISI Kevin Moran Let's try this again. Good morning.
- 11/30/2022
|
Here's Why You Should Retain Cardinal Health (CAH) Stock Now
- Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and a diversified product portfolio. However, the cost of products continues to rise.
- 11/24/2022
|
Good Stocks To Invest In Now? 3 Dividend Aristocrats Stocks For Your List
- Check out these three dividend aristocrats in the stock market this week.
- 11/22/2022
|
The 3 Best Blue-Chip Stocks to Buy Now
- When a bear market comes roaring, investors want to own the best blue-chip stocks. Believe it or not, there have been stocks recently hitting new 52-week and all-time highs.
- 11/17/2022
|
Cardinal Health's (CAH) Velocare to Enhance at-Home Care
- Cardinal Health's (CAH) latest launch is expected to significantly expand its at-Home Solutions supply chain and logistics services, thereby improving patient care.
- 11/17/2022
|
Bert's October Dividend Income Summary
- We received $801.63 in October dividend income. This was the first quarter we received a dividend from Vanguard's S&P 500 Index fund (VOO).
- 11/09/2022
|
Three Stocks Rise, Watchlist Grows With Midterm Elections, Fed In Focus
- As Leaderboard stocks Enphase Energy, Wingstop and Cheniere Energy navigate Fed rate hikes, all eyes now turn to the midterm elections. The post Three Stocks Rise, Watchlist Grows With Midterm Elections, Fed In Focus appeared first on Investor's Business Daily.
- 11/07/2022
|
Cardinal Health (CAH) Q1 Earnings and Revenues Top Estimates
- Cardinal Health's (CAH) fiscal first-quarter results benefit from the solid performance of the Pharmaceutical segment.
- 11/04/2022
|
Cardinal Health, Inc. (CAH) Q1 2023 Earnings Call Transcript
- Cardinal Health, Inc. (NYSE:CAH ) Q1 2023 Earnings Conference Call November 4, 2022 8:30 AM ET Company Participants Kevin Moran - Vice President of Investor Relations Jason Hollar - Chief Executive Officer Trish English - Interim Chief Financial Officer Conference Call Participants Elizabeth Anderson - Evercore Lisa Gill - JPMorgan Kevin Caliendo - UBS Erin Wright - Morgan Stanley Michael Cherny - Bank of America Eric Percher - Nephron Research George Hill - Deutsche Bank A.J. Rice - Credit Suisse Charles Rhyee - Cowen Steven Valiquette - Barclays Operator Good day, and welcome to the First Quarter Fiscal Year 2023 Cardinal Health Earnings Conference Call.
- 11/04/2022
|
Cardinal Health (CAH) Q1 Earnings and Revenues Surpass Estimates
- Cardinal (CAH) delivered earnings and revenue surprises of 25% and 5.81%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 11/04/2022
|
Cardinal Health Inches Higher On First-Quarter Beat, Maintained Guidance
- Cardinal Health topped first-quarter estimates on Friday and maintained its adjusted EPS view, leading CAH stock to rise. The post Cardinal Health Inches Higher On First-Quarter Beat, Maintained Guidance appeared first on Investor's Business Daily.
- 11/04/2022
|
Cardinal Health stock jumps toward 5-year high after big profit and revenue beats, affirmed outlook
- Shares of Cardinal Health Inc. CAH, +0.83% jumped 4.4% toward a five-year high in premarket trading Friday, after the drug and laboratory products distributor reported fiscal first-quarter profit and revenue that beat expectations, as strength in generics and branded pharmaceuticals helped offset inflationary supply chain costs. Net income for the quarter to Sept.
- 11/04/2022
|
Cardinal Health (CAH) to Post Q1 Earnings: What's in Store?
- Cardinal Health's (CAH) first-quarter fiscal 2023 results are likely to reflect solid performance in the Pharmaceutical segment. However, inflation and supply chain constraints are likely to have continued.
- 10/31/2022
|
S&P 500 Biotech Giant Vertex Leads 5 Stocks Showing Strength
- S&P 500 giant Vertex and Cheniere Energy, the largest U.S. liquefied natural gas producer, are setting up bullishly in the bear market. The post S&P 500 Biotech Giant Vertex Leads 5 Stocks Showing Strength appeared first on Investor's Business Daily.
- 10/22/2022
|
Check 5 Broker-Friendly Stocks for Returns Amid Market Chaos
- Broker-favorite stocks like American Airlines (AAL), Delta (DAL), CVR Energy (CVI), Bunge Limited (BG) and Cardinal Health (CAH) should be on an investor's watch list.
- 10/21/2022
|
Cardinal Health Clears Base, But Can It Maintain Uptrend?
- Cardinal Health, which distributes branded and generic pharmaceuticals and other healthcare products, cleared a cup-with-handle buy point Wednesday.
- 10/20/2022
|
The 3 Best Blue-Chip Stocks to Buy Now
- Investors are starting to clamor about whether we have seen the low for 2022 or, at the very least, whether the lows we reached last month will hold for the next several weeks. In any case, however investors really should be looking for the best blue-chip stocks to buy.
- 10/19/2022
|
Here's Why You Should Retain Cardinal Health (CAH) Stock Now
- Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and a diversified product portfolio. However, the cost of products continues to rise.
- 10/13/2022
|
Vertex Among 9 Stocks To Watch In Struggling Market
- As the market indexes work through a downturn, Vertex is among nine stocks to watch showing relative strength. The post Vertex Among 9 Stocks To Watch In Struggling Market appeared first on Investor's Business Daily.
- 10/03/2022
|
3 Blue-Chip Stocks to Buy to Tap Into a Hidden Bull Market
- We're in the midst of a bear market. That's something investors haven't seen in quite some time.
- 09/27/2022
|
Seeking Income? Consider These 3 Dividend Aristocrats
- During times of heightened volatility, an established income stream is undoubtedly a major positive, allowing investors to offset losses in other positions and reap those sweet dividend payouts.
- 09/15/2022
|
Cardinal Health (CAH) Lowers Medical Segment Income Guidance
- Cardinal Health (CAH) projects Medical segment loss to be in the range of $25 million to $55 million for the first quarter of fiscal 2023, owing to inventory charges related to the company's gloves portfolio.
- 09/14/2022
|
What's Happening With Cardinal Health Stock?
- Cardinal Health stock (NYSE: CAH) has seen a significant 36% rise this year, outperforming the broader S&P500 index, which is down 15%.
- 09/13/2022
|
Cardinal Health cuts earnings outlook for Medical segment, sees $25 million in inventory charges
- Cardinal Health Inc. CAH, -1.23% cut its fiscal first-quarter earnings outlook for its Medical segment, citing ongoing simplification efforts that are expected to result in $25 million in inventory charges related to its gloves portfolio. The company now expects a Medical segment loss of $55 million to $25 million, compared with a previous guidance range for a loss of $20 million to a profit of $20 million.
- 09/13/2022
|
A shake-up on Cardinal Health's board could pave the way for activist fund Elliott to create value
- Cardinal Health recently entered an agreement with Elliott Management, agreeing to appoint four director nominees to the board.
- 09/10/2022
|
Here's Why You Should Retain Cardinal Health (CAH) Stock Now
- Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and a diversified product portfolio. However, the cost of products continues to rise.
- 09/09/2022
|
Cardinal Health (CAH) Stock: Why It Fell 2.08% Today
- The stock price of Cardinal Health (CAH) fell by 2.08% today. This is why.
- 09/06/2022
|
Cardinal Health to form new board committee to review business as part of corporate governance moves agreed with Elliott
- Cardinal Health Inc. CAH, -0.46% announced a series of measures Tuesday aimed at boosting shareholder value and said activist investor Elliott Investment Management's Steven Barg will join its board. Among the moves, the medical products and services company will for a new Board committee to conduct a review of its strategy, portfolio, capital-allocation framework and operations.
- 09/06/2022
|
2 High-Yielding Dividend Stocks You Can Buy and Hold for Years
- Their payouts are likely to continue rising.
- 09/01/2022
|
The 5 Best and 5 Worst Performers in the S&P 500 in August
- EPAM Systems was the best performer in the index in August. Ball Corp. was the worst.
- 08/31/2022
|
S&P 500 Stock Market Winners Today
- Oil stocks were S&P 500 winners Monday, including Diamondback Energy. Bristol Myers Squibb was among the big losers.
- 08/29/2022
|
10 Stocks (Not In The Energy Sector) Are Up 30% Or More This Year
- It's been almost all about energy stocks in the S&P 500 this year. But not entirely.
- 08/26/2022
|
Failing in an Oligopoly Takes Serious Mismanagement
- One of the U.S.'s three dominant drug-distribution companies, Cardinal Health, is in the crosshairs of an activist investor.
- 08/22/2022
|
Cardinal Health Receives Bull Notes After Activist Investor News
- The shares of Cardinal Health Inc (NYSE:CAH) have been on quite a tear lately, up 26.7% in the last month, with only two negative days since July 19.
- 08/16/2022
|
Activist investor Elliott Management discloses large stake in Cardinal Health
- Activist investor Elliott Management has a large position in Cardinal Health Inc. and is seeking a handful of seats on the medical-products distributor's board, according to people familiar with the matter.
- 08/15/2022
|
Elliott Management Has Large Position in Cardinal Health
- The activist investor is seeking a handful of seats on the medical-products distributor's board, according to people familiar with the matter.
- 08/15/2022
|
Bert's July Dividend Income Summary | Dividend Investing 2022
- Our total dividend income decreased from $771.96 received in July 2021. Canadian Imperial takes the crown for the largest dividend payment of the month.
- 08/15/2022
|
Cardinal Health, Inc. (CAH) CEO Michael Kaufmann on Q4 2022 Results - Earnings Call Transcript
- Cardinal Health, Inc. (NYSE:CAH ) Q4 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Company Participants Kevin Moran - VP, IR Michael Kaufmann - CEO & Director Jason Hollar - CFO Conference Call Participants Lisa Gill - JPMorgan Chase & Co. George Hill - Deutsche Bank Michael Cherny - Bank of America Merrill Lynch Steven Valiquette - Barclays Bank Eric Percher - Nephron Research Charles Rhyee - Cowen and Company Rivka Goldwasser - Morgan Stanley Kevin Caliendo - UBS Elizabeth Anderson - Evercore ISI Operator Good day, and welcome to the Fourth Quarter and Full Year 2022 Cardinal Health Inc. Earnings Conference Call. Today's conference is being recorded.
- 08/11/2022
|
Cardinal Health (CAH) Q4 Earnings Lag Estimates, Revenues Top
- Cardinal Health's (CAH) fiscal fourth-quarter results benefit from a solid performance in the Pharmaceutical segment.
- 08/11/2022
|
Cardinal Health (CAH) Lags Q4 Earnings Estimates
- Cardinal (CAH) delivered earnings and revenue surprises of -10.26% and 5.62%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- 08/11/2022
|
Cardinal Health shares slump premarket after profit miss, CEO change
- Cardinal Health Inc. shares CAH, +1.59% slumped 4.5% in premarket trade Thursday, after the drug distributor missed profit estimates for the second quarte and announced a leadership change. The company posted net income of $138 million, or 50 cent a share, for the quarter, up from $116 million, or 40 cents a share, in the year-earlier period.
- 08/11/2022
|
Cardinal Health's (CAH) New Buyout to Boost Medication Adherence
- Cardinal Health's (CAH) latest acquisition is expected to significantly improve patients' health outcomes with improved medication adherence and increased satisfaction.
- 07/12/2022
|
New Strong Sell Stocks for July 8th
- ACER, CAH, and DRI have been added to the Zacks Rank #5 (Strong Sell) List on July 8, 2022.
- 07/08/2022
|
Cardinal Health (CAH) Buys Bendcare CPO-GPO, Invests in Its MSO
- Cardinal Health's (CAH) latest acquisition is expected to significantly boost its distribution opportunities and improve patient service.
- 07/07/2022
|
Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2022 on August 11
- DUBLIN, Ohio , July 7, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2022 on August 11, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.
- 07/07/2022
|
We Are in a Recession: 7 Dividend Aristocrats Are the Best Second-Half Ideas
- The second-quarter gross domestic product (GDP) is likely to end up being negative, as the latest data from the Atlanta Fed's GDPNow tracker predicts real GDP growth of −1.0% as of June 30, down from +0.3% on June 27.
- 07/05/2022
|
5 High-Conviction Stocks to Buy in This Market Correction
- Sometimes you just have to hold your nose and dive in, knowing that the near future may still dish out unnerving volatility.
- 06/30/2022
|
Cardinal Health (CAH) Ties Up to Deliver Products Via Drones
- Cardinal Health's (CAH) latest collaboration is expected to significantly boost its distribution strategy and improve patient service.
- 06/29/2022
|
7 Oversold Stocks to Buy After the Market Crash
- These oversold stocks are trading at multi-year lows and offer tremendous long-term growth potential to investors looking for bargains. The post 7 Oversold Stocks to Buy After the Market Crash appeared first on InvestorPlace.
- 06/24/2022
|
2 dividend aristocrats stocks for June, 2022
- 2022 might be said to be in a bear market since the majority of equities are now trading at lower.
- 06/13/2022
|
9 ‘Strong Buy' Dividend Aristocrats to Buy Now in Case Elon Musk Is Right
- In the history of the United States, there have been a handful of true visionaries that changed life and the world as we know it.
- 06/06/2022
|
Healthcare Stock Looks Ripe for Analyst Upgrades
- On Cardinal Health Inc (NYSE:CAH) stock's weekly chart, the equity just retested a trendline connecting higher lows since December 2021.
- 05/31/2022
|
7 High-Yield Retirement Stocks to Buy for Your Nest Egg
- These 7 high-yield retirement stocks to buy are among a list of companies that are dividend aristocrats and offer great dividends. The post 7 High-Yield Retirement Stocks to Buy for Your Nest Egg appeared first on InvestorPlace.
- 05/26/2022
|
7 Beaten-Down Growth Stocks That Look Like Big Bargains Right Now
- These beaten-down growth stocks look like big bargains as they are now heavily oversold despite their reassuring prospects. The post 7 Beaten-Down Growth Stocks That Look Like Big Bargains Right Now appeared first on InvestorPlace.
- 05/26/2022
|
Nordstrom Breaks Retail's Losing Streak, But This Stock Just Broke a Cardinal Rule
- Markets had another topsy-turvy day.
- 05/24/2022
|
The 7 Highest-Yielding Dividend Stocks to Buy Now for Income
- Highest-yielding dividend stocks offer add stability and consistent returns to portfolios The post The 7 Highest-Yielding Dividend Stocks to Buy Now for Income appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn't matter if you have $500 in savings or $5 million.
- 05/24/2022
|
8 ‘Strong Buy' Dividend Aristocrats Will Hold Up in the Coming Recession
- Despite the way the financial news talking heads try to spin it, and Wall Street firms projecting that a recession is likely 12 to 24 months from now, we are teetering on one right now.
- 05/20/2022
|
Healthcare Stock to Target as the Broader Market Plummets
- Medical retailer Cardinal Health Inc (NYSE:CAH) is eyeing relatively modest losses today, considering the severity of the broader market's selloff.
- 05/18/2022
|
7 Stock Picks to Play the Post-Pandemic Return of Dental Visits
- Although Covid-19 allowed people the excuse to not see their dentist, the necessary return could benefit these dental stocks to buy. The post 7 Stock Picks to Play the Post-Pandemic Return of Dental Visits appeared first on InvestorPlace.
- 05/09/2022
|
This 1 Healthcare Dividend Stock Has Risen While Others Struggle
- An extended agreement with a leading pharmacy has boosted investor confidence.
- 05/07/2022
|
Cardinal Health's Shares Fall as Inflation and Supply Chain Constraints Hit Q3 Earnings
- Cardinal Health Inc (NYSE: CAH) has reported Q3 FY22 adjusted EPS of $1.45, down 5% Y/Y, missing the consensus of $1.52 Q2 sales increased 14% Y/Y to $44.8 billion, beating the consensus estimate of $43.16 billion. The pharmaceutical segment increased 17% to $41 billion, driven primarily.
- 05/05/2022
|
Cardinal Health, Inc. (CAH) CEO Mike Kaufmann on Q3 2022 Results - Earnings Call Transcript
- Cardinal Health, Inc. (NYSE:CAH ) Q3 2022 Earnings Conference Call May 5, 2022 8:30 AM ET Corporate Participants Kevin Moran - Vice President, Investor Relations Mike Kaufmann - Chief Executive Officer Jason Hollar - Chief Financial Officer Conference Call Participants Charles Rhyee - Cowen Eric Percher - Nephron Research Michael Cherny - Bank of America Lisa Gill - JPMorgan Ricky Goldwasser - Morgan Stanley Elizabeth Anderson - Evercore ISI George Hill - Deutsche Bank AJ Rice - Credit Suisse Eric Coldwell - Baird Steven Valiquette - Barclays Operator Good day and welcome to the Cardinal Health, Inc. Third Quarter Fiscal Year 2022 Earnings Conference Call. Today's conference is being recorded.
- 05/05/2022
|
Cardinal Health (CAH) Q3 Earnings Miss Estimates
- Cardinal (CAH) delivered earnings and revenue surprises of -5.84% and 4.26%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 05/05/2022
|
Cardinal Health's stock falls 6% after earnings miss
- Shares of Cardinal Health Inc. CAH, +2.89% tumbled 6.0% in premarket trading on Thursday after the medical and pharmaceutical distributor missed on earnings for the quarter. Cardinal Health had a net loss of $1.4 billion, or $5.05 per share, in its third quarter of 2022, after net income of $119 million, or 40 cents per share, in the same quarter a year ago.
- 05/05/2022
|
Medical Product Stocks' Earnings May 5 Roster: MCK, CAH & PODD
- The Medical Product companies' quarterly results are likely to reflect base business recovery. Let's see how MCK, CAH and PODD are poised ahead of their earnings releases.
- 05/04/2022
|
Cardinal Health (CAH) to Post Q3 Earnings: What's in Store?
- Cardinal Health's (CAH) fiscal third-quarter results are likely to reflect solid performance in the Pharmaceutical segment.
- 05/03/2022
|
Here's Why You Should Retain Cardinal Health (CAH) Stock Now
- Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and a diversified product portfolio. However, contraction in gross margin is a woe.
- 04/21/2022
|
8 ‘Strong Buy' Rated Dividend Aristocrats to Buy Now in Case of a Total Market Collapse
- Even though some early first-quarter earnings have come in very solid, the reality is the market is teetering and could be ready to plunge.
- 04/18/2022
|
Cardinal Health to Webcast Discussion of Third-Quarter Results for Fiscal Year 2022 on May 5
- DUBLIN, Ohio , April 1, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2022 on May 5 prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.
- 04/01/2022
|
Cardinal Health (CAH) to Extend Medical Distribution Presence
- Cardinal Health's (CAH) plans to build a new facility in Columbus, OH, can expand its medical distribution footprint in the region.
- 03/31/2022
|
3 Lucrative Stocks From the Promising Dental Supplies Industry
- Despite the COVID-19 pandemic-induced challenges, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.
- 03/29/2022
|
Cardinal Health Remains A Bargain
- Cardinal Health Remains A Bargain
- 03/23/2022
|
Cardinal Health (CAH) Unveils the First Surgical Incise Drape
- Cardinal Health's (CAH) introduction of the first surgical incise drape is likely to lower SSIs.
- 03/21/2022
|
Here's Why You Should Retain Cardinal Health (CAH) Stock Now
- Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and a diversified product portfolio. However, contraction in gross margin is a woe.
- 03/15/2022
|
3 Dividend Aristocrats to Buy in a Volatile Market
- Dividend aristocrats are a particularly intriguing area of the market to consider, as investors can rely on these companies for consistent increases in payouts over the years.
- 03/15/2022
|
Should Value Investors Pick Cardinal Health (CAH) Stock Now?
- Let's see if Cardinal Health (CAH) stock is a good choice for value-oriented investors right now from multiple angles.
- 03/15/2022
|
U.S. should review drugmakers' opioid settlement tax breaks - House panel
- The U.S. Justice and Treasury Departments should review the tax deductions four drugmakers made related to their $26 billion opioid settlement, the U.S. House Oversight and Reform Committee said in a statement on Monday.
- 03/14/2022
|
Dividend Income Update January 2022
- With February already underway, it is time for all dividend income investors to look back at the previous month and see how much passive dividend income our portfolios generated.
- 02/22/2022
|
Why Cardinal Health Is A Sound Buy In This Crazy Market
- Cardinal Health continues its track record of strong revenue growth.
- 02/15/2022
|
Cardinal Health: Call The Doctor, Share Buybacks Have Me Swooning
- CAH has had a rough go the past few years with the opioid epidemic and coronavirus pandemic impacting their bottom line. Profit margins leave much to be desired and need to improve. Investors can expect a conservative total return CAGR of 14.7% over 5 years.
- 02/07/2022
|
Cardinal Health (CAH) Q2 Earnings and Revenues Top Estimates
- Cardinal Health's (CAH) fiscal second-quarter results benefit from a solid performance in the Pharmaceutical segment.
- 02/03/2022
|
Cardinal Health, Inc. (CAH) CEO Mike Kaufmann on Q2 2022 Results - Earnings Call Transcript
- Cardinal Health, Inc. (CAH) CEO Mike Kaufmann on Q2 2022 Results - Earnings Call Transcript
- 02/03/2022
|
Cardinal Health (CAH) Beats Q2 Earnings and Revenue Estimates
- Cardinal (CAH) delivered earnings and revenue surprises of 3.25% and 1.02%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
- 02/03/2022
|
Cardinal Health's Q4 Earnings Hit By Inflationary Impacts, Supply Chain Constraints; Lowers FY22 Outlook
- Cardinal Health CAH has reported Q2 FY22 adjusted EPS of $1.27, down 27% Y/Y, beating the Street estimate of $1.23. Thousands of new traders are learning the ins and outs on how to find profitable trades every day with Benzinga Trading School.
- 02/03/2022
|
Cardinal Health (CAH) to Post Q2 Earnings: What's in Store?
- Cardinal Health's (CAH) fiscal second-quarter results are likely to reflect solid performance in the Pharmaceutical segment.
- 01/31/2022
|
Ember expands into cold chain medical shipping with new device, Cardinal Health partnership
- Last year, Ember outlined one of the more fascinating expansions of recent vintage we've seen in the hardware space. Primarily known for its smart mugs designed to keep their contents hot, the firm took a long, hard look at the cold chain — specifically, the transport of medicine across distances.
- 01/31/2022
|
Good, Better, Great: 7 Assets To Buy In 2022
- Good, Better, Great: 7 Assets To Buy In 2022
- 01/27/2022
|
Want to Make an Extra $4,000 in 2022? Invest $78,000 in These 3 Dividend Stocks
- And if you hang onto these investments, that income could even rise over time.
- 01/22/2022
|
7 Low Labor-Cost Stocks to Buy for Solid Margins in 2022
- These seven low-labor-cost stocks -- including Apple and PayPal -- are buys as the U.S. labor market tightens and wages rise in 2022. The post 7 Low Labor-Cost Stocks to Buy for Solid Margins in 2022 appeared first on InvestorPlace.
- 01/21/2022
|
Cardinal Health: Attractive Long-Term Investment At 10.0x Forward P/E
- Cardinal Health looks like a great long-term value investment current trading at 10.0x forward P/E. The company does a good job returning cash to shareholders through share repurchases of 2.1% annually in addition to the current 3.76% dividend yield.
- 01/15/2022
|
Bear of the Day: Cardinal Health (CAH)
- Earnings are not as healthy as they could be.
- 01/13/2022
|
New Strong Sell Stocks for January 12th
- ASH, CAH, and ESTA have been added to the Zacks Rank #5 (Strong Sell) List on January 12, 2022
- 01/12/2022
|
Cardinal Health, Inc. (CAH) Management Presents at 40th JPMorgan Annual Healthcare Conference (Transcript)
- Cardinal Health, Inc. (CAH) Management Presents at 40th JPMorgan Annual Healthcare Conference (Transcript)
- 01/10/2022
|
Cardinal Health Expects Inflationary Impact, Supply Chain Constraints To Hit Volumes In FY22
- Cardinal Health Inc (NYSE: CAH) shares are trading lower after the company warned of additional inflationary effects and lower volumes from global supply chain constraints with lower-than-anticipated offset from pricing actions. As a result, the incremental impact will be nearly $150 million – $175 million on FY22 medical segment profit and $0.40 – $0.45 per share on non-GAAP EPS.
- 01/10/2022
|
Cardinal Health lowers expectations for medical segment due to inflation, supply chain
- Cardinal Health CAH, +3.29% said Monday the impact of inflation and supply chain disruptions will reduce its fiscal 2022 medical segment unit profit by $150 million to $175 million. Cardinal Health now expects fiscal year 2022 profit that's 40 cents to 45 cents below its earlier expectations.
- 01/10/2022
|
Here's Why You Should Retain Cardinal Health (CAH) Stock Now
- Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and diversified product portfolio. However, contraction in gross margin is a woe.
- 01/05/2022
|
Cardinal Health to Webcast Discussion of Second-Quarter Results for Fiscal Year 2022 on February 3
- DUBLIN, Ohio, Jan. 3, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2022 on February 3 prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.
- 01/03/2022
|
Upcoming Ex-Dividend Dates: December 30-January 7, 2022
- We provide a summary of upcoming ex-dividend dates in a quick reference table.
- 12/30/2021
|
5 High-Yielding Dividend Aristocrats Are ‘Strong Buy' Stock Ideas for 2022
- It is hard to believe 2021 is all but over and 2022 is upon us. The Santa Claus rally has carried the S&P 500 back to new all-time highs and everything seems set up for a strong January.
- 12/29/2021
|
2 High-Yield Anti-Bubble Blue-Chip Bargains For A Rich 2022 And Beyond
- In 2022 high valuations will likely combine with the current Wall of Worry to create increased volatility (and more blue-chip investment opportunities for smart investors). Anti-bubble blue-chip investing is a great way to minimize risk, maximize safe yield, and can help you retire rich, and stay rich in retirement.
- 12/27/2021
|
Top Dividend Aristocrats Tag 4 To Buy For January
- "Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years." - Kiplinger. The 65 Aristocrats screened as of December 23, 2021, represented all eleven Morningstar Sectors. Broker targeted-top-ten net-gainers ranged 14.59%-32.89% topped by MDT and LEG.
- 12/26/2021
|
Options Income Series: Earn High Income Safely And Consistently - December 2021
- We explain why selling the cash-covered puts and covered calls is a safer choice and earns a high income. We will discuss how to formulate an options income strategy that's sustainable and repeatable.
- 12/25/2021
|
7 Stocks to Buy if Covid-19 Becomes Endemic
- Watching the developments of the Covid-19 crisis, it could become endemic. Here's what that means for certain stocks to buy.
- 12/20/2021
|
Santa Is Delivering 10 High-Yield Dividend Aristocrat Bargains You Won't Want To Miss
- Santa Is Delivering 10 High-Yield Dividend Aristocrat Bargains You Won't Want To Miss
- 12/15/2021
|
Cardinal Health Is A Great Bargain Buy, Here's Why
- Cardinal Health has a strong track record of revenue growth, which continued in the latest quarter. Management expects supply chain disruptions to subside by the end of the current fiscal year.
- 12/14/2021
|
Want to Collect $500 Each Month? Invest $123,553 Into These 3 Dividend Stocks
- Not only do these companies they offer high-yielding payouts, but they have solid track records of boosting them regularly.
- 12/13/2021
|
15 Best Dividends On Earth Priced To Buy In December
- Kiplinger "insights for investors" online, first-published 91 "Top Dividend Stocks From Around The World" 7/13/20. Two Kiplinger articles provided this 105 Best Dividend Stocks on Earth compiled 7/1/21. 40 European “Dividend Aristocrats,” showed 10 years of stable or increasing dividends; 65 S&P 500 Aristocrats showed 25 years of increases for U.S. companies.
- 12/11/2021
|
Here's Why You Should Retain Cardinal Health (CAH) Stock Now
- Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and diversified product portfolio. However, contraction in gross margin is a woe.
- 12/06/2021
|
3 Incredible Value Stocks to Buy Before 2021 Is Over
- Great companies trading at cheap prices? Yes, please.
- 12/04/2021
|
5 Dividend Aristocrat Bargains Near 52-week Lows
- As people kick off Black Friday shopping across the U.S., five dividend aristocrat stocks with high guru ownership that are trading near 52-week lows are Cardinal Health Inc. ( CAH , Financial), AT&T Inc. ( T , Financial), Medtronic PLC ( MDT , Financial), International Business Machines Corp ( IBM , Financial) and Leggett & Platt Inc. ( LEG , Financial), according to the All-in-one Screener, a Premium feature of GuruFocus.
- 11/26/2021
|
Cardinal Health: This 4% Yielding Dividend Aristocrat Could Triple In The Next 5 Years
- Cardinal Health: This 4% Yielding Dividend Aristocrat Could Triple In The Next 5 Years
- 11/23/2021
|
3 Promising Stocks From the Buoyant Dental Supplies Industry
- Despite the COVID-19 pandemic induced challenges, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.
- 11/23/2021
|
Cardinal Health's (CAH) Arm Unveils Supply Automation Solution
- Cardinal Health's (CAH) business introduces new offering for clinical labs that can enable them to focus on patient care.
- 11/19/2021
|
McKesson, Cardinal Health, AmerisourceBergen Face $95B Opioid Trial In Washington: Reuters
- A Washington state trial against McKesson Corporation (NYSE: MCK), Cardinal Health Inc (NYSE: CAH), and AmerisourceBergen Corp (NYSE: ABC) for the U.S. opioid epidemic is slated to kick off today, Reuters reported. Washington Attorney General Bob Ferguson declined to join a $26 billion nationwide settlement and has accused the drug distributors of creating a public nuisance by failing to prevent the diversion of prescription pills into illegal channels.
- 11/15/2021
|
Cardinal Health Pivots Towards Profit Despite $6.37B Settlement
- Cardinal Health is one of the beneficiaries of the growing biosimilar market.
- 11/11/2021
|
Dividend Income Summary: Bert's October 2021 Report
- Dividend Income Summary: Bert's October 2021 Report
- 11/09/2021
|
Cardinal Health, Inc. (CAH) CEO Mike Kaufmann on Q1 Fiscal 2022 Results - Earnings Call Transcript
- Cardinal Health, Inc. (CAH) CEO Mike Kaufmann on Q1 Fiscal 2022 Results - Earnings Call Transcript
- 11/09/2021
|
Cardinal Health (CAH) Q1 Earnings Lag, Revenues Top Estimates
- Although Cardinal Health (CAH) witnessed gross margin contraction in its fiscal first-quarter results, rise in revenues in both its segments is encouraging.
- 11/09/2021
|
Cardinal Health (CAH) Misses Q1 Earnings Estimates
- Cardinal (CAH) delivered earnings and revenue surprises of -2.27% and 5.29%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
- 11/09/2021
|
Cardinal Health Post Mixed Q1 Earnings; Reaffirms FY22 Adjusted EPS Outlook
- Cardinal Health (NYSE: CAH) reported Q1 FY22 adjusted EPS of $1.29, down from $1.51 a year ago, missing the Street estimate of $1.33. Q1 sales increased 13% Y/Y to $44 billion, beating the consensus estimate of $41.93 billion.
- 11/09/2021
|
Cardinal Health stock gains as profit misses expectations but revenue beats and outlook affirmed
- Shares of Cardinal Health Inc. CAH, +0.18% rose 1.5% in premarket trading Tuesday, after the drug distributor and make of lab products reported fiscal first-quarter profit that missed expectations, as supply chain costs weighed on its medical business, but revenue rose above forecasts. The company swung to net income of $271 million, or 94 cents a share, from a loss of $253 million, or 86 cents a share, in the year-ago period.
- 11/09/2021
|
112 S&P High Yield Dividend Aristocrats Deliver More Dog Per Dollar
- "S&P High Yield Dividend Aristocrats index is designed to measure the performance of companies within the S&P Composite 1500 that have consistently increased dividends every year for at least 20 years." - spindices.com.
- 11/05/2021
|
Cardinal Health (CAH) to Post Q1 Earnings: What's in Store?
- Cardinal Health's (CAH) fiscal first-quarter results are likely to reflect solid performance in the Pharmaceutical segment.
- 11/04/2021
|
Dividend Income Summary: Lanny's October 2021 Summary
- In October, we (my wife and I) received a total of $966.97 of dividend income.
- 11/03/2021
|
My, Oh My, 3 High-Yield Dividend Aristocrat Strong Buys
- My, Oh My, 3 High-Yield Dividend Aristocrat Strong Buys
- 10/25/2021
|
Cardinal Health: Deep Value, High Yield, Are You Putting Cash To Work?
- Cardinal Health's share price has been beaten down due to what I see as being transient and one-time events. Pressures are expected to ease in the second half of its current fiscal year, with growth normalizing in the pharma and medical segments.
- 10/17/2021
|
Journey Biosciences and Cardinal Health OptiFreight® Logistics Collaborate to Improve Long-Term Diabetes Care
- LEBANON, N.H., Oct. 14, 2021 /PRNewswire/ -- Journey Biosciences, Inc., a biotechnology company with an innovative proactive diagnostic screening technology for high risk kidney complications, including Diabetic Kidney Disease (DKD), today announced a collaboration with Cardinal Health (NYSE: CAH) OptiFreight® Logistics that will increase control and visibility across every transportation modality.
- 10/14/2021
|
Here's 14 Top Dividends On Earth At Ideal Prices For October
- Kiplinger "insights for investors" online first offered a list of 91 "Top Dividend Stocks From Around The World" 7/13/20. Two Kiplinger articles provided this 102 Top Dividend Stocks list 7/1/21. 39 European “Dividend Aristocrats” showed 10 years of stable or increasing dividends; 65 S&P 500 Aristocrats showed 25 years of increases for U.S. companies.
- 10/09/2021
|
Cardinal Health: Still Cheap Despite The Opioid Settlements
- Cardinal Health: Still Cheap Despite The Opioid Settlements
- 10/06/2021
|
Cardinal Health's (CAH) Unit to Aid Canadian Healthcare System
- Cardinal Health's (CAH) subsidiary to support the Canadian Healthcare system against COVID-19 with vaccination policy.
- 09/30/2021
|
7 Deep Value Stocks That Are an Even Better Buy Now After Tanking
- Whether they've pulled back as of late or have been depressed for a while, consider these 7 deep value stocks screaming buys. The post 7 Deep Value Stocks That Are an Even Better Buy Now After Tanking appeared first on InvestorPlace.
- 09/29/2021
|
Drug Distributors Ink First Opioid Settlement With Cherokee Nation
- Cardinal Health Inc (NYSE: CAH), McKesson Corporation (NYSE: MCK), and AmerisourceBergen Corp (NYSE: ABC), accused of U.S. addiction crisis, have struck a settlement with a tribal government, Reuters reports. As part of the deal with Cherokee Nation's territory in Oklahoma, the three companies will pay $75 million over six and half years to resolve claims linked to the opioid epidemic in the region.
- 09/28/2021
|
Cardinal Health to Webcast Discussion of First-Quarter Results for Fiscal Year 2022 on November 9
- DUBLIN, Ohio, Sept. 27, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2022 on November 9 prior to the opening of trading on the New York Stock Exchange.
- 09/27/2021
|
Dividend Champion And Contender Highlights: Week Of September 26
- A weekly summary of dividend activity for Dividend Champions and Contenders.
- 09/26/2021
|
Hedge Funds Dump Stocks: Move to These 5 Big Dividend Winners Now
- While we stand just 5% off the all-time highs, it sure doesn't feel like it. After two lousy weeks and Monday's big sell-off, when we finally hit the elusive 5% decline that took almost a year to happen, Monday's late reversal showed that once again, the “buy the dip” crowd will wade into even the largest of sell-offs to buy stocks.
- 09/22/2021
|
Cardinal Health establishes goal to reduce Scope 1 and Scope 2 greenhouse gas emissions 50% by 2030
- DUBLIN, Ohio, Sept. 20, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced it has established a goal to reduce Scope 1 and Scope 2 greenhouse gas (GHG) emissions 50% by 2030.
- 09/20/2021
|
Cardinal Health's (CAH) CEO Mike Kaufmann Presents at Morgan Stanley 19th Annual Global Healthcare Conference (Transcript)
- Cardinal Health's (CAH) CEO Mike Kaufmann Presents at Morgan Stanley 19th Annual Global Healthcare Conference (Transcript)
- 09/14/2021
|
Why Cardinal Health Is A Dividend Champion
- Why Cardinal Health Is A Dividend Champion
- 09/07/2021
|
Distributors Announce Proposed Opioid Settlement Will Proceed to Next Phase
- CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that, under the previously announced proposed settlement agreement and process designed to resolve the opioid claims of state and local governmental entities, they have determined that enough states have agreed to settle to proceed to the next phase. Under the proposed settlement agreement and process, all U.S. States, territories
- 09/04/2021
|
Remember, Remember To Come Back In September: 6 Stock Picks
- While the stock market seems extremely expensive, it is still a market of stocks enabling us to find some good picks. Four sleep-well stocks might be the two consumer goods companies Reckitt Benckiser and Henkel as well as the two healthcare companies Cardinal Health and Amgen.
- 09/01/2021
|
7 Top Stocks To Buy And Hold Forever
- Wall Street keeps reminding us of the benefits of stocks to buy and hold since the early weeks of the pandemic. And here are a few to watch.
- 08/27/2021
|
NRx Pharma, Cardinal Health Ink Zyesami Distribution Pact
- NRx Pharmaceuticals Inc (NASDAQ: NRXP) has signed an agreement with Cardinal Health Inc (NYSE: CAH) to provide third-party logistics and distribution of Zyesami upon the potential FDA Emergency Use Authorization (EUA) approval. In May, NRx applied for EUA to the FDA for Zyesami (aviptadil) for critical COVID-19 patients with respiratory failure.
- 08/26/2021
|
Could These 2 Dividend Aristocrats Break Their Payout-Hiking Streaks Next Year?
- Cardinal Health and Clorox have posted some disappointing results lately.
- 08/25/2021
|
Cardinal Health Expands its DE&I Efforts with Comprehensive Talent Strategy
- DUBLIN, Ohio, Aug. 23, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today a comprehensive talent strategy to increase representation of diverse employees at the manager level and above by 2030. This commitment is specifically aimed at increasing the company's global leadership representation of women, as well as African American and Black, Asian, Latinx, Indigenous and all other ethnically diverse groups in leadership roles in the U.S. "Diversity, equity and inclusion are business imperatives," said Mike Kaufmann, CEO of Cardinal Health.
- 08/23/2021
|
Cardinal Health: A Solid Business Got Even Cheaper
- Cardinal Health reported mixed quarterly results and missed analysts' expectations causing a steep drop for its share price. With a stable balance sheet, that is improving and close to a settlement about the opioid lawsuits, we can expect more consistency of Cardinal Health in the years to come.
- 08/20/2021
|
Dividend Income Summary: Bert's July 2021 Summary
- In July, we received $771.96 in dividend income! Our top dividend payment for the month was a HUGE special dividend payment from T. Rowe Price.
- 08/14/2021
|
Cardinal Health announces redemption of outstanding notes
- DUBLIN, Ohio, Aug. 13, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it is sending an irrevocable notice of early redemption to the holders of all of the Company's 2.616% notes due June 2022 that are outstanding as of the early redemption date (aggregate principal amount of $572,171,000). The early redemption date is set to September 15, 2021, pursuant to the June 2, 2008 indenture and the 2.616% notes.
- 08/13/2021
|
Cardinal Health Extends Pharmaceutical Distribution Agreements with CVS Health
- DUBLIN, Ohio, Aug. 11, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has extended its agreements with CVS Health to distribute pharmaceuticals to retail pharmacies and distribution centers through June 30, 2027. "We value our long-standing partnership with CVS Health, and we are honored to continue our important work together to bring our best-in-class abilities together for their customers," stated Mike Kaufmann, CEO of Cardinal Health.
- 08/11/2021
|
Cardinal Health partners with Abbott and Quidel to offer rapid OTC COVID-19 tests
- DUBLIN, Ohio, Aug. 10, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced its efforts to commercialize and broaden access to over-the-counter rapid COVID-19 tests through partnerships with Abbott and Quidel Corporation ("Quidel"). Cardinal Health will leverage its expansive distribution network to support broad access to Quidel's QuickVue® At-Home OTC COVID-19 Test and Abbott's BinaxNOW™ COVID-19 Antigen Self-Test, which allow consumers to easily perform tests for the virus without a prescription.
- 08/10/2021
|
Dividend Income Summary: Lanny's July 2021 Summary
- In July, we (my wife and I) received a total of $1,147.79 of dividend income. Despite the pandemic from COVID-19, dividend income continues to grow, due primarily to additional investment and reinvestment.
- 08/06/2021
|
Cardinal Health stock tumbles to pace S&P 500 losers, after big Q4 profit miss and downbeat outlook
- Shares of Cardinal Health Inc. tumbled 13.7% toward a nine-month low in afternoon trading Thursday, after the distributor of drugs and laboratory products reported a big fiscal fourth-quarter earnings miss, and provided a downbeat outlook, as results were hurt by a $197 million COVID-related inventory reserve, related to personal protective equipment. The stock, which paced the S&P 500's decliners, was also on track to suffer the biggest one-day selloff since May 2018.
- 08/05/2021
|
Cardinal Health, Inc. (CAH) CEO Mike Kaufmann on Q4 2021 Results - Earnings Call Transcript
- Cardinal Health, Inc. (CAH) CEO Mike Kaufmann on Q4 2021 Results - Earnings Call Transcript
- 08/05/2021
|
Cardinal Health (CAH) Lags Q4 Earnings Estimates
- Cardinal (CAH) delivered earnings and revenue surprises of -34.75% and 6.63%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 08/05/2021
|
Cardinal Health (CAH) Q4 Earnings Lag, Revenues Top Estimates
- Although Cardinal Health (CAH) witnessed margin contraction in its fiscal fourth-quarter results, rise in revenues in both its segments is encouraging.
- 08/05/2021
|
Cardinal Health reports fourth quarter and full year results for fiscal year 2021
- DUBLIN, Ohio, Aug. 5, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported that fourth-quarter fiscal 2021 revenue increased 16% to $42.6 billion. This increase includes the favorable prior year comparison from reduced pharmaceutical demand related to COVID-19.
- 08/05/2021
|
Cardinal Health completes sale of Cordis business to Hellman & Friedman
- DUBLIN, Ohio, Aug. 2, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) and Hellman & Friedman (H&F) announced today the completion of the previously announced sale of Cardinal Health's Cordis business to H&F. The sale price of approximately $1 billion includes the buyer's assumption of certain liabilities and the seller's retention of certain working capital accounts.
- 08/02/2021
|
7 F-Rated Stocks to Avoid for the Rest of 2021
- In a churning market like this, you want to steer clear of stocks that are floundering. Here are sevens stocks to avoid today.
- 08/02/2021
|
Cardinal Health (CAH) to Post Q4 Earnings: What's in Store?
- Cardinal Health's (CAH) fiscal fourth-quarter results are likely to reflect solid performance in Pharmaceutical segment.
- 08/02/2021
|
5 Stocks to Play Low Interest Rates—While They Last
- These companies could borrow money at lower rates and use the proceeds to buy back stock—making their shares more attractive to investors.
- 07/22/2021
|
US States Get $26B Settlement Deal in Opioid Abuse Litigation
- Attorney generals of several states reach settlement deal with J&J (JNJ) and three drug distributors - MCK, CAH and ABC - related to thousands of opioid abuse litigations. Non-participating states may join the deal soon.
- 07/22/2021
|
States announce $26 billion settlement to resolve opioid lawsuits: RPT
- Chris Meekins, Healthcare Policy Research Analyst at Raymond James, joins Yahoo Finance's Kristin Myers and Alexis Christoforous to discuss healthcare talks in Washington this week and the latest news on the opioid lawsuits.
- 07/21/2021
|
Distributors Announce Proposed Opioid Settlement Agreement
- CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have negotiated a comprehensive proposed settlement agreement which, if all conditions are satisfied, would result in the settlement of a substantial majority of opioid lawsuits filed by state and local governmental entities. While the companies strongly dispute the allegations made in these lawsuits, they believe the pr
- 07/21/2021
|
Drug distributors settle New York opioid claims for up to $1.18 bln
- NEW YORK, July 20 (Reuters) - The three largest U.S. drug distributors agreed mid-trial to pay up to $1.18 billion to settle claims by New York state and two of its biggest counties over their role in the nationwide opioid epidemic, the state's attorney general said on Tuesday.
- 07/20/2021
|
McKesson, Cardinal Health, AmerisourceBergen stocks surge after $1.1 billion opioid settlement with NY AG
- Shares of McKesson Corp. , Cardinal Health Inc. and AmerisourceBergen Corp. all surged more than 4% in morning trading Tuesday, after the New York Attorney General Letitia James announced a $1.1 billion settlement agreement with the drug distributors to combat the opioid epidemic. James said the agreement resolves claims for the companies' role in helping fuel the epidemic, and will remove the companies from the ongoing opioid trial.
- 07/20/2021
|
Cardinal Health (CAH) Introduces 2 New Digital Solutions
- Cardinal Health (CAH) launches NavixRx Compliance Packaging and E-Commerce Storefront to allow independent pharmacists to expand services and support medication adherence.
- 07/20/2021
|
Cardinal Health launches NavixRx™ Compliance Packaging and E-Commerce Storefront
- DUBLIN, Ohio, July 15, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today launched two new innovative solutions – Cardinal HealthTM NavixRxTM Compliance Packaging and E-Commerce Storefront – to help independent pharmacies meet changing consumer expectations and offer personalized and convenient on-demand services. NavixRxTM Compliance Packaging NavixRxTM Compliance Packaging provides independent pharmacies a solution to outsource compliance packaging for patients taking two or more prescriptions daily.
- 07/15/2021
|
3 Stocks to Tap the Promising Dental Supplies Industry
- Despite the COVID-19 pandemic induced challenges, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical-Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.
- 07/15/2021
|
102 'Top Dividend Stocks On Earth' July Update
- Kiplinger "insights for investors" online, first listed 91 "Top Dividend Stocks From Around The World" 7/13/20. Two recent Kiplinger articles provided 102 Top Dividend Stocks on Earth as of 7/1/21. 39 European “Dividend Aristocrats,” show 10 years of stable or increasing dividends; 65 S&P 500 Aristocrats show 25 years of increases for U.S. companies.
- 07/04/2021
|
Here's Why You Should Retain Cardinal Health (CAH) Stock Now
- Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and diversified product portfolio. However, segmental weakness is a woe.
- 06/30/2021
|
Cardinal Health: The Cheapest Dividend Aristocrat You Can Buy
- Cardinal Health: The Cheapest Dividend Aristocrat You Can Buy
- 06/30/2021
|
New York Takes Drugmakers, Drug Retailers To Legal Trial Over Opioid
- Teva Pharmaceutical Industries Ltd (NYSE: TEVA), Endo International Plc (NASDAQ: ENDP), and AbbVie Inc's (NYSE: ABBV) Allergan misleadingly marketed opioid drugs as having a low addiction risk, a lawyer for a New York county told jurors, urging them to hold the companies liable. Jayne Conroy, representing Suffolk County, also said that the drug distributors - AmerisourceBergen Corp (NYSE: ABC), Cardinal Health Inc (NYSE: CAH), and McKesson Corp (NYSE: MCK) failed to report suspicious opioid orders as required.
- 06/29/2021
|
7 Cheap Stocks to Buy Now While They're Still Cheap
- Retail investors looking for cheap stocks for the second half of 2021 could benefit from researching these seven equities. The post 7 Cheap Stocks to Buy Now While They're Still Cheap appeared first on InvestorPlace.
- 06/24/2021
|
13 Upcoming Dividend Increases Including 2 Dividend Kings
- 13 Upcoming Dividend Increases Including 2 Dividend Kings
- 06/24/2021
|
Cardinal Health to Webcast Discussion of Fourth-Quarter and Year-End Results for Fiscal Year 2021 on August 5
- DUBLIN, Ohio, June 24, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2021 on August 5 prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.
- 06/24/2021
|
Cardinal Health: A Beaten Down Aristocrat
- The stock has underperformed the last couple of years.
- 06/18/2021
|
Outcomes™ partners with Medicaid plans to help Ohio Medicaid members get vaccinated
- DUBLIN, Ohio, June 17, 2021 /PRNewswire/ -- In response to Ohio Governor Mike DeWine's request that business leaders help increase vaccination rates, four Ohio Managed Care Organizations (MCOs) are partnering with Outcomes™ to leverage the expertise and trusted status of local pharmacists for vaccine consultation and administration, particularly in underserved communities. On behalf of Buckeye Health Plan, Molina, Paramount and UnitedHealthcare, Outcomes, recently launched by Cardinal Health (NYSE: CAH), created a Needs Immunization service on the Connect™ platform to engage local pharmacists in personal outreach to Ohio Medicaid members who have not yet received a COVID-19 vaccination.
- 06/17/2021
|
Cardinal Health's (CAH) Arm Receives FDA Nod for LYMPHOSEEK
- Cardinal Health's (CAH) Nuclear & Precision Health Solutions receive FDA approval for LYMPHOSEEK injection.
- 06/11/2021
|
Cardinal Health™ Nuclear & Precision Health Solutions Receives U.S. Food and Drug Administration Approval for New LYMPHOSEEK® Pediatric Indication
- DUBLIN, Ohio, June 10, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that LYMPHOSEEK® (technetium Tc 99m tilmanocept) injection – the first and only radiopharmaceutical agent specifically designed for targeted lymphatic mapping and guiding sentinel lymph node biopsies (SLNB) – has been approved for pediatric use by the U.S. Food and Drug Administration (FDA). "This new indication opens the door for physicians, oncologists and nuclear medicine specialists to more accurately stage the spread of disease using lymphatic mapping in pediatric cancer patients," said Tiffany Olson, President of Nuclear & Precision Health Solutions at Cardinal Health.
- 06/10/2021
|
Oncologists have grown more comfortable with CAR-T therapy, research finds
- DUBLIN, Ohio, June 3, 2021 /PRNewswire/ -- Four years after the approval of the first CAR-T cell therapies, oncologists are referring more patients for treatment and becoming more comfortable with the cost. However, payer approvals and cumbersome administrative processes are still key barriers, according to new research published from Cardinal Health Specialty Solutions.
- 06/03/2021
|
4 Dividend Increases Expected In June 2021
- 4 Dividend Increases Expected In June 2021
- 06/02/2021
|
3 Top Dividend Stocks That Hiked Their Payouts in May
- The lowest yield on this list is 2.9%.
- 06/02/2021
|
Cardinal Health Just Became A Better Deal
- Cardinal Health Just Became A Better Deal
- 05/28/2021
|
The 91 'Best Dividend Stocks On Earth' For June
- Kiplinger "insights for investors" online, first offered this list of 91 "Top Dividend Stocks From Around The World" July 13, 2020. Data updated 5/25/21 revealed 13 yields ripe for picking. These International “Dividend Aristocrats,” have raised dividends at least five straight years (Canadian) 10 years (European Union) or 25 years (U.S. companies).
- 05/27/2021
|
Pharmacy stocks tumble on report Amazon is weighing a push into physical pharmacies (AMZN, CVS, RAD, WAG, CAH, MCK, ABC)
- Shares of drug retailers including Walgreens Boots Alliance and CVS dropped on Wednesday, as Amazon was reported to be looking at options to set up physical pharmacy locations in the US. Talks at Amazon about setting up standalone pharmacies are mostly exploratory and there are no firm plans to open physical locations, three people familiar with the matter told Insider. Such a move would be part of a plan by the online retail behemoth to earn a larger share of the country's $370 billion prescription drug market.
- 05/26/2021
|
Cardinal Health Can Generate Impressive Income
- CAH has been a long-term disappointment to investors. The Wall Street consensus is neutral-to-bullish, with expected 12-month price appreciation of 11.4-15.8%.
- 05/26/2021
|
Here's Why You Should Retain Cardinal Health (CAH) Stock Now
- Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and diversified product portfolio. However, segmental weakness is a woe.
- 05/25/2021
|
IYH: Healthcare Dashboard For May
- IYH: Healthcare Dashboard For May
- 05/17/2021
|
Cardinal Health announces redemption of outstanding notes
- DUBLIN, Ohio, May 14, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it is sending an irrevocable notice of early redemption to the holders of all of the Company's 3.200% notes due June 2022 that are outstanding as of the early redemption date (aggregate principal amount of $237,558,000) and $262,442,000 in aggregate principal amount of the Company's 2.616% notes due June 2022. The early redemption date is set to June 15, 2021, pursuant to the June 2, 2008 indenture and the notes.
- 05/14/2021
|
2 Cheap Dividend Stocks You Can Buy Right Now
- These low-cost stocks will provide generous payouts to income investors.
- 05/13/2021
|
Dividend Increases: May 1-7, 2021
- Dividend Increases: May 1-7, 2021
- 05/12/2021
|
Dividend Income Summary: Bert's April 2021 Summary
- Each month, we share the amount of dividend income we received and compare the results to the previous year. Until the stock market was stabilized and the first stimulus bill was passed, there were a lot of undervalued dividend stocks that we were able to add to our portfolios.
- 05/10/2021
|
10 Of The Best Value Picks Among Dividend Aristocrats
- Dividend Aristocrats can be a great choice for investors looking for reliable income and stocks that can outperform during a recession. Not all Dividend Aristocrats are necessarily attractive at the same time, however.
- 05/08/2021
|
PepsiCo, Cardinal Health, and 3 Other Companies That Raised Their Dividends
- PepsiCo, Cardinal Health, and Baxter were among the large companies that declared dividend increases this week.
- 05/08/2021
|
Cardinal Health Invests In An Advanced Visibility Solution
- Cardinal Health projected making capital expenditures in this fiscal year of between $400 million and $450 million; these investments will be primarily for information technology and infrastructure. On the IT side, Cardinal has invested in an advanced visibility solution.
- 05/07/2021
|
Cardinal Health, Inc. (CAH) CEO Mike Kaufmann on Q3 2021 Results - Earnings Call Transcript
- Cardinal Health, Inc. (CAH) CEO Mike Kaufmann on Q3 2021 Results - Earnings Call Transcript
- 05/06/2021
|
Cardinal Health Stock Tumbles After Q3 Earnings Fall Short Of Expectations; Narrowed FY21 Adjusted EPS Guidance
- Cardinal Health (NYSE: CAH) reported the third-quarter FY21 adjusted EPS of $1.53, which missed the consensus estimate of $1.55. The earnings dropped 6% Y/Y, reflecting a higher non-GAAP effective tax rate.
- 05/06/2021
|
Cardinal Health reports third-quarter results for fiscal year 2021
- DUBLIN, Ohio, May 6, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported third-quarter fiscal year 2021 revenue of $39.3 billion, in-line with the third quarter of last year. Third-quarter GAAP operating earnings decreased 16% to $473 million, primarily due to the write-down of the net assets held for sale from the planned divestiture of the Cordis business.
- 05/06/2021
|
6 Dividend Increases Expected In May 2021
- Dividend stocks continue to amaze. If the goal is to produce a passive income stream that will one day cover our expenses, making sure that income stream grows is critical.
- 05/05/2021
|
Cardinal Health launches Outcomes™
- DUBLIN, Ohio, April 27, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today launches Outcomes™, a digital ecosystem connecting pharmacists, payers and pharmaceutical companies to mitigate the challenges of medication non-adherence. Outcomes delivers digital health solutions for personalized medication therapy management, digital patient engagement, and telepharmacy, via its Connect™ platform, so these three customer groups can improve patient adherence to medication, drive better health outcomes for patients, and lower the cost of care.
- 04/27/2021
|
Sell Or Hold - What To Do With These 3 Misfits
- Sell Or Hold - What To Do With These 3 Misfits
- 04/25/2021
|
Cardinal Health (CAH), HHS Partner to Offer Pandemic Support
- The contract should help Cardinal Health (CAH) provide critical pandemic support in partnership with the U.S. government.
- 04/20/2021
|
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
- Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
- 04/15/2021
|
Here's Why You Should Hold on to Cardinal Health (CAH) Stock
- Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and diversified product portfolio.
- 04/13/2021
|
Cardinal Health awarded Strategic National Stockpile contract for PPE storage and distribution
- DUBLIN, Ohio, April 13, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the storage and distribution of 80,000 pallets of personal protective equipment (PPE) to support the Strategic National Stockpile (SNS), part of the Office of the Assistant Secretary for Preparedness and Response within HHS. "Cardinal Health is uniquely positioned to get critical products to healthcare providers and first responders as effectively, safely, and swiftly as possible in response to the COVID-19 pandemic," said Steve Mason, CEO Medical Segment.
- 04/13/2021
|
Dividend Stock Purchase: Lanny's March 2021 Summary
- Dividend Stock Purchase: Lanny's March 2021 Summary
- 04/13/2021
|
Cardinal Health: Exciting Opportunity In A Boring Industry
- Cardinal Health Inc. makes an attractive 11-15% annual free cash flow yield. The company offers high investor safety with a strong balance sheet, leading industry position, and Dividend Aristocrat status.
- 04/12/2021
|
Cardinal Health (CAH) Unveils Navista TS to Boost Patient Care
- Cardinal Health (CAH) Specialty Solutions' newly launched Navista TS will help community oncologists to improve patient care and become successful in value-based care while reducing costs.
- 04/09/2021
|
Cardinal Health Launches Navista™ TS to Help Oncology Practices Improve Patient Care, Lower Costs and Drive Success in Value-Based Care
- DUBLIN, Ohio, April 7, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) Specialty Solutions today launched Cardinal Health™ Navista™ Tech Solutions (TS), an advanced suite of technology solutions to help community oncologists improve outcomes and costs associated with patient treatment as they transition to value-based care. "Community-based oncology practices are facing unprecedented pressure as they pivot to adapt to value-based reimbursement models," said Heidi Hunter, President of Cardinal Health Specialty Solutions.
- 04/07/2021
|
Worried About Inflation? These 3 Stocks Can Help
- You can't stop it, but you can give yourself a chance of keeping up with inflation.
- 04/04/2021
|
Cardinal Health to Webcast Discussion of Third-Quarter Results for Fiscal Year 2021 on May 6
- DUBLIN, Ohio, March 30, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2021 on May 6 prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.
- 03/30/2021
|
Cardinal Health: Where Rising Price Meets A Bargain Valuation
- Cardinal Health may be recovering from its opioid crisis setback in investor demand and valuation. Under normal operating circumstances, Wall Street would be valuing the stock at a price north of $100 currently.
- 03/29/2021
|
Hunting For Recession-Proof Bargains: 10 Picks As Prey
- In the following article, I present 10 recession-proof stocks that are undervalued right now. Including companies from the healthcare sector like Gilead Sciences, Amgen, Novo Nordisk, Walgreens Boots Alliance, CVS Health, Cardinal Health and Bayer.
- 03/29/2021
|
5 High-Yielding Dividend Aristocrat Stocks Are Perfect Now for Worried Investors
- With March almost over, many investors are looking to the second quarter and beyond.
- 03/26/2021
|
Cardinal Health: A Fair Company At A Wonderful Price
- Cardinal Health is one of the three major medical distribution companies in the United States. There are a few issues with Cardinal Health like the fluctuating net income during the last two decades and the declining margins.
- 03/25/2021
|
MedTech to Gain From Economic Stimulus Bill: 3 Stocks to Buy
- Grab these three top stocks - ABT, HOLX and BIO - that continue to show tremendous promise and stand to benefit from the historic stimulus package.
- 03/25/2021
|
5 BofA Securities Top Value Stocks to Buy That Also Pay Big Dividends
- For years, analysts and portfolio managers have anticipated the return of value stocks as the market has moved higher, and for years they have continued to underperform growth stocks.
- 03/25/2021
|
Cardinal Health (CAH) Inks Deal to Divest Cordis Business
- Cardinal Health (CAH) divests its Cordis business to focus on strategic growth areas.
- 03/15/2021
|
Cardinal Health to sell Cordis business to Hellman & Friedman for $1 billion
- Cardinal Health Inc. announced Friday an agreement to sell its minimally invasive cardiovascular technology business Cordis for about $1 billion to Hellman & Friedman. Shares of the pharmaceutical distributor and maker of laboratory products rose 0.5% in premarket trading.
- 03/12/2021
|
Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman
- DUBLIN, Ohio, March 12, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately $1 billion, which includes buyer's assumption of certain liabilities and seller's retention of certain working capital accounts. The transaction is expected to close in the first half of Cardinal Health's fiscal year 2022, subject to customary closing conditions and regulatory clearances.
- 03/12/2021
|
Here's Why You Should Retain Cardinal Health (CAH) Stock Now
- Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and diversified product portfolio.
- 03/11/2021
|
3 Stocks to Capitalize on Promising Dental Supplies Industry
- 3 Stocks to Capitalize on Promising Dental Supplies Industry
- 03/10/2021
|
3 High-Yield Stocks for the Dividend Investor
- The following stocks may be of interest to dividend investors as they are offering much higher dividend yields than the S&P 500 Index. The benchmark index's dividend yields 1.52% as of Friday, March 5.
- 03/07/2021
|
The 91 Kiplinger 'Top Dividend Stocks On Earth' March Update
- The 91 Kiplinger 'Top Dividend Stocks On Earth' March Update
- 03/03/2021
|
Dividend Income Summary: Bert's January 2021 Summary
- Dividend Income Summary: Bert's January 2021 Summary
- 02/24/2021
|
5 Hot Stocks Coiling for a Breakout in 2021
- These hot stocks did not get a lot of love in 2020 despite excellent fundamentals. All that will change as they break out upward this year.
- 02/17/2021
|
February 2021 Undervaluation - Financials, Real Estate, Industrials/IT And Pharma
- February 2021 Undervaluation - Financials, Real Estate, Industrials/IT And Pharma
- 02/11/2021
|
Cardinal Health, Inc. (CAH) CEO Mike Kaufmann on Q2 2021 Results - Earnings Call Transcript
- Cardinal Health, Inc. (CAH) CEO Mike Kaufmann on Q2 2021 Results - Earnings Call Transcript
- 02/05/2021
|
Cardinal Health (CAH) Q2 Earnings & Revenues Top Estimates
- Cardinal Health's (CAH) fiscal second-quarter results reflect strong segmental performance.
- 02/05/2021
|
Cardinal Health (CAH) Beats Q2 Earnings and Revenue Estimates
- Cardinal (CAH) delivered earnings and revenue surprises of 20.00% and 0.01%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
- 02/05/2021
|
Cardinal Health: Q2 Earnings Insights
- Shares of Cardinal Health (NYSE:CAH) moved higher by 1.1% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 14.47% year over year to $1.74, which beat the estimate of $1.44.
- 02/05/2021
|
Cardinal Health (CAH) to Post Q2 Earnings: What's in Store?
- Cardinal Health's (CAH) fiscal second-quarter results are likely to reflect solid performance in Pharmaceutical segment.
- 02/02/2021
|
The 9 Best Retirement Stocks to Buy if You're Over 50
- Looking to build a portfolio that balances income and growth through your retirement? Consider these retirement stocks.
- 01/27/2021
|
Cardinal Health: Healthcare Dividend Aristocrat - Second Look
- Cardinal Health: Healthcare Dividend Aristocrat - Second Look
- 01/27/2021
|
3 Cheap Dividend Aristocrats to Buy Right Now
- The lowest yield on this list is 2.5% and well above what the average S&P 500 stock pays today.
- 01/22/2021
|
Medical Device Aristocrats For A High Class Dividend Portfolio
- Healthcare aristocrats benefit from significant medical device contributions. By and large these healthcare aristocrats share favorable quant metrics on Seeking Alpha, albeit with significant variations among the five.
- 01/21/2021
|
Cardinal Health, Inc. (CAH) CEO Mike Kaufmann Presents at 39th Annual J.P. Morgan Healthcare Conference (Transcript)
- Cardinal Health, Inc. (CAH) CEO Mike Kaufmann Presents at 39th Annual J.P. Morgan Healthcare Conference (Transcript)
- 01/11/2021
|
4 Dividend-Paying Undervalued MedTech Stocks for Gains in 2021
- Here we discuss four dividend-paying value stocks, MCK, CAH, BDX and HRC, which though trading cheap now, have solid chances of a rebound in the second half of 2021.
- 01/08/2021
|
Cardinal Health (CAH) Unveils New Logistics Management Tool
- Cardinal Health's (CAH) company, OptiFreight Logistics, launched TotalVue Analytics to help healthcare supply chain leaders to drive cost savings.
- 01/07/2021
|
Cardinal Health to Webcast Discussion of Second-Quarter Results for Fiscal Year 2021 on February 5
- DUBLIN, Ohio, Jan. 4, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2021 on February 5 prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning...
- 01/04/2021
|
The 10 Most Reliable Value Stocks to Buy for 2021
- As uncertainty continues and growth stocks remain richly priced, these 10 value stocks could be your ticket to gains in 2021. The post The 10 Most Reliable Value Stocks to Buy for 2021 appeared first on InvestorPlace.
- 12/11/2020
|
When a COVID-19 Vaccine Is Ready, This Company Is Prepared for Action
- One medical distribution company has been through this before.
- 12/08/2020
|
Deep Dive: Only these five dividend stocks made the cut in a ‘safer and better' screen
- The companies had to reach yield and sales hurdles.
- 11/25/2020
|
Should You Expect A Rebound After Cardinal Health Stock's 12% Drop?
- Cardinal Health's stock fell -11.9% in the last 5 trading days. While that may be concerning for investors, we believe that it is not a signal to get out of the stock.
- 11/25/2020
|
Dividend Income Summary: Lanny's October 2020 Summary
- In October, we (my wife and I) received a total of $839.12 of dividend income. We had two massive dividend payments that came in from Philip Morris and Canadian Imperial.
- 11/13/2020
|
Cardinal Health Partners with CDC to Support Vaccine Access for Pharmacies
- DUBLIN, Ohio, Nov. 11, 2020 /PRNewswire/ -- Cardinal Health (NYSE: CAH) has reached an agreement with the Centers for Disease Control and Prevention (CDC) to act as a network administrator in Phase 2 of the Federal Pharmacy Partnership Strategy for COVID-19, which will enable retail...
- 11/11/2020
|
The Bottom Fishing Club: Cardinal Health
- After years of underperformance vs. the U.S. stock market, Cardinal may be on the takeoff runway. Two positive catalysts have appeared in early November.
- 11/10/2020
|
Cardinal Health, Inc. (CAH) CEO Mike Kaufmann on Q3 2020 Results - Earnings Call Transcript
- Cardinal Health, Inc. (CAH) CEO Mike Kaufmann on Q3 2020 Results - Earnings Call Transcript
- 11/05/2020
|
Cardinal Health records $1 billion opioid-related charge, but stock surges as adjusted profit beats forecasts
- Shares of Cardinal Health Inc. rallied 5.0% in premarket trading Thursday, after the health care services company reported a fiscal first-quarter adjusted profit and revenue that rose above expectations, and raised its full-year earnings outlook. The company reported a net loss that narrowed to $253 million, or 86 cents a share, from a loss of $4.92 billion, or $16.65 a share, as the company recorded a $1.02 billion charge in connection with opioid lawsuits this year, after a $5.63 billion charge last year.
- 11/05/2020
|
Cardinal Health Reports First Quarter Fiscal 2021 Results
- DUBLIN, Ohio, Nov. 5, 2020 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2021 revenues of $39.1 billion, an increase of 5% from the first quarter of last year. First quarter GAAP operating loss was $624 million due to a $1.0 billion pre-tax accrual...
- 11/05/2020
|
65 November Dividend Aristocrats
- "S&P 500® Dividend Aristocrats measure performance of S&P 500 companies that have increased dividends every year for 25 consecutive years."---us.spindices.com. The 65 Aristocrats of November 2020 represent ten of eleven Morningstar Sectors (no Technology). Broker targeted-top-ten net-gainers ranged 19.36%-45.91% topped by XOM & CVX 11/3/20.
- 11/05/2020
|
Buy These 8 Dividend-Paying Companies
- We seem to be in the throes, possibly only the beginning of a COVID-19 dip. This is thrilling, if only for investors - horrible for the population. It is made more intense by the upcoming US election as well as the seeming impossibility of a new stimulus plan before the election.
- 10/28/2020
|
State Treasurer Rejects Cardinal Health Compensation Package
- The compensation proposal fails to hold executives accountable for opioid losses, Treasurer Wooden's office said.
- 10/21/2020
|
IBM Retirement Fund Has $446,000 Stock Position in Cardinal Health, Inc. (NYSE:CAH)
- IBM Retirement Fund boosted its stake in Cardinal Health, Inc. (NYSE:CAH) by 39.0% in the third quarter, Holdings Channel reports. The firm owned 9,503 shares of the company’s stock after purchasing an additional 2,667 shares during the quarter. IBM Retirement Fund’s holdings in Cardinal Health were worth $446,000 at the end of the most recent […]
- 10/21/2020
|
Cardinal Energy Ltd. (CJ.TO) (TSE:CJ) Shares Cross Below 200-Day Moving Average of $0.52
- Cardinal Energy Ltd. (CJ.TO) (TSE:CJ)’s stock price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.52 and traded as low as $0.41. Cardinal Energy Ltd. (CJ.TO) shares last traded at $0.42, with a volume of 210,383 shares traded. Several research […]
- 10/21/2020
|
N95 Respirators Market | $382.9 Million Incremental Growth During 2020-2024 | Technavio
- The Global N95 Respirators Market will grow by USD 382.90 mn during 2020-2024
- 10/20/2020
|
Election HQ: Cardinal & Pine's Live Blog On NC's 2020 Election
- Biden or Trump? Cooper or Forest? Blue or red? Look here for up-to-date news on North Carolina's historic 2020 election.
- 10/19/2020
|
United States Healthcare Personal Protective Equipment Market Report 2020 - ResearchAndMarkets.com
|
Regentatlantic Capital LLC Has $379,000 Stock Position in Cardinal Health, Inc. (NYSE:CAH)
- Regentatlantic Capital LLC lowered its holdings in Cardinal Health, Inc. (NYSE:CAH) by 25.9% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 8,083 shares of the company’s stock after selling 2,819 shares during the quarter. Regentatlantic Capital LLC’s holdings in Cardinal Health were worth $379,000 […]
- 10/16/2020
|
Brookstone Capital Management Makes New Investment in Cardinal Health, Inc. (NYSE:CAH)
- Brookstone Capital Management purchased a new stake in Cardinal Health, Inc. (NYSE:CAH) during the third quarter, according to its most recent filing with the SEC. The firm purchased 6,096 shares of the company’s stock, valued at approximately $286,000. Other large investors also recently made changes to their positions in the company. Flagship Harbor Advisors LLC […]
- 10/16/2020
|
Flagship Harbor Advisors LLC Acquires 1,505 Shares of Cardinal Health, Inc. (NYSE:CAH)
- Flagship Harbor Advisors LLC raised its holdings in Cardinal Health, Inc. (NYSE:CAH) by 29.9% in the 3rd quarter, HoldingsChannel reports. The firm owned 6,546 shares of the company’s stock after purchasing an additional 1,505 shares during the quarter. Flagship Harbor Advisors LLC’s holdings in Cardinal Health were worth $307,000 at the end of the most […]
- 10/16/2020
|
Global Flow Diversion Aneurysm Treatment Market- Featuring Acandis GmbH, Boston Scientific Corp., Cardinal Health Inc., Among Others
- The Global Flow Diversion Aneurysm Treatment Market will grow by USD 1.64 bn during 2020-2024
- 10/16/2020
|
Surgical Mask Market | Increase in the Number of Surgeries Globally to Boost the Market Growth | Technavio
- The Global Surgical Mask Market will grow by USD 2.41 bn during 2020-2024
- 10/15/2020
|
65 Dividend Aristocrats Optimal October Outcomes
- S&P 500 Dividend Aristocrats measure performance of S&P 500 companies that have increased dividends every year for 25 consecutive years. - us.spindices.com.
- 10/10/2020
|
CO2 Incubators Market | Growth of Global Life Science Market to Boost the Market Growth | Technavio
- The Global CO2 Incubator Market will grow by USD 100.29 mn during 2020-2024
- 10/10/2020
|
Worldwide Industry for Embolic Protection Devices to 2025 - Featuring Boston Scientific, Abbott & Medtronic Among Others
- DUBLIN, Oct. 9, 2020 /PRNewswire via COMTEX/ --
DUBLIN, Oct. 9, 2020 /PRNewswire/ -- The "Embolic Protection Devices Market - Global Outlook and Forecast...
- 10/09/2020
|
Insights on the Single-use Negative Pressure Wound Therapy Devices Global Market to 2027 - Featuring Acelity LP, Cardinal Health & ConvaTec Among Others - ResearchAndMarkets.com
|
Global Embolic Protection Devices Market (2020 to 2025) - Outlook and Forecast - ResearchAndMarkets.com
|
9 Dividend Stocks That Can Help Anyone Looking for Income
- Barron’s took the S&P 500 Dividend Aristocrats and sifted through them to find companies with strong balance sheets, free cash flow growth between 2017 and 2019, and a free cash flow yield of more than 1%.
- 10/05/2020
|
Rapid Plasma Reagin Test Market Competitive Insights and Outlook 2020
- Oct 02, 2020 (Market Insight Reports) --
Global Rapid Plasma Reagin Test Market Research Report published by market insight reports explores the current...
- 10/02/2020
|
$16 Billion Medical Gowns Market - Global Outlook & Forecast 2020-2025: COVID-19 will Drive the Future Growth of the Market - ResearchAndMarkets.com
|
AA Ireland bought by Olivier Sarkozy-led fund for more than €240m
- Roadside assistance firm ‘will continue to operate as an Irish-based company’ says CEO
- 10/01/2020
|
COVID-19 Recovery Analysis: Anesthesia Laryngeal Masks Market|Rising Number of Surgeries and Emergency Cases to Boost Market Growth | Technavio
- The Global Anesthesia Laryngeal Masks Market will grow by $ 55.76 mn during 2020-2024
- 09/29/2020
|
Radiopharmaceuticals Market- Roadmap for Recovery From COVID-19|Rising Burden of Neurological Disorders to Boost Market Growth | Technavio
- The Global Radiopharmaceuticals Market will grow by USD 3.58 bn during 2020-2024
- 09/28/2020
|
Single-use Negative Pressure Wound Therapy Devices Market- Roadmap for Recovery from COVID-19 | Increase in Product Launches to Boost Market Growth | Technavio
- The Global Single-use Negative Pressure Wound Therapy Devices Market will grow by USD 374.41 mn during 2020-2024
- 09/27/2020
|
Dividend Champion And Contender Highlights: Week Of September 27
- A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which changed their dividends.
- 09/26/2020
|
Cardinal Health : to Webcast Discussion of First-Quarter Results for Fiscal Year 2021 on November 5 | MarketScreener
|
Worldwide Neonatal Critical Care Industry to 2026 - Key Drivers and Restraints - ResearchAndMarkets.com
|
COVID-19 Recovery Analysis: Helicobacter Pylori Diagnostics Market | Resistance Of H. Pylori To Antibiotics to boost the Market Growth | Technavio
- The Global Helicobacter Pylori Diagnostics Market will grow by USD 209.59 mn during 2020-2024
- 09/22/2020
|
Cardinal Energy Ltd (OTCMKTS:CRLFF) Short Interest Up 14.6% in August
- Cardinal Energy Ltd (OTCMKTS:CRLFF) saw a significant growth in short interest in the month of August. As of August 31st, there was short interest totalling 199,100 shares, a growth of 14.6% from the August 15th total of 173,700 shares. Based on an average trading volume of 9,900 shares, the short-interest ratio is currently 20.1 days. […]
- 09/19/2020
|
Cardinal Resources (TSE:CDV) Stock Price Passes Above 200 Day Moving Average of $0.51
- Cardinal Resources Ltd (TSE:CDV)’s stock price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.51 and traded as high as $1.03. Cardinal Resources shares last traded at $1.03, with a volume of 7,829 shares. Separately, Beacon Securities reiterated a “sell” rating on shares of […]
- 09/19/2020
|
Global Helicobacter Pylori Diagnostics Market (2020 to 2024) - Featuring Abbott Laboratories, bioMerieux & Quest Diagnostics Among Others - ResearchAndMarkets.com
|
COVID-19 Recovery Analysis: Surgical Drapes Market | Growing Prevalence of HAIs to boost the Market Growth | Technavio
- The Global Surgical Drapes Market will grow by $ 536.73 mn during 2020-2024
- 09/17/2020
|
Flow Diversion Aneurysm Treatment Market- Roadmap for Recovery from COVID-19 | Improvements In Detection of UIAs to boost the Market Growth | Technavio
- The Global Flow Diversion Aneurysm Treatment Market will grow by USD 1.64 bn during 2020-2024
- 09/16/2020
|
Dividend Aristocrats See 6 Star September Selections
- S&P 500® Dividend Aristocrats measure performance of S&P 500 companies that have increased dividends every year for 25 consecutive years.---us.spindices.com.
- 09/15/2020
|
Cardinal Health, Inc. (CAH) CEO Mike Kaufmann Presents at Morgan Stanley 18th Annual Global Healthcare Conference (Transcript)
- Start Time: 11:15 End Time: 11:46 Cardinal Health, Inc. (NYSE:CAH) Morgan Stanley 18th Annual Global Healthcare Conference September 14, 2020, 11:15 AM ET Company Participants Mike Kaufmann - CEO Kevin Moran - VP, IR Conference Call Participants Ricky Goldwasser - Morgan Stanley Presentation Ricky Goldwasser Hi, everyone, and thank you for joining us today at Morgan Stanley’s Global Healthcare Conference.
- 09/14/2020
|
Disposable Gloves Market In US- Roadmap for Recovery from COVID-19 | Rapid Spread Of COVID-19 to boost the Market Growth | Technavio
- The Disposable Gloves Market in US will grow by USD 1.01 bn during 2020-2024
- 09/14/2020
|
Medical Textiles Market- Roadmap for Recovery from COVID-19 | Demand For Non-woven Medical Textiles to boost the Market Growth | Technavio
- The Global Medical Textiles Market will grow by USD 2.99 bn during 2020-2024
- 09/12/2020
|
I'm Investing $50,000 In These Dividend-Paying Companies
- When I posted my monthly update and noted my large increase in my cash position, from 4% to over 10%, some readers messaged/asked me how I intend to invest this.
- 09/11/2020
|
The Retirees' Dividend Portfolio: John And Jane's August Taxable Account Update
- The Taxable account generated $1,674.90 of dividends in August of 2020 compared with $1,591.52 of dividends in August of 2019.
- 09/10/2020
|
A 91 Kiplinger 'Most Reliable Dividend Stocks On Earth' September Update
- Kiplinger insights for investors online, offered this list of 91 Top Dividend Stocks From Around The World July 13.
- 09/09/2020
|
Calm Down: This Time Won't Be Different
- The market closed down last week. Investors are getting jittery.
- 09/06/2020
|
The Rose 89 Stock Portfolio August 2020 Update
- 20 company dividend payments were received, increasing income by 32%, reversing the low income of July, making Q3 up 2.5% from April and May of Q2.
- 09/03/2020
|
Cardinal Health: Don't Forget About This Undervalued Aristocrat
- As discounts thin and valuations rise to record-highs, it's easy to fall into the trap of investing in yield for the sake of yield, and not safety.
- 09/02/2020
|
Why You Need to Buy These 8 Dividend Stocks Now
- The U.S.-China trade war is rapidly devolving into an uncontrollable mess. In this circumstance, one of your best moves is to buy stable dividend aristocrats.
- 08/31/2020
|
Global Isolation Gowns Market and Impact of COVID-19 (2020-2025) - ResearchAndMarkets.com
|
Immunovant Up On Data, And Other News: The Good, Bad And Ugly Of Biopharma
- Immunovant stock shoots up on positive trial data news. REGENXBIO received FDA approval for Phase II trial of RGX-314.
- 08/27/2020
|
Cardinal Health: Back In Value Territory
- Cardinal Health is one of the Big 3 healthcare distributors, and serves hospitals, health systems, and pharmacies in the U.S. and around the world.
- 08/26/2020
|
COVID-19 Pandemic Impact on Global Enteral Syringe Market 2020-2024 | Technavio
- The Global Enteral Syringe Market will grow by USD 196.72 mn during 2020-2024
- 08/26/2020
|
Illumina Welcomes Kathryne Reeves as Chief Marketing Officer
- Illumina Welcomes Kathryne Reeves as Chief Marketing Officer
- 08/25/2020
|
3 Dividend Stocks That Pay You Better Than Coca-Cola Does
- The strength of its dividend is just one of the reasons why investors, including Mr. Warren Buffett, choose to hold Coca-Cola (NYSE: KO) stock. Berkshire Hathaway began purchasing Coca-Cola in 1988, and through subsequent purchases and four two-for-one stock splits, Buffet has built a collection that now totals 400 million shares. Consequently, the $1.3 billion investment yields $656 million annually in dividend income.
- 08/19/2020
|
PRESS DIGEST - Wall Street Journal - Aug. 19
|
Dividend Aristocrats Show Six Best Mid-August Selections
- S&P 500® Dividend Aristocrats measure performance of S&P 500 companies that have increased dividends every year for 25 consecutive years.-- us.spindices.com.
- 08/18/2020
|
Drug-Distributor Stocks Rise as Opioid Settlement Looks Closer After Report on More Talks
- A group of state attorneys general are demanding more from Johnson & Johnson and the nation’s top drug distributors to settle the sprawling opioid litigation than the companies agreed to pay last year, according to a Tuesday report in The Wall Street Journal.
- 08/18/2020
|
U.S. states seek $26.4 bln from drug firms in opioid litigation - WSJ
|
WSJ News Exclusive | States Seek $26.4 Billion From Drug Companies in Opioid Litigation
- States are asking for around $26.4 billion from major pharmaceutical industry players to help pay for damage wrought by the opioid crisis, the latest demand in yearslong litigation seeking to hold companies accountable for widespread drug addiction.
- 08/18/2020
|
Cardinal Health Inc (CAH) Files 10-K for the Fiscal Year Ended on June 30, 2020
- Cardinal Health Inc (CAH)(30-Year Financial) files its latest 10-K with SEC for the fiscal year ended on June 30, 2020. Continue reading...
- 08/14/2020
|
Cardinal Health Inc (CAH) Files 10-K for the Fiscal Year Ended on June 30, 2020
- Cardinal Health Inc (CAH)(30-Year Financial) files its latest 10-K with SEC for the fiscal year ended on June 30, 2020. Continue reading...
- 08/14/2020
|
Motorhome Retirement: July Update - Yellowstone!
- We continued our summer adventure with a trip to Yellowstone National Park. Income exceeded expenses for the month.
- 08/14/2020
|
Cardinal Health Inc (CAH) Files 10-K for the Fiscal Year Ended on June 30, 2020
- Cardinal Health Inc (CAH)(30-Year Financial) files its latest 10-K with SEC for the fiscal year ended on June 30, 2020. Continue reading...
- 08/14/2020
|
Cardinal Health Inc (CAH) Files 10-K for the Fiscal Year Ended on June 30, 2020
- Cardinal Health Inc (CAH)(30-Year Financial) files its latest 10-K with SEC for the fiscal year ended on June 30, 2020. Continue reading...
- 08/14/2020
|
Cardinal Health Inc (CAH) Files 10-K for the Fiscal Year Ended on June 30, 2020
- Cardinal Health Inc (CAH)(30-Year Financial) files its latest 10-K with SEC for the fiscal year ended on June 30, 2020. Continue reading...
- 08/13/2020
|
The Retirees' Dividend Portfolio: John And Jane's July Taxable Account Update
- The Taxable account generated $1,337.01 of dividends in July of 2020 compared with $1,030.43 of dividends in July of 2019.
- 08/13/2020
|
How Much Did Cardinal Health's(NYSE:CAH) Shareholders Earn From Share Price Movements Over The Last Five Years?
- The main aim of stock picking is to find the market-beating stocks. But the main game is to find enough winners to...
- 08/11/2020
|
COVID-19 Impacts: Medical Device Manufacturing Outsourcing Market will Accelerate at a CAGR of almost 11% through 2020-2024 | Focus On Reducing Medical Device Manufacturing Cost to Boost Growth | Technavio
- The Global Medical Device Manufacturing Outsourcing Market will grow by USD 39.25 bn during 2020-2024
- 08/10/2020
|
Ocular Therapeutix™ Reports Second Quarter 2020 Financial Results and Business Update
- Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative the
- 08/07/2020
|
Coronavirus update: U.S. case tally climbs above 4.8 million as Trump contradicts health experts to claim virus will ‘go away’
- The number of confirmed cases of the coronavirus that causes COVID-19 in the U.S. rose above 4.8 million on Thursday, a day after President Donald Trump...
- 08/06/2020
|
How Does Cardinal Health's Debt Look?
- Shares of Cardinal Health Inc. (NYSE: CAH) moved higher by 7.47% in the past three months. Before having a look at the importance of debt, let's look at how much debt Cardinal Health has.Cardinal Health's Debt Based on Cardinal Health's balance sheet as of May 11, 2020, long-term debt is at $6.75 billion and current debt is at $508.00 million, amounting to $7.26 billion in total debt. Adjusted for $2.33 billion in cash-equivalents, the company's net debt is at $4.93 billion.Investors look at the debt-ratio to understand how much financial leverage a company has. Cardinal Health has $41.15 billion in total assets, therefore making the debt-ratio 0.18. Generally speaking, a debt-ratio more than 1 means that a large portion of debt is funded by assets. As the debt-ratio increases, so the does the risk of defaulting on loans, if interest rates were to increase. Different industries have different thresholds of tolerance for debt-ratios. For example, a debt ratio of 25% might be higher for one industry, whereas normal for another.Why Investors Look At Debt? Debt is an important factor in the capital structure of a company, and can help it attain growth. Debt usually has a relatively lower financing cost than equity, which makes it an attractive option for executives.However, interest-payment obligations can have an adverse impact on the cash-flow of the company. Equity owners can keep excess profit, generated from the debt capital, when companies use the debt capital for its business operations.See more from Benzinga * A Look Into Energy Sector Value Stocks * Looking Into CommScope Holding Co's Return On Capital Employed * Understanding Caterpillar's Unusual Options Activity(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- 08/06/2020
|
Blue Chip DRiP Portfolio: July Dividends + Cashing Out
- Our July dividend income was up both QoQ and YoY, much to my surprise. The -33% dividend reduction from Dominion was unexpected, but I'm happy we still received $676.39 from 14 different stocks in July.
- 08/06/2020
|
Cardinal Health CEO says COVID-19 impact was ‘balanced between pharma and medical segment’: exclusive
- Michael C. Kaufmann, Cardinal Health CEO, joins Yahoo Finance’s The First Trade with Alexis Christoforous and Brian Sozzi to discuss the company’s quarterly report, impact of the coronavirus pandemic and much more.
- 08/06/2020
|
Cardinal Health (CAH) Q4 Earnings Top Estimates, Revenues Lag
- Cardinal Health's (CAH) fiscal fourth-quarter results reflect weak segmental performance.
- 08/06/2020
|
Cardinal Health (CAH) Tops Q4 Earnings Estimates
- Cardinal (CAH) delivered earnings and revenue surprises of 14.29% and -0.99%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
- 08/06/2020
|
Cardinal's stock rises 2%; company had a $130 million impact as a result of the pandemic in the quarter
- Shares of Cardinal Health Inc. rallied 2.4% after the medical distributor reported better-than-expected earnings for its fiscal fourth quarter. The company had earnings of $656 million, or $2.23 a share, in the fourth quarter of 2020, up from $194 million, or 65 cents a share, in the same quarter a year ago. Adjusted earnings per share were $1.04, against a FactSet consensus of 90 cents. Cardinal said earnings for the quarter had a net negative impact of approximately $130 million as a result of people avoiding visits to the doctor and delaying elective procedures during the COVID-19 pandemic. It had also a $579 million pre-tax gain due to the sale of its stake in a company that owned NaviHealth, a post-acute care company that was sold to UnitedHealth Group's Optum in May. Cardinal reported $36.7 billion in revenue for the quarter, down 2% from $37.4 billion in the quarter a year ago. The FactSet consensus was $36.8 billion in revenue. Pharmaceutical sales were flat, at $33.2 billion, while medical segment sales fell 13% to $3.5 billion. Cardinal's stock has gained 13.9% year-to-date. The S&P 500 is up 3.0% for the year.
- 08/06/2020
|
Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2020
- Cardinal Health (NYSE: CAH) today reported fourth quarter fiscal year 2020 revenues of $36.7 billion, a decrease of 2 percent from the fourth quarter last year. GAAP operating earnings were $270 million and non-GAAP operating earnings were $442 million in the quarter, both of which include an estimated net negative impact of approximately $130 million due to the COVID-19 pandemic. GAAP diluted earnings per share (EPS) were $2.23, which included a pre-tax gain of $579 million related to the divestiture of a minority equity interest. Fourth quarter non-GAAP diluted EPS were $1.04.
- 08/06/2020
|
A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Jobless Claims Report
- Pre-open movers
U.S. stock futures traded slightly higher in early pre-market trade, after recording gains in the earlier session. Investors are awaiting earnings results from...
- 08/06/2020
|
July 2020 Portfolio Update - Good Q2 2020, A Few Investments
- It's time to look over last month's investments and dividends. While we've seen some small recovery and ups and downs, the market seems to remain largely unchanged, with perhaps the slightest bit of pandemic apprehension due to increasing numbers.
- 08/05/2020
|
Cardinal Health (CAH) to Post Q4 Earnings: What's in Store?
- Cardinal Health's (CAH) fiscal fourth-quarter results are likely to reflect solid performance in Medical segment.
- 08/04/2020
|
COVID-19 Impacts: N95 Respirators Market will Accelerate at a CAGR of almost 9% through 2020-2024 | High Demand During Pandemics to Boost Growth | Technavio
- The Global N95 Respirators Market will grow by USD 382.90 mn during 2020-2024
- 08/04/2020
|
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.89%
- U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.89%
- 08/03/2020
|
COVID-19 Impacts: Antiseptic and Disinfectant Products Market will Accelerate at a CAGR of about 7% through 2020-2024 | Increasing Number of Surgical Procedures Worldwide to Boost Growth | Technavio
- The Global Antiseptic and Disinfectant Products Market will grow by $ 3.48 bn during 2020-2024
- 08/01/2020
|
The jobs report and congressional politics may matter more for markets than earnings in the week ahead
- The market could lose some exuberance as the calendar turns to August, and investors await Friday's July employment report.
- 07/31/2020
|
10 Biggest Health Care Companies
- With CVS Health in the 1 spot, these are the 10 biggest health care companies by trailing 12-month revenue.
- 07/30/2020
|
Poll: Donald Trump Leads Joe Biden by Two Points in North Carolina
- Donald Trump leads presumptive Democrat nominee Joe Biden by two points in North Carolina, according to a poll.
- 07/30/2020
|
Earnings Preview: Cardinal Health (CAH) Q4 Earnings Expected to Decline
- Cardinal (CAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/30/2020
|
Cardinal Resources amends bid agreement with Shandong Gold
- Cardinal Resources has entered into a deed with Shandong Gold Mining to amend the bid implementation agreement, following its takeover bid on 18 June.
- 07/30/2020
|
U.S. judge rejects imposing attorney fee levy on opioid lawsuit settlements
- A federal judge overseeing thousands of opioid lawsuits declined on Monday to grant a demand by plaintiffs attorneys for fees that could be worth billions of dollars, a request drug company defendants had said would jeopardize settlement talks. In February, a committee of plaintiffs attorneys requested that U.S. District Judge Dan Polster in Cleveland order a 7% fee assessment against any settlement. The request could amount to $3.3 billion, based on a $48 billion settlement proposal that five companies including Johnson & Johnson have been negotiating with various state attorneys general.
- 07/27/2020
|
6 Health Care Stocks Trading With Low Price-Sales Ratios
- Walgreens Boots Alliance on the list Continue reading...
- 07/27/2020
|
Global Drug Eluting Balloons (DEBs) Market Analysis Highlights the Impact of COVID-19 2020-2024| Growing Demand for Cath Labs to Boost Market Growth | Technavio
- The Global Drug Eluting Balloons (DEBs) Market will grow by $ 476.64 mn during 2020-2024
- 07/27/2020
|
Why You Need to Buy These 8 Dividend Stocks Now
- The U.S.-China trade war is rapidly devolving into an uncontrollable mess. In this circumstance, one of your best moves is to buy stable dividend aristocrats.
- 07/24/2020
|
Coronavirus: Why your local hospital may also need stimulus checks
- One well-known hospital CEO says the government may need to send stimulus to hospitals to help them get through the COVID-19 pandemic.
- 07/23/2020
|
Miller/Howard Investments Q2 2020 Quarterly Report
- Miller/Howard Investments is an employee-owned, research-driven firm managing portfolios for a range of investors, from high-net-worth individuals to large institutions.
- 07/23/2020
|
Cardinal Health Sees Relative Strength Rating Climb To 73
- Cardinal Health shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
- 07/22/2020
|
Motorhome Retirement: June Update, Finally Off To The Black Hills
- We finally got to get out and enjoy some the wonders the United States has to offer. We visited the Black Hills National Forest and the Badlands National Park.
- 07/22/2020
|
COVID-19 Impact & Recovery Analysis - CO2 Incubator Market (2020-2024) | Growth of Global Life Science Market to Boost Growth | Technavio
- The Global CO2 Incubator Market will grow by $ 100.29 mn during 2020-2024
- 07/22/2020
|
Analysts Are Bullish on Top Services Stocks: Cardinal Health (CAH), ArcBest (ARCB) - Markets
- There’s a lot to be optimistic about in the Services sector as 3 analysts just weighed in on Cardinal Health
- 07/21/2020
|
Disposable Medical Gloves Market to reach USD 14.03 billion by 2027; Rising Importance of Personal Hygiene and Safety to Propel Growth: Fortune Business Insights™
- The global disposable medical gloves market is projected to gain impetus from the increasing awareness about health and safety, especially after the COVID-19
- 07/21/2020
|
3 Dividend Stocks That Pay You More Than Pepsi
- Many investors have turned to PepsiCo (NASDAQ: PEP) for its dividend. Further, they show paths to predictable growth that point to future dividend hikes. If you're seeking stocks such as these that are also trading at an opportune buy point, you should consider Cardinal Health (NYSE: CAH), Prudential Financial (NYSE: PRU), and Verizon Communications (NYSE: VZ).
- 07/21/2020
|
The Retirees' Dividend Portfolio: John And Jane's May Taxable Account Update
- The Taxable account generated $1,407.88 of dividends in June of 2020 compared with $936.06 of dividends in June of 2019.
- 07/20/2020
|
The Retirees' Dividend Portfolio: John And Jane's May Taxable Account Update
- The Taxable account generated $1,407.88 of dividends in June of 2020 compared with $936.06 of dividends in June of 2019.
- 07/20/2020
|
Quidel’s Sofia® SARS Antigen FIA Updates EUA Performance Data to 96.7% PPA Versus PCR; Product Supports U.S. Initiatives to Expand Access to COVID-19 Testing in Nursing Homes; Receives CE Mark for Use With Sofia® and Sofia® 2 Instruments
- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnosti
- 07/18/2020
|
COVID-19 Impact and Recovery Analysis - Medical Textiles Market 2020-2024 | Demand for Non-woven Medical Textiles to Boost Growth | Technavio
- The Global Medical Textiles Market will grow by USD 2.99 bn during 2020-2024
- 07/17/2020
|
Cardinal Health Inc (NYSE:CAH) Stock Position Cut by Wesbanco Bank Inc.
- Wesbanco Bank Inc. lessened its stake in Cardinal Health Inc (NYSE:CAH) by 3.3% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,968 shares of the company’s stock after selling 307 shares during the period. Wesbanco Bank Inc.’s holdings in Cardinal Health were worth […]
- 07/16/2020
|
These 10 Dividend Aristocrats Recently Raised Their Payouts
- The Aristocrats returned minus 35% from Jan. 1 through March 23, trailing the broader market by about five percentage points. But since then, the Aristocrats’ total return is about 42%, close to the S&P 500’s result.
- 07/16/2020
|
These 10 Dividend Aristocrats Recently Raised Their Payouts
- The Aristocrats returned minus 35% from Jan. 1 through March 23, trailing the broader market by about five percentage points. But since then, the...
- 07/16/2020
|
July 2020 Dividend Picks - Real Estate, Industrials, Communications And Pharma
- The time has come for us to look at just what sort of companies may be appealing to invest in during this month.
- 07/16/2020
|
Here's Why You Should Retain Merit Medical (MMSI) for Now
- Stocks Analysis by Zacks Investment Research covering: Medtronic PLC, Cardinal Health Inc, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated. Read Zacks Investment Research's latest article on Investing.com
- 07/15/2020
|
Veracity Capital LLC Buys New Position in Cardinal Health Inc (NYSE:CAH)
- Veracity Capital LLC purchased a new position in shares of Cardinal Health Inc (NYSE:CAH) during the second quarter, Holdings Channel.com reports. The firm purchased 7,185 shares of the company’s stock, valued at approximately $375,000. Several other institutional investors have also bought and sold shares of CAH. Manchester Financial Inc. boosted its holdings in shares of […]
- 07/14/2020
|
COVID-19 Impact & Recovery Analysis - Disposable Gloves Market in US (2020-2024) | Rapid Spread Of COVID-19 to Boost Growth | Technavio
- The Disposable Gloves Market in US will grow by $ 1.01 bn during 2020-2024
- 07/14/2020
|
The R.I.P. Portfolio's Q2 2020 Update
- This real-money portfolio was first introduced to the Seeking Alpha community in December 2015. The portfolio underperformed its benchmark in Q2 2020 and it is lagging the S&P 500's performance since late 2015.
- 07/13/2020
|
DNB Asset Management AS Reduces Stock Holdings in Cardinal Health Inc (NYSE:CAH)
- DNB Asset Management AS lowered its stake in shares of Cardinal Health Inc (NYSE:CAH) by 20.4% during the 2nd quarter, HoldingsChannel reports. The fund owned 49,784 shares of the company’s stock after selling 12,796 shares during the period. DNB Asset Management AS’s holdings in Cardinal Health were worth $2,598,000 as of its most recent filing […]
- 07/12/2020
|
State of Alaska Department of Revenue Raises Stake in Cardinal Health Inc (NYSE:CAH)
- State of Alaska Department of Revenue raised its position in Cardinal Health Inc (NYSE:CAH) by 3.1% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 51,922 shares of the company’s stock after acquiring an additional 1,553 shares during the quarter. State of Alaska […]
- 07/12/2020
|
A textbook Wall Street activism play is unfolding with underperforming software company Virtusa
- A battle heats up between a deep-research investor with a private equity mindset and an underperforming small cap software stock.
- 07/11/2020
|
Dividend Champion And Contender Highlights: Week Of July 12
- A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which changed their dividends.
- 07/11/2020
|
These Dividend Stocks Have Solid Payout Prospects — and a Built-In Exit Strategy
- After notching a roughly 18% gain in April and May, the S&P; 500 has gained only about 2% since early June. Here are Barron’s picks for S&P; 500 stocks with attractive, but not ultrahigh, dividend yields.
- 07/07/2020
|
5 Cheap Dividend Stocks To Buy For Healthy Yields and Huge Upside
- These 5 cheap dividend stocks to buy have high potential upside, reasonable price-to-earnings ratios and yields of 3% or greater.
- 07/07/2020
|
Here Are a Few Sectors and Three Dozen Stocks That Strategists Think Will Rise on a Blue Wave
- Strategists in recent days have been gaming out market implications of a Democratic sweep in November’s elections, with sectors that stand to benefit including infrastructure and green technology.
- 07/07/2020
|
Yield Screen Identifies T. Rowe as a Dividend Payer Player. Cardinal Health Is Out.
- After notching a roughly 18% gain in April and May, the S&P 500 has gained only about 2% since early June. That means few changes to the Barron’s screen...
- 07/07/2020
|
Global Medical Personal Protective Equipment Market (2020 to 2025) - Analysis by Product Type, End-user, Region & Country - ResearchAndMarkets.com
|
COVID-19 Impact & Recovery Analysis- Alcohol Wipes Market 2019-2023 | Stringent Regulations on Disinfection and Sterilization to Boost Growth | Technavio
- The Global Alcohol Wipes Market will grow by USD 327.58 mn during 2019-2023
- 07/06/2020
|
Is Cardinal Health a Great Dividend Stock? | The Motley Fool
- The company increased its payouts earlier this year.
- 07/05/2020
|
Blue Chip DRiP Portfolio: June Dividends And Covered Calls Update
- June dividend income was better than anticipated, considering the widespread dividend slashing and freezes. Even with a suspension from Ford, and a stinging cut
- 07/03/2020
|
Intravenous Stopcock Market to Surpass US$ 570.4 Million globally by end of 2027, Says CMI
- North America region is projected to be the most lucrative region in intravenous stopcock market, owing to the rising prevalence of chronic diseases.
- 07/03/2020
|
Cardinal Health to Webcast Discussion of Fourth-Quarter and Year-End Results for Fiscal Year 2020 on August 6
- Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2020 on August 6 prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.
- 07/02/2020
|
Cardinal Health (CAH) Stock Sinks As Market Gains: What You Should Know
- Cardinal Health (CAH) closed at $51.68 in the latest trading session, marking a -0.98% move from the prior day.
- 07/01/2020
|
Telix Pharmaceuticals share price jumps 16% on FDA designation
- The Telix Pharmaceuticals share price rocketed 17% today following the announcement of an FDA designation for one of Telix's renal cell cancer products.
- 07/01/2020
|
Flow Diversion Aneurysm Treatment Market 2020-2024 | Improvements in Detection of UIAs to Boost Growth | Technavio
- The Global Flow Diversion Aneurysm Treatment Market will grow by USD 1.64 bn during 2020-2024
- 07/01/2020
|
CARDINAL HEALTH, INC. : Ex-dividend day for | MarketScreener
|
Telerehabilitation Market to Reach USD 9.13 Billion by 2027; Technological Advancement in Healthcare Services to Augment Growth, says Fortune Business Insights™
- Key Companies Profiled are MIRA Rehab Limited, Jintronix., Doctor On Demand, Inc., Care Innovations, LLC., American Well, NeoRehab, Hinge Health, Inc., Koninklijke Philips N.V. and other key market players.
- 06/30/2020
|
CARDINAL HEALTH, INC. : Détachement de dividende | Zone bourse
|
State of Tennessee Treasury Department Sells 67,340 Shares of Cardinal Health Inc (NYSE:CAH)
- State of Tennessee Treasury Department reduced its holdings in shares of Cardinal Health Inc (NYSE:CAH) by 49.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 68,767 shares of the company’s stock after selling 67,340 shares during the quarter. State of Tennessee Treasury […]
- 06/29/2020
|
Cardinal Health Inc (CAH) To Go Ex-Dividend on June 30th
- Cardinal Health Inc (NYSE:CAH) declared a quarterly dividend on Monday, May 11th, Zacks reports. Investors of record on Wednesday, July 1st will be paid a dividend of 0.486 per share on Wednesday, July 15th. This represents a $1.94 dividend on an annualized basis and a yield of 3.85%. The ex-dividend date of this dividend is […]
- 06/28/2020
|
